Analysis of slmo, a gene required for normal motor function in Drosophila melanogaster by Dee, Chris T.
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap
A Thesis Submitted for the Degree of PhD at the University of Warwick
http://go.warwick.ac.uk/wrap/72136
This thesis is made available online and is protected by original copyright.
Please scroll down to view the document itself.
Please refer to the repository record for this item for information to help you to
cite it. Our policy information is available from the repository home page.
Analysis of slmo, a gene required for
normal motor function in Drosophila
melanogaster
A thesis submitted for the degree of Doctor of Philosophy
University of Warwick
By
Christopher T. Dee
Department of Biological Sciences
University of Warwick
May 2004
Table of Contents
Table of contents I
List of figures VIII
List of tables X
Acknowledgements XI
Declaration XII
Summary XIII
List of common abbreviations XIV
Chapter 1: Introduction 1
1.1 Drosophila as a model organism 2
1.2 Larval locomotor behaviour 3
1.3 Dissecting the circuitry 4
1.4 P-element mutagenesis 7
1.5 The enhancer trap 8
1.6 Applications of the GAL4 system in exploring neural circuitry 9
1.7 Identification ofP(GAL4)c682 14
1.8 Molecular cloning of slmo 15
1.9 Sterility phenotype of slmoc682 homo zygotes 17
1.10 Generation of a slmo null allele 23
1.11 Aims 24
Chapter 2: Materials and Methods 26
2.1 Fly manipulations 29
2.1.1 Fly food
2.1.1.1 Standard fly food
2.1.1.2 Apple agar medium
2.1.2 Fly stocks
2.1.3 Behavioural assay
2.2 DNA manipulations
2.2.1 Agarose gel electrophoresis
2.2.2 Molecular cloning
2.2.2.1 Restriction digestions
2.2.2.2 Dephosphorylation of DNA 32
29
29
29
29
31
31
31
32
2.2.2.3 Ligation of DNA fragments into plasmid vectors 32
2.2.2.4 LB cultures and LB agar plates 33
2.2.2.5 Preparation of competent cells for transformation 33
2.2.2.6 Transformation of competent cells 34
2.2.2.7 Production of glycerol stocks 34
2.2.2.8 Preparation of plasmid DNA 34
2.2.2.9 Colony PCR 35
2.2.3 Polymerase chain reaction (PCR) 35
2.2.3.1 Primer design 35
2.2.3.2 Basic PCR 35
2.2.3.3 Piu and Pwo PCR 36
2.2.4 Isolation of genomic DNA from Drosophila 36
2.2.5 DNA sequencing 36
2.2.6 In vitro mutagenesis 37
II
2.3 RNA manipulations 37
2.3.1 Maintenance of RNase free environment 37
2.3.2 Whole mount in situ hybridisation 37
2.3.2.1 Preparation of Digoxygenin (DIG) labelled
RNA probe 37
2.3.2.2 Acid hydrolysis of RNA probes 38
2.3.2.3 Collection of embryos 38
2.3.2.4 Fixation 39
2.3.2.5 Post-fixation 39
2.3.2.6 Pre-hybridisation 39
2.3.2.7 Hybridisation 40
2.3.2.8 Detection 40
2.3.2.9 Mounting 41
2.3.3 Extraction of total RNA from Drosophila 41
2.3.4 RT-PCR 41
2.3.4.1 First strand cONA synthesis 41
2.3.4.2 Amplification of first strand cONA 42
2.3.4.3 Semi-quantitative analysis 42
2.4 Protein manipulations 43
2.4.1 Preparation of Drosophila protein 43
2.4.2 Preparation of S. cerevisiae protein 43
2.4.3 SOS-polyacrylamide gel (SOS-PAGE) analysis 44
2.4.4 Staining ofSOS-PAGE gels 44
2.4.5 Western blotting 45
2.4.5.1 Transfer of protein to nitrocellulose membrane 45
III
2.4.5.2 Immunodetection of membrane bound antigens 45
2.4.5.3 Colour development 45
2.4.6 In vitro transcription - translation 46
2.5 Whole mount antibody staining 46
2.5.1 Dissection of Drosphila embryos and larvae 46
2.5.2 Antibody staining 47
2.6 Cell culture techniques 48
2.6.1 Maintenance 48
2.6.2 Liquid nitrogen stocks 48
2.6.3 Transfection and staining 48
2.6.4 Fluorescence microscopy 49
2.6.5 Confocal microscopy 49
2.7 Production of transgenic Drosophila 49
2.7.1 Preparation of DNA for injection 49
2.7.2 Fly transformation 50
2.7.3 Mapping of inserts 50
2.8 Yeast manipulations 50
2.8.1 Yeast media 50
2.8.2 Yeast transformation 51
2.8.3 Large scale transformation 52
2.9 Electron microscopy 53
Chapter 3: Analysis of slmo Function in the Drosophila Central
Nervous System
3.1 Introduction
54
55
IV
3.2 Results 56
3.2.1 sima mutant lethality and behavioural phenotype 56
3.2.2 Expression analysis of the P(GAL4)c682 enhancer trap 60
3.2.2.1 Expression in the embryonic CNS 61
3.2.2.2 Expression in the larval CNS 64
3.2.2.3 Expression in the adult CNS 67
3.2.2 Inactivation of marked neurons with UAS-TeTxLC 70
3.2.4 Analysis of sectioned mutant CNS 71
3.2.5 Examination of axon transport in mutant larvae 74
3.3 Discussion 79
Chapter 4: Subcellular Localisation of Simo 83
4.1 Introduction 84
4.2 Results 86
4.2.1 Production of slmo-GFP and GFP-slmo fusion constructs 86
4.2.1.1 Cloning of sima coding sequence into mammalian
expression vectors
4.2.1.2 Confirmation of fusions by in vitro
transcription/translation
4.2.1.3 Localisation of fusion proteins to the
mitochondria
4.2.2 Production of Drosophila GFP fusion transgenics
4.2.2.1 Construction of slmo-GFP and
GFP-slmo transgenes
4.2.2.2 Generation of transgenic Drosophila
87
89
92
93
97
101
v
4.2.2.3 Analysis of transgenic lines 103
1044.3 Discussion
Chapter 5: Bioinformatic Analysis of the Simo Family
5.1 Introduction
5.2 Results
5.2.1 Conservation
5.2.2 Phylogenetic analysis
5.3 Discussion
109
110
110
110
III
119
Chapter 6: Analysis of the slmo Related Drosophila Genes
prelil and real-time 123
6.1 Introduction 124
6.2 Results 124
6.2.1 Subcellular localisation ofPrel and Retm 124
6.2.1.1 Production of GFP fusion constructs 126
6.2.1.2 Expression of GFP fusions in cell culture 127
6.2.2 Endogenous expression of prel and retm 130
6.2.3 Characterisation of the P-elernent insertion lines
1(2)kI2402 and KG05639
6.3 Discussion
138
148
Chapter 7: Yeast-2-Hybrid Screen
7.1 Introduction
7.2 Results
151
152
153
VI
7.2.1 Construction of LexA-slmo bait plasmid 156
7.2.2 Testing the bait for autoactivation of reporters 157
7.2.3 Test that the bait fusion is expressed in the yeast system 159
7.2.4 Isolation of candidate interacting proteins 162
7.3 Discussion 165
Chapter 8: General Discussion 175
8.1 Introduction 176
8.2 The role of slmo in the CNS 176
8.3 The association of Slmo with the mitochondria 178
8.4 A role in mitochondrial protein sorting 180
8.5 The function of Prel and Retm 183
8.6 Implications for human disease 185
References 187
Appendix 206
VII
List of Figures
1.1: Schematic representation of the slmo gene structure
1.2: Germline and somatic stem cells of the Drosophila testis
1.3: Male sterility phenotype of slmoc682 homozygotes
16
19
21
3.1: slmo mutants exhibit defects in locomotor behaviour
3.2: Expression ofP(GAL4)c682 in stage 16 embryos
3.3: Expression of the P(GAL4)c682 in stage 17 embryos
3.4: Expression ofP(GAL4)c682 in the 1st instar larva
3.5: Expression ofP(GAL4)c682 in the 3rd instar larva
3.6: Expression ofP(GAL4)c682 in the adult brain
59
63
65
66
68
69
3.7: Synaptic excitation ofmotoneurons in TeTxLC expressing embryos 72
3.8: Analysis of sectioned Slmo'l69ml mutant CNS 75
3.9: The slmo gene product is not required for normal axonal transport 77
4.1: peR amplification of the slmo coding region 88
4.2: Production ofGFP fusion constructs 90
4.3: Expression of fusion proteins in vitro 91
4.4: Localisation ofN- and C-terminal GFP-tagged Slmo in NIH-3T3
fibroblasts
4.5: Schematic map showing the genomic fragment used to generate
GFP-slmo and slmo-GFP transgenes 95
94
4.6: Introduction of the EGFP coding sequence into the slmo gene 98
4.7: Production of GFP fusion transgenes 102
4.8: Analysis of pGFP-slmo transgenic lines 105
VIII
5.1: Multiple sequence alignment of the Slmo protein family 113
5.2: Phylogeny of the Slmo family of proteins (2000) 115
5.3: Slmo related proteins containing the CRAL- TRIO domain 117
5.4: Phylogeny of the Slmo family of proteins (2004) 118
6.1: Schematic representation of the prel and retm gene structures 125
6.2: PCR amplification of the prel and retm coding regions 128
6.3: Production of Pre I and Retm OFP fusion constructs 129
6.4: Localisation ofN- and C-terminal OFP-tagged Prel in NIH-3T3
fibroblasts
6.5: Localisation ofN- and C-terminal OFP-tagged Retm in NIH-3T3
fibroblasts 132
131
6.6: Expression of prel during embryonic development 134
6.7: Expression ofretm during embryonic development 135
6.8: Developmental expression of prel and retm 137
6.9: Position of the 1(2)k12402 and K005639 P-elements 140
6.10: Crossing scheme for 1(2)kI2402 excision screen 142
6.11: Growth of prei(2)k 12402 homozygous larvae 142
6.12: Expression of retm in the relmKG05639mutant 144
6.13: Identification ofa retm deletion allele 147
7.1: Schematic representation of the yeast-2-hybrid system assay 154
7.2: Construction of the bait plasmid 158
7.3: Test to determine whether the bait can autoactivate reporters 160
IX
7.4: Expression of the LexA-Slmo bait fusion in yeast 161
7.5: Selection of candidate Slmo interactions 164
7.6: Flowchart to summarise the interaction trap screen performed
using LexA-Slmo as the bait 166
List of Tables
2.1: Fly stocks used
2.2: Typical PCR cycle
2.3: Primers for RT-PCR
4.1: Summary of transgenic lines
5.lA: Slmo related sequences identified in 2000
5.lD: Slmo related sequences identified in 2004
6.1: List ofKG05639 excision strains
7.1: Candidates identified from the yeast-2-hybrid screen
30
35
42
103
112
112
145
167
x
Acknowledgments
Many thanks go to all of the following people. Kevin Moffat for his always
selfless and attentive supervision, and for his practical contribution to the yeast-2-
hybrid screen. Richard Baines, who perfonned all electrophysiology, provided
essential help with dissections, and who's thoughtful advice on this project was
always greatly appreciated. Che-Hsiung Liu (my mentor for two years), Chris Mee,
Ed Pym, Wendy Moore, Pete Hawkins and Nara Muraro for help, advice and
entertainment value. Finally, thanks to my Mum and Dad, and especially Crystal for
often necessary support and encouragement.
Some of the data in this thesis has been published in:
Carban, A., Reeve, S., Dee, C.T., Baines, R.A. and Moffat, K.G. (2003) Mutation
in slowmo causes defects in Drosophila larval locomotor behaviour. Invert Neurosci.
[Epub ahead of print]
XI
Declaration
I hereby declare that all of the work reported in this thesis is my own unless
stated otherwise in the text or figure legend. None of this work has been previously
submitted for any other degree or at any other institution. All sources of information
used in the preparation of this thesis are indicated by reference.
C.T. Dee
XII
Summary
The stereotyped motor behaviour of the Drosophila larva provides a useful
model for the development and function of neural circuitry. However, the cellular
and molecular basis of this behaviour is poorly understood. Reported in this thesis is
an analysis of slowmo (slmo), a gene previously shown to be expressed in the
developing embryonic central nervous system of Drosophila. Null mutants of slmo
are able to hatch, but the resulting larvae exhibit a progressive phenotype of
defective locomotor activity. An enhancer trap, P(GAL4)c682, which is inserted in
the slmo locus, reports expression in a subset of neurons within the embryonic, larval
and adult central nervous systems. Inactivation of marked neurons with tetanus toxin
light chain leads to severely impaired motor function, but not total paralysis.
Affected embryos are capable of some sporadic movements, but are unable to hatch
and normal peristaltic contraction waves are largely absent. The slmo gene is shown
to encode a member of a novel family of conserved proteins of unknown function.
GFP fusions of Slmo are shown to localise to the mitochondria in a cultured cell line.
Two novel slmo related genes, termed pre/i/ (pre!) and real-time (retm), are
identified in Drosophila. The prel gene is expressed ubiquitously during embryonic
development, and disruption of the gene by a P-insertion results in lethality during
larval development. retm encodes a member of a novel subclass of larger Slmo
related proteins which contain the conserved CRAL- TRIO domain thought to be
involved in the transport of small hydrophobic ligands. GFP fusions of both Prel and
Retm are also associated with the mitochondria in cell culture, suggesting this might
be true all proteins of this family. Using a yeast-2-hybrid approach, the identification
of candidate Slmo interacting proteins is described, providing a basis for future work
on the function of Slmo.
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Chapter 1: Introduction
1.1 Drosophila as a model organism
The nervous system represents the most complex organ system of animals,
and is composed of a vast range of neurons and glia, which interact in a precise and
intricate manner. The neurons extend axons, which must form the appropriate
synaptic connections in a highly complex neural network. This network provides the
basis for critical functions such as the control of behaviour, learning and memory.
The Drosophila melanogaster nervous system has long been established as an
excellent model system in which to study the development and function of the
nervous system. Its relative simplicity, combined with an amenability to powerful
genetic, molecular, anatomical and electrophysiological techniques make it possible
to dissect the emergence and function of nervous system structure, as well as the
roles of the individual circuits, cells, and molecules within it.
Much research has focussed on the adult fly, where the isolation and
characterisation of mutations which modify behaviour has provided insights into the
molecular and cellular basis for a variety of adult behaviours such as circadian
rhythms (Hall, 1998), olfaction (Carlson, 1996), courtship (Hall, 1994; Yamamoto et
al., 1997), hearing (Eberl, 1999), learning (Carew, 1996; Davis, 1996; Dubnau and
Tully, 1998), vision (Zuker, 1992; Zuker, 1996) and locomotion (Strauss and
Heisenberg, 1993). In addition, it has been possible to link certain behavioural tasks
to particular structures of the brain. For example, it has been shown that the
mushroom bodies are critical for complex behaviours such as olfactory learning and
memory (Heisenberg, 2003; Roman and Davis, 2001), control of spontaneous
walking activity (Martin et al., 1998), and the mediation of context generalisation in
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visual learning (Liu et al., 1999; Waddell and Quinn, 2001). Similarly, the central
complex has been shown to be involved in the higher control and modulation of
locomotor behaviour (Martin et al., 1999; Strauss, 2002), and it is now well
established that the ''jump response" escape behaviour is mediated by the giant fibre
system (Allen et al., 1998; Allen et al., 2000).
The developing Drosophila embryo on the other hand, has proven invaluable
as a model for the establishment of neuronal circuits, in this case, of the larval
nervous system. During embryogenesis, the machinery underlying larval behaviour is
assembled, and circuits are generated and begin to function. In particular, there has
been rapid progress in unravelling the mechanisms involved in early development of
the nervous system, such as neurogenesis, axon growth and guidance, target
recognition and the formation of synaptic terminals (Bhat, 1998; Goodman, 1993;
Prokop, 1999; Tessier-Lavigne and Goodman, 1996). More recently, some progress
has been made on the later stages of nervous system development when the basic
connectivity is established, and the component neurons develop their electrical
properties while maturing as part of a functional circuit (Baines, 2003; Baines et al.,
1999; Baines et al., 2002; Baines et al., 2001).
1.2 Larval locomotor behaviour
Drosophila larvae crawl by performing rhythmic, longitudinal waves of
cyclic muscle contraction and extensions of the body known as telescopic peristalsis
(Berrigan, 1995). When larvae move spontaneously across a plain non-nutritive
substrate, periods of linear locomotion are interrupted by phases of head swinging
and digging, followed by a change in direction. Larval locomotion therefore
represents a simple, stereotyped behaviour comprised of episodes of co-ordinated
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motor output and decision making (Wang et al., 1997). However, the basic
machinery which drives the peristalsis performed by larvae is primarily established
during the later stages of embryonic development, and underlies the vigorous
movements of the embryo prior to and during the hatching process (13-16 hours after
laying; hatching occurs at approximately 21 hours) (Kaliss, 1939; Suster and Bate,
2002). Repeated waves of forward and backward peristalsis begin to occur within the
vitelline membrane, and are supplemented by swinging and wriggling movements of
the head. Once the egg shell is punctured, repeated forward peristaltic movements
drive the new larva out of its vitelline and chorionic membranes (Siekhaus and
Fuller, 1999).
An important achievement in neurobiology would be to elucidate both the
development, and regulation, of the functional properties of defined neuronal circuits
that underlie particular behaviours. The relatively simple, coordinated motor output
that drives larval locomotion provides a compelling model, in which a range of
powerful techniques can be employed (see below). In particular, it may be possible to
identify exactly which cells are involved in driving this behaviour, which molecules
are required to regulate the functional development of these cells, and which genes
are involved in modulating the output of such a circuit in order to meet the
requirements of a specific behaviour.
1.3 Dissecting the circuitry
In the last few years, some studies have begun to examine the nature of the
circuitry that drives larval locomotion in Drosophila. In general, rhythmic motor
activities are based on the output of specialised neural networks called central pattern
generators (CPOs) (Marder and Bucher, 2001). In most systems, these represent
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circuits of pre-motor interneurons that are capable of generating patterned, rhythmic
discharges in motor neurons. The defining quality of a CPG is that it is capable of
producing this rhythmic activity independently (in the absence of extrinsic timing
information), and indeed, many isolated central networks will generate fictive motor
patterns as in vitro preparations (Marder and Bucher, 2001). It is this property that
allows these circuits to form the basis of a wide range of repetitive behaviours, such
as feeding in crustaceans (Nusbaum and Beenhakker, 2002) and molluscs (ling and
Weiss, 2002), swimming in Xenopus (Sun and Dale, 1998) and zebrafish (Drapeau et
al., 2002; Saint-Amant and Drapeau, 2001), and respiration in both mammals
(Bellingham, 1998) and crabs (Dicaprio, 1997; Dicaprio et al., 1997). In insects,
CPGs located in the ventral nerve cord ganglia, have been shown to drive walking
behaviour of adult locusts (Ryckebusch and Laurent, 1994), larval feeding in
Drosophila (Gorczyca et al., 1991) and larval locomotion in the hawkmoth (Johnston
et al., 1999; Johnston and Levine, 1996). Electrophysiological evidence supports the
notion that this is also true for the rhythmic peristalsis in Drosophila larvae (Baines
et al., 1999; Baines et al., 2002; Baines et al., 2001; Cattaert and Birman, 2001).
Despite this, the development ofCPGs is still poorly understood (Fenelon et al.,
1998; Marder and Bucher, 2001).
Although a CPG is capable of generating the basic rhythmic output that
drives such behaviours in isolation, in reality movement depends on interactions of
the CPG with sensory feedback and descending commands from the brain
(Dickenson, 2000; Marder and Bucher, 2001). These act to activate, block and
modulate the output of these circuits according to the requirements of the particular
behaviour. In addition, multiple CPGs must interact with each other in order to
coordinate muscle innervation in the appropriate pattern. In this case, the muscles of
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different segments must contract in the correct temporal-spatial pattern for telescopic
peristalsis. Furthermore, any CPG must interact, directly or indirectly, with the
appropriate motoneurons. The importance of these extra layers of complexity was
elegantly illustrated by the elimination of all sensory input from a developing
Drosophila embryo (Suster and Bate, 2002). Under these circumstances, the CPG
driving locomotory peristalsis is still able to develop and produce coordinated
rhythmic output. Despite this, the resultant larvae exhibited severely abnormal
locomotor activity. These larvae are able to produce coordinated peristaltic
contraction waves, but sensory feedback is required to ensure the predominant
direction of peristaltic waves is from posterior to anterior, and therefore, to integrate
the rhythmic output into an actual pattern of locomotion. It has also been shown that
the motoneurons that excite locomotory muscles require synaptic excitation in order
to acquire their normal electrical properties (Baines et al., 2001), the implication
being that the precise functional development of individual components of the circuit
is not autonomous, but dependent on the integrated circuit as a whole. The overall
circuitry that governs larval locomotion therefore carries a considerable amount of
subtlety, but still represents a more easily interpretable system than that of a higher
cognitive behaviour such as learning.
The isolation of mutants has proven widely informative in establishing the
biochemical basis of behaviour and neural development in Drosophila (1.1). Mutant
screens in the vertebrate system of zebrafish have also demonstrated the potential of
a forward genetic approach to understanding the nature of locomotor circuits (Bate,
1999; Drapeau et al., 2002; Granato et al., 1996). Additional advantages of
Drosophila are the availability of neuronal markers, in the form of enhancer traps
(O'Kane and Gehring, 1987), and the ability to spatially target the expression of
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transgenes using the GAL4-UAS system (Brand and Perrimon, 1993). In this thesis, I
have applied these approaches in an attempt to identify cells and molecules involved
in regulating the development, maturation and function of the larval locomotor
circuit.
1.4 P-element mutagenesis
Many of the classical genetic screens in Drosophila involved the use of
chemical mutagenesis, using ethyl methane sulphonate (EMS) or ethyl nitro so urea
(Nusslein- Volhard and Wieschaus, 1980; Wieschaus et al., 1984). This method is
highly efficient at inducing mutations, but the changes made to the DNA are subtle,
often of a single nucleotide. Mutations identified by phenotype are therefore difficult
to isolate and clone. Transposable elements also provide a potent means of disrupting
gene function (Kidwell, 1986). The ability of these mobile fragments to excise from
and reinsert into the genome creates the possibility that a genetic lesion will be
created at the insertion site. This approach greatly facilitates cloning as the identified
transposon leaves a molecular tag in or near the interrupted gene (Cooley et al.,
1988). Over the last couple of decades, extensive research has focussed on the P-
family of transposable elements, which have been developed to form the basis of a
range of powerful genetic manipulations.
P-elements are naturally occurring transposons that move via a non-
replicative mechanism without the need for an RNA intermediate. A full length P-
element contains 31bp terminal inverted repeats and 11bp subterminal inverted
repeats, which are critical for efficient transposition (O'Hare and Rubin, 1983).
Transposition also requires the action of a transposase, which can be encoded from
within the P-element, or from an extrinsic source (another P-element) (Engels, 1984;
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Kidwell, 1986). Importantly, P-elements exhibit a high degree of mobility, and are
able to retain this mobility despite drastic modifications to their internal sequences.
Experimentally modified P-elements can therefore be used to manufacture stable
transgenic strains (Fujioka et al., 2000). In addition, movement of the P-element can
be controlled by limiting the availability of the transposase (Engels, 1984; Kidwell,
1986). As result, it has been possible to mobilise engineered P-elements in large
genetic screens, and isolate vast numbers of stable mutant lines. In particular, this
technique has been successfully applied by the Berkley Drosophila genome project
(BDGP) as part of the gene disruption project (Spradling et al., 1999)
(http://www.fruitfly.org/p _disrupt/index.html), which has now isolated
corresponding mutants of more than 25% of essential genes. In addition, a large
database of P-element insertion lines has also been generated commercially
(http://genexel.comlenglhtmlgenisys.htm ).
1.5The enhancer trap
The enhancer trap technique initially developed by O'Kane and Gehring
(1987), offers an alternative approach to the traditional P-element mutagenesis
screen, and has been employed to identify and clone many neurally important genes.
This method is based on engineered P-elements which contain a reporter gene under
the control of a weak constitutive promoter. Significant levels of reporter gene
expression require that the P-element become inserted into the Drosophila genome
close to an endogenous enhancer of gene expression (Bellen et al., 1989). The
pattern of reporter expression should therefore reflect part or all of that of the
endogenous gene associated with the regulatory element. In this way it is possible to
generate large numbers of enhancer trap insertion lines and screen for genes by
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expression pattern, without requiring the selection of a phenotype (Wilson et al.,
1989). A researcher interested in the larval locomotor circuit might therefore look for
enhancer traps expressed in the embryonic and larval ventral nerve cord. In addition,
the insertion site may have disrupted either the coding sequence of the corresponding
gene, or an important regulatory sequence (see section 1.4). Where this is not the
case, it is often possible to generate deletions of the gene via imprecise excision of
the P-element, or selection of male recombination events (Kidwell, 1986; Preston et
al.,1996).
Many enhancer traps employ the E.coli lacZ gene as an easily assayable
reporter. However, the system is far more versatile when the reporter used is GAL4,
a yeast transcriptional activator which is functional in Drosophila (Brand and
Perrimon, 1993). GAL4 will drive the expression of any gene engineered under the
control of the "upstream activating sequence" (UAS). Rather than visualising GAL4
directly, it can be used to drive a variety of secondary reporters with different
advantageous properties, such as UAS-lacZ or UAS-Green Fluorescent Protein
(GFP). With the pattern of expression established, this system can be used to drive a
range ofUAS transgenes, allowing in vivo manipulation of the GAL4 expressing
cells. It is this property that has made the GAL4-UAS system a particularly useful
tool.
1.6 Applications of the GAL4 system in exploring neural circuitry
The spatial control of trans gene expression provided by the GAL4-UAS
system has proven one of the most productive experimental techniques applied to the
Drosophila system (Brand and Perrimon, 1993). The versatility of this genetic tool
provides an elegant method for elucidating the nature of poorly defined neural
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circuits. Initially, this system facilitates the anatomical characterisation of specific
neuronal circuitry by targeted expression of a variety of different reporter genes. In
addition, it is possible to control the expression of toxic gene products, which will
disrupt the normal function of defined groups of cells in an otherwise normally
functioning fly. Indeed, relatively inaccessible cells can be disabled in vivo as long as
there is an appropriately expressing GAL4 line. In this way, it is possible to examine
the role of particular cells and cell-cell interactions, an important step in
understanding the cellular basis of behaviour.
The GAL4 system provides a means with which to label and visualise neural
pathways, whilst avoiding the technical limitations associated with direct dye-filling
of small Drosophila neurons with tracers such as Oil or Lucifer yellow (Bossing and
Technau, 1994; Sink and Whitington, 1991). Various UAS-tau trans genes have been
used to visualise the axons of specific neurons (Ito et al., 1997). By simply crossing
certain GAL4 lines with transgenic lines bearing VAS-tau, the microtubule based
Tau protein can be introduced into particular neurons where it is actively distributed
into all cellular processes. Tau protein can then be detected directly with an antibody
(Ito et al., 1997), but has also been expressed as fusions with GFP and lacZ (Hidalgo
et al., 1995; Murray et al., 1998). More recently VAS-mC08GFP has been widely
used for the same purpose, in this case allowing the targeted expression of a fusion
protein which anchors brightly fluorescent GFP to the cell membrane (Lee and Luo,
1999). The plant lectin wheat germ agglutinin (WGA), a protein that has been shown
to transfer across synapses, has also been expressed in Drosophila neurons under
VAS control as a method for identifying the pre-synaptic targets of GAL4 expressing
neurons (Tabuchi et al., 2000).
10
In some cases the GAL4 system has been used to express toxins such as the A
chains of ricin (RTA) (Allen et 01.,2002; Hidalgo et al., 1995) and diptheria (DTA)
(Lin et al., 1995), as an effective method with which to selectively ablate particular
populations of cells and examine the developmental consequences. Alternatively, the
gene products of genes such as ced3, ice, head involution defective (hid) and reaper
(rpr) can be used to elicit cell death in Drosophila by driving them into apoptosis
(Shigenaga et al., 1997; Zhou et al., 1997). This approach has proved useful in
describing a number of developmental phenomena. For example, specific ablation of
embryonic glia by targeted expression ofa VAS-RTA transgene demonstrated the
crucial role of these cells in the establishment and maintenance of axon tracts
(Hidalgo et al., 1995). Likewise, cell ablation by expression of both VAS-RTA and
VAS-DT A has been used to examine the role of pioneer neurons in the developing
embryonic CNS (Hidalgo and Brand, 1997). This technique has also been used to
ablate brain structures thought to be mediating particular behaviours (McNabb et al.,
1997; Renn et al., 1999). However, for behavioural studies, the usefulness of targeted
cell ablation is often limited given that the death of a cell can affect the fate,
development or function of surrounding neurons (Lin et al., 1995).
The tetanus toxin light chain (TeTxLC) gene (Sweeney et al., 1995) and a
semi-dominant, temperature sensitive allele of the Drosophila shibire gene (shitsl)
(Kitamoto, 2001) have both been brought under control of the GAL4 system as a
means of silencing neuronal function, whilst avoiding the problems associated with
cell ablation. Tetanus toxin belongs to the family of clostridial neurotoxins and in
nature consists of two polypeptide chains. The heavy chain mediates the
translocation of the light chain to the neuronal cytosol, where the light chain acts
catalytically to inhibit synaptic transmission from the cell (Schiavo et al., 2000).
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Delivery of the isolated TeTxLC into neuronal cells (e.g. using the GAL4 system) is
sufficient by itself to inhibit all exocytotic neurotransmitter release. The toxin
operates by proteolytic cleavage of a small membrane protein called neuronal
Synaptobrevin (n-Syb) (also known as the vesicle associated membrane protein or
VAMP), an essential component of the machinery regulating exocytosis of synaptic
vesicles (Sweeney et al., 1995). TeTxLC will therefore silence the synaptic output of
any neuron in which it is expressed, but its mode of action is also specific to neuronal
cells. This property increases the number of GAL4 lines available to the
experimenter, as any extraneous expression of the toxin in non-neuronal tissues, such
as glia or muscle, can effectively be ignored.
Unsurprisingly, embryos that express TeTxLC throughout the nervous system
are paralysed, and do not show the coordinated peristaltic contractions characteristic
of the later stages of embryogenesis (Sweeney et al., 1995). Importantly however,
the embryonic nervous system assembles normally in the absence of evoked synaptic
release. There are no apparent changes to the morphology of the nervous system, and
synapses are able to form on muscles as normal. UAS-TeTxLC is therefore regarded
as a method for selectively inactivating groups of neurons in an otherwise
developmentally and functionally normal nervous system. In reality of course,
inhibition of synaptic transmission from a neuron can have more subtle
developmental consequences, as it will inevitably disrupt the activity dependant
phase of development by which neurons develop their functional characteristics. In
this way, the tetanus toxin offers a method by which to learn about this important
aspect of neuronal development. For example, Baines et al. (1999) were able to
demonstrate that targeted expression of TeTxLC in particular embryonic
motoneurons not only caused the failure of synaptic transmission between these
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neurons and their target muscles, but that these motoneurons themselves receive
substantially less synaptic input. The implication of this result is that a mechanism of
retrograde signalling is required from the postsynaptic neuron to modulate the
functional properties of its presynaptic partner, and more broadly reinforces the
notion that neuronal circuits require functional interplay between individual cells to
refine their active properties.
TeTxLC has been employed widely in conjunction with the GAL4 system to
analyse a broad range of behaviours in both adults and larvae, including studies of
locomotor activity. In the adult brain, targeted expression of TeTxLC in groups of
neurons within the mushroom bodies and the central complex has demonstrated the
involvement of these structures in regulating locomotor activity. In the case of the
mushroom bodies, disruption with the neurotoxin results in increased locomotor
activity (Martin et al., 1998), whilst inactivation of particular groups of cells within
the central complex was found to causes more subtle defects in the maintenance and
temporal patterning of locomotor activity (Martin et al., 2002; Martin et al., 1999).
In the larval system, Suster et al. (2002) used UAS-TeTxLC to screen for GAL4
lines that express in groups of neurons important for the regulation of locomotion.
This toxigenetic method has made it possible to inhibit the activity of very
discreet groups of neurons and examine their role in behaviour. However, the
potential of this approach to drive toxin expression in particular cells and brain
structures is limited by the available GAL4 lines. This problem is exacerbated by the
fact that most GAL4 enhancer trap lines are expressed at various stages of
development and that the toxic nature ofTeTxLC will impair development at an
early stage. UAS_shits1 was envisaged as a means by which to circumvent some of
these problems, by inhibiting neuronal activity in a conditional manor (Kitamoto,
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2001). The Drosophila shi gene encodes the protein dynamin, a vital component of
the machinery required for synaptic vesicle recycling. The semi-dominant allele shls1
is defective in this process at restrictive temperatures (>29°C), and when over
expressed, will cause rapid and reversible inhibition of synaptic transmission even in
the presence of a wild type allele. The researcher therefore has temporal control over
the effector gene, permitting the use of GAL4 lines in later stages of development
that might have resulted in earlier lethality when expressing TeTxLC. More recently,
attention has been devoted to the development of an inducible GAL4 system, in
which it is the transcriptional activator itself that is conditionally active thereby
allowing temporal control over the expression of any UAS transgene. The Gene-
Switch GAL4 system combines the S. cerevisae GAL4 domain with the human
progesterone receptor ligand binding domain, and the human p65 transcriptional
activation domain (Roman et al., 2001). RU486, an anti progestin, will bind to the
progesterone receptor ligand binding domain and activate the Gene-Switch molecule.
The Gene-Switch GAL4 system can therefore be used to generate numerous lines
under the control of various enhancer sequences (Roman and Davis, 2002), but
restricting the availability of RU486 through specific feeding regimes can be used to
control the activity of the GAL4.
1.7 Identification of P(GAL4)c682
P(GAL4 )c682, was originally isolated as part of a screen for enhancer trap
lines expressed in the adult nervous system (D. Shepherd, University of
Southampton). In particular, expression had been described in the cell bodies and
axons of the giant fibre system, as with other lines studied in the Moffat lab at the
time (Allen et al., 1998). Using UAS-lacZ as the reporter, Carhan (1999) was able to
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confirm this, and also described expression in other cell bodies of the adult brain and
ventral nerve cord. In addition, reporter expression was shown to be restricted to cell
bodies in the developing ventral nerve cord of stage 16 embryos. This type of neural
expression pattern strongly suggests that the enhancer trap marks a gene which
functions in the nervous system. Indeed, following the cloning of the corresponding
gene (section 1.8), in situ hybridisation using a Digoxygenin labelled DNA probe
also showed embryonic expression of the endogenous transcript to be CNS specific.
However, it was also noted that males homozygous for the insert were sterile, and it
is this phenotype that has formed the basis of previous research by Carhan (1999)
and Reeve (2002).
1.8 Molecular Cloning of slmo
The gene marked by the P(GAL4)e682 enhancer trap was originally named
kisir (Turkish for sterile), but is now referred to as slowmo (slmo) on account of the
striking sluggish behaviour exhibited by slmo null mutants (see chapter 3). The
P(GAL4)c682 insertion was originally mapped to the 26B region of the left ann of
the Drosophila second chromosome, and genomic DNA flanking the P-element was
cloned by plasmid rescue (Bellen et al., 1989; Carhan, 1999; Wilson et al., 1989). It
was then possible to isolate the corresponding eDNA by using the rescued sequence
to screen existing cDNA (Stratagene) and eosmid libraries (Hoheisel et al., 1991).
Examination of the sequence revealed a gene with a simple two-ex on structure, and
an open reading frame contained entirely within the second exon (Figure 1.1). The
EST database also indicates the existence of an additional transcript transcribed from
an alternative promoter. The coding sequence is predicted to encode a 215 amino
acid protein of 25kDa molecular weight, although later analysis by western blot has
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Figure 1.1: Schematic representation of the slmo gene structure. The slmo gene is expressed
as two alternative transcripts which differ at the 5' ends. Both transcripts are mapped relative to
each other as though transcribed from the same strand. All numbers refer to the 6kb genomic
DNA fragment cloned by Carhan (1999) (Appendix 1). The 2A7 transcript (green blocks) was
originally isolated from a cDNA library (Carhan, 1999), and was found to have a two exon
structure. The enhancer trap P(GAL4)c682 is inserted within the single intron. The second
transcript 2021 (grey blocks) was identified from the EST database (Reeve, 2002). The ORF
(black blocks) is identical in both transcripts and is predicted to encode a 215 amino acid protein
of unknown function. The A69m1 deletion, was generated by imprecise excision of the p,
element, and represents a slmo null allele.
shown the protein to migrate on a polyacrylamide gel as a 30kDa molecule,
presumably due to post-translational modification (Reeve, 2002). Sequencing out of
the P-element revealed that the P(GAL4)c682 insertion site is within the single slmo
intron, and further analysis of this allele (referred to as SlmoC682) by northern blot
(Carhan, 1999) and western blot (Reeve, 2002) has shown that this does not represent
a null allele, although expression is substantially down regulated.
Analysis of the predicted Slmo protein sequence does not reveal any
characterised domains or a recognised localisation signal that might offer clues as to
function. Importantly however, the predicted Slmo protein was found to be highly
conserved, and Carhan (1999) reported homologues from human, mouse, chicken, C.
elegans, S. cerevisiae and S. pornbe. Despite this, no function has been assigned to
any member of this protein family. The closest human homologue, CGI-I07 (Lai et
al., 2000), exhibits 55% identity and 70% similarity to Slmo at the protein level, and
has been identified by the BodyMap project as being expressed in the adult brain
(Sese et al., 2001). The chicken protein, px19 (Niu et al., 1996), and the human
protein PREll (Guzman-Rojas et al., 2000) are more distantly related, and are
expressed in a variety of tissues including brain, lung, liver, kidney and B-
lymphocytes. No other mutant phenotypes have been reported, although it is known
that knockouts of homologous genes in S. cerevisiae (T. Endo pers. comm., Nagoya
University) and C. elegans (http://www.wormbase.org, release WS115, date
15/01/04) are not lethal.
1.9 Sterility phenotype of Slmoc:682 homozygotes
The Drosophila germline, both in the male (Gonczy et al., 1997) and the
female (King and Lin, 1999), are primarily of interest as models for studying stem
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cell function. Stem cells have the unique ability to divide asymmetrically,
regenerating the parental stem cell, whilst also producing daughter cells able to
proliferate and differentiate into specific cell types. In this way, different stem cell
populations form the basis of an organism, initially producing the cells of the
developing embryo, then later generating and maintaining tissues and organs such as
blood (Dzierzak et al., 1998), skin (Toma et al., 2001), nervous system (Doetsch et
al., 1999), and the germline (Lin, 2002). The Drosophila gonad provides a relatively
simple, well-characterised organ in which both the actively dividing stem cells, and
the surrounding support cells, are clearly defined. In addition, these cells can be
studied and manipulated with the powerful molecular and genetic approaches
available in Drosophila (Fuller, 1993; Lin, 2002).
Stem cell function is regulated and maintained in a contained micro-
environment referred to as a niche. Here essential support cells are thought to send
molecular signals to the stem cells, which act to repress differentiation of the parental
stem cell and control proliferation and specification of the daughter cells (Spradling
et al., 2001). In males the niche is composed ofa group of somatic hub cells at the
apex of the tubular shaped testes (Figure 1.2). These remain in constant contact with
both the germline stem cells (GSCs) and the pairs of somatic stem cells (SSCs) that
flank each GSC (Lin, 2002). In this way the hub cells can communicate with the
stem cell population via multiple signalling pathways, and maintain the integrity of
the stem cell system. As the GSCs divide, the daughter progeny or gonialblasts are
displaced away from the hub, and undergo four synchronous divisions with
incomplete cytokinesis. The result is the generation of a cyst of 16 interconnected
spermatogonia that remain enclosed by two somatic cyst cells (derived from the
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Figure 1.2: Germline and somatic stem cells of the Drosophila testis.
A. The Drosophila testis is a coiled tubular structure. Scale bar is equal
to 100J..lm.B. Schematic diagram representing the apical tip of the testis.
Only 2 out of 5-9 germline stem cells (GSCs) are represented with their
accompanying pairs of somatic stem cells (SSCs). Both GSCs and SSCs
remain in constant contact with somatic hub cells at the apex where
they divide to generate a gonialblast (GB) surrounded by two cyst cells.
The GB undergoes four synchronous divisions with incomplete
cytokinesis resulting in 16 interconnected spermatogonia enclosed by
the two somatic cyst cells. Figure adapted from Lin (2002) and Carhan
(1999).
SSCs). These must then undergo several further phases of division and
differentiation to develop into mature sperm (Fuller, 1993).
Carhan (1999) showed that in males homozygous for the slmoc682 allele, this
tightly controlled process is completely disrupted at an early stage. Dissection from
4-10 day old mutant males revealed severely shrivelled testes, while other genital
structures such as the paragonial glands and ejaculatory duct appeared to have
developed normally (Figure 1.3A). Importantly, no mature sperm are present in the
seminal vesicalis. Staining of the testes contents with anti-Vasa, a well characterised
marker of the germline, demonstrated that the testes are completely devoid of any
germinal content (Figure 1.3C). Closer inspection of newly eclosed testes showed
that the hub cells are initially present, and some cells apparently go through the early
divisions of the germline. However, by 24hours post-ec1osion, no cells can be
identified and vacuolations appear, which become rapidly more pronounced over the
next few days (Figure 1.3E, F) and may be the result of apoptosis (although this has
never been formally tested). Indeed, degeneration of the germline is already apparent
in the testes of 3rd instar larvae (Reeve, 2002).
Mutations in many genes can disrupt gametogenesis, largely because the
germline is particularly sensitive to defects in general or metabolic functions.
However, very few cause clear arrests in the early proliferation phase of
spermatogenesis (Castrillon et al., 1993; Fuller, 1993). It has been argued that slmo
may be in some way involved in the cell-cell signalling events that constitute the
stem cell niche (Carhan, 1999; Reeve, 2001). Certainly, it is true that expression
reported by promoter constructs driving lacZ (Reeve, 2002), appears to be absent
from the early germline. This line of thought is also supported by parallel work in the
female germline. Carhan (1999) had classified female slmoc682 homozygotes as
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Figure 1.3: Male sterility phenotype of slmoc682 homozygotes. A. Testes
dissected from slmoc682 homozygous males show abnormal morphology.
Testes (t) appear shrivelled when compared to the coiled tubular shaped
testes of the control wild type fly (B). Other genital structures such as the
paragonial glands (pg), seminal vesicalis (sv) and the ejaculatory duct (ed)
appear to have developed normally. C. Staining with the germline marker
anti-Vasa demonstrates a lack of germinal content in the slmoc682 mutant as
compared to the strong staining observed in wild type testes (D). E.Newly
eclosed mutant testes contain some cellular architecture, and cell bodies can
be seen (black arrow). F. In aged testes no cells can be identified, and
severe vacuo lations (black arrows) have developed by 5 days post-eclosion.
Scale bar is A,B: lOOf..Lm,C-F: lOum. Images taken from Carhan (1999).
having a severe reduction in fecundity, although not completely sterile. Since then
Reeve (2002) has described a similar phenotype in the ovaries to that seen in the
testes, with the majority of the female germline failing to divide beyond an early
stage. Using the FLP-FRT system of site directed recombination (Xu and Rubin,
1993), it was possible to remove slmo function from specifically within the germline
(Theodosiou and Xu, 1998). However, the somatic terminal filament and cap cells
that form the stem cell niche in females (Lin, 2002), still expressed the wild type
slmo gene. The germline was able to develop normally in these genetically
manipulated ovaries, proving that the germline lesion in slmoc682 mutant females
results from abnormal function of the somatic cells.
However, it is important to keep in mind that similar sterility phenotypes can
be caused by mutation of genes not involved in signalling. Alleles of chickadee (chi)
and diaphanous (dia) result in similar male sterility phenotypes to that seen in
slmoc682 homozygotes, and both were isolated in screens for male sterile mutants
(Castrillion et al., 1993; Fuller, 1993). chi encodes a Drosophila profilin protein and
is known to play an important role in the assembly of cytoskeletal actin filaments
(Castrillion et al., 1993; Verheyen and Cooley, 1994), although homologues have
been implicated in signal transduction (Lassing and Lindberg, 1985; Goldschmidt-
Clermont et al., 1990). dia encodes a member of the Formin Homology family, and
is critical for actin mediated cytokinesis (Castrillion and Wasserman, 1994; Afshar et
al., 2000). In both these cases the germline dies at an early stage, although the
somatic cell lineages survive. The use of enhancer trap markers of hub and cyst cell
lineages showed that somatic cells are also still present in slmoc682 mutant testes
(Carhan, 1999). Null alleles of both chi and dia result in lethality, as is the case for
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slmo (see 1.10), whilst the male sterile alleles also disrupt development of the female
germline.
1.10 Generation of a slmo null allele
The presence of a P-element in the slmo intron disrupts, but does not
eliminate transcription of the gene. Carhan (1999) performed an excision screen,
primarily in an attempt to generate precise excisions of the enhancer trap that
returned to fertility, therefore proving the insertion to be the cause of the sterility
phenotype. A total of 108 excision events were generated, as determined by
reversion to a white eye phenotype (indicating removal of the mini-white gene,
located as a marker within the P-element). As expected, the majority (85) were
restored to fertility, whilst 17 excision lines remained sterile. More importantly, six
homozygous lethal lines were also isolated. One of these, designated ~69m 1, was
later proven by Southern blot analysis (Reeve, 2002) to represent an imprecise
excision event, in which a 5' portion of the slmo coding sequence (including the
ATG start codon) has been deleted (Figure 1.1). This null allele is referred to as
slmo' ..69ml.
Carhan (1999) reported that embryos homozygous for slmot169ml hatch into
first instar larvae, but that the mutant larvae are immobile and never reach the second
instar stage. Subsequently, Reeve (2002) suggested that newly hatched mutant larvae
are mobile, but progress towards paralysis in the following hours. A variety of
defects have the potential to cause an immobility phenotype, for example, defective
muscle development (Bate, 1993). Alternatively, lack of movement could be a
secondary effect of a more global problem. However, given that embryonic
expression of slmo (as reported by the enhancer trap and in situ hybridisation) is
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specific to the nervous system, it is reasonable to propose that the defect in slmo''!.69ml
mutants is specific to the nervous system. Staining of embryos with various markers
of CNS morphology does not reveal any gross defects in nervous system
development (Carhan, 1999). Likewise, examination of the peripheral nervous
system (PNS) suggests that motoneuron axons have developed correctly and formed
the appropriate synapses (Reeve, 2002).
1.11 Aims
1) Use of P(GAL4)c682 as a tool for examining neuronal circuitry
This enhancer trap had been shown to be expressed specifically, but not
ubiquitously within the CNS. I chose to examine expression of the GAL4 line in
detail, and explore possible use of the enhancer trap in identifying cells involved in
neuronal circuitry.
2) To determine the potential role of slmo in the Drosophila nervous system
Previous research had clearly implicated an involvement of slmo in the
development and/or function of the Drosophila nervous system. However, at the
beginning of this project, this potentially very interesting relationship had been
largely neglected. It was therefore desirable to perform a more detailed analysis of
the null mutant phenotype and its possible causes.
3) Function of the Slmo protein
Very little is known about any proteins in the Slmo family, and it is important
to gain as much insight into the functional properties of these proteins as possible. I
chose to use three approaches: First, to establish the subcellular localisation of Slmo,
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second, to search for interacting proteins, and third, to perform a functional analysis
of the two Drosophila homologues I identified from the database.
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Chapter 2: Materials and Methods
2.1 Fly manipulations
2.1.1 Fly food
2.1.1.1 Standard fly food
Flies were routinely raised on media consisting of 94g sucrose, 18g yeast,
103g maize, 5.6g agar and l Smls ofNipagen (Tegosept M, p-hydroxy benzoic acid
methyl ester, 10% w/v in ethanol) per litre of distilled water. Fly food was stirred
well, allowed to simmer for approximately 15mins to kill live yeast, and then
allowed to cool prior to the addition of the Nipagen. The food was then dispensed
into 113 pint bottles or plastic vials, and allowed to set overnight. A few drops of a
live yeast suspension was added to each vial or bottle and allowed to dry before use.
2.1.1.2 Apple agar medium
For the collection of embryos and larvae, flies were allowed to mate and lay
on an apple juice based medium. Medium reagents (250mls apple juice, 25g sucrose,
25g agar) were made to Ilitre in distilled water. Medium was then simmered until the
ingredients had fully dissolved, and allowed to cool before the addition of 15mls
Nipagen (10%w/v in ethanol). The medium could then be dispensed into 4.5cm Petri
dishes and stored at 4°C. Apple plates were warmed to room temperature before use.
2.1.2 Fly stocks
All fly stocks were maintained on standard food in vials at 18°C.
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Table 2.1: Fly stocks used
Stock Details Genotype Source
CS Canton-S +;+;+ Martin
(wild-type stock) Heisenberg,
Wurzberg
WCS Canton-S carrying WII18;+;+
white (WIllS) mutation Lab stock
yw Canton-S carrying yellow (yl) ylwll18; +; + Bloomington
and white (WIllS) mutation stock centre
w; CyO/Sp Balancer stock w; CyO/Sp Lab stock
for mapping
w; CyO/If; Double-balancer stock Lab stock
TM6BIMKRS for mapping w; CyO/ If; TM6B/MKRS
slmoc682 Enhancer trap P(GAL4)c682 w; slmoc682/CyO[krGALA,UASGFPl Lab stock
I d69ml slmo null allele w; slmod69ml/ CyO[krGALA,UASGFPl Lab stockstmo
Df(2L)BSC5 Chromosome 2 deficient Df(2L)BSC5, w[+mC]/SM6a Bloomington
/SM6a for the 26B region stock centre
UAS-GFP Expression of GFP w; +; UAS-GFP Bloomington
stock centre
UAS GFP directed to w; CyO/ If; UAS-mCD8GFP Sean Sweeney,
-mCD8GFP the cell membrane UCSF, California
UAS-GFPn GFP localised to w; +; UAS-GFPn Bloomington
the cell nucleus stock centre
UAS-TeTxLC Tetanus (G) toxin w; +; UAS- TeTxLC Sean Sweeney,
light chain UCSF, California
UAS-TeTxLC Inactive form ofTeTxLC, w; +; UAS-TeTxLC-VIF Sean Sweeney,
-VIF negative control UCSF, California
D42-GAL4, GFP is expressed in w; +/+; P(w+)D42-GAL4; Bill Saxton,
UAS-mitoGFP most motoneurons and P{w+mC=UASmito-GFP3M2}, e Indiana
is directed exclusively
to the mitochondria
GFPslmo2FI GFP-slmo fusion transgenic w; CyO/If; pGFPslmo2FI Drosophila
transgenesis
GFPs/mo3F2 " w; CyOJIf; pGFPs/mo3F2 "
GFPs/mo3MI " w; CyO/1f; pGFPs/mo3MIITM6B "
GFPs/mo4MI " w; pGFPslmo4MIJ CyO "
GFPslmo4M2 " w; CyO/ If; pGFPslmo4M2 "
GFPslmo4F2 " w; CyO/ If; pGFPslmo4F2ITM6B "
GFPs/mo4F3 " w; CyO/ If; pGFPslmo4F3 "
ChaGAL4; GFP expressed in w; ChaGAL4; UASGFP Richard
UASGFP cholinergic neurons Baines,
Warwick
pret(2)kI2402 P-insert allele of pre/ yw; pret(2)k12402JCyO[krGALA,UASGFPl Bloomington
(CG8806) stock centre
retmKG05639 P-insert allele of retm / ;retmP {y[+mDint2]w[BR.E,BR] Bloomington
(CG9528) =SUPor-P}KG05639; ry[506] stock centre
Dr!l2-3 Transposase source w; CyOJ Sp; Dr!l2-3ITM6B Bloomington
stock centre
SM2-3 Transposase source w; CyO/ Sp; SM2-3ITM6B Lab stock
retmd69 retm (CG9528) deletion w; retmA69 Excision
allele screen
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2.1.3 Behavioural assay
Larvae, aged 0-2hrs and I8-20hrs post-hatching, were genotyped by selection for or
against the CyO [kruppelGAL4 UASGFP] balancer chromosome (Casso et al., 2000)
and then placed on a fresh, room temperature agar plate and allowed 5mins to
acclimatise. The number of full body peristaltic contraction waves completed within
3mins was then counted. For each larva, three independent recordings were taken,
and then averaged to produce a single data point. A sample of 15 larvae was
examined for each genotype. For some samples the non-parametric Kruskal-Wallis
test was used to test the significance of the behavioural assay using SPSS 10.0 for
Windows (standard version, SPSS Inc.).
2.2 DNA manipulations
2.2.1 Agarose gel electrophoresis
Agarose gels used for DNA analysis were prepared by dissolving 1% (w/v)
agarose in IX TBE buffer (89mM Tris-HCI, pH8, 89mM boric acid, ImM EDTA),
and adding 0.5J.1g1mlethidium bromide (Sigma). DNA samples were mixed with
DNA loading buffer (IOmM Tris-HCI, 50mM EDTA, 10% Fico1l400, 0.25%
Bromophenol blue, 0.25% Xyline Cyanol FF, 0.4% Orange G) before loading. Gels
were run at between 100-160V until DNA fragments had migrated the desired
distance. A lkb DNA ladder (Invitrogen) was used to compare size of samples. Gels
were visualised on a GelDoc digital UV light box (Bio-Rad) and photographed.
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2.2.2 Molecular cloning
2.2.2.1 Restriction digestions
DNA was routinely cut with various restriction enzymes according to the
manufacturers instructions. Digestions were performed in 15-100IlI reaction volumes
containing 1X reaction buffer (appropriate for the particular enzyme) and <10%
volume of restriction enzyme. Reactions were incubated at 37°C (or the optimal
temperature for the relevant enzyme) for 1-2hrs. Digests were terminated by gel
electrophoresis (2.2.1), and the resolved DNA fragments could be purified from the
gel using the GeneCleanII kit (QBIOgene) according to the manufacturers
instructions.
2.2.2.2 Dephosphorylation of DNA
For dephosphorylation, vector DNA digested for cloning (2.2.2.1) was
incubated in a reaction mixture containing 0.2U alkaline phosphatase (calf intestine
isolated, Roche), and the appropriate buffer for 15mins at 37°C, then 15mins at 56°C.
A further 0.1U of the enzyme was then added, before incubating again for I5mins at
37°C then 15mins 56°C. DNA was purified from the enzyme using the GeneClean II
kit (QBIOgene) according to the manufacturers instructions.
2.2.2.3 Ligation of DNA fragments into plasmid vectors
"Sticky end" ligations were performed using T4 DNA ligase (MBI
Fermentas), with molar ratio of approximately 1:3 vector to insert. Reactions used
between 50-200ng linearised and dephosphorylated vector DNA, 5 units T4 DNA
ligase, IX T4ligase buffer and were performed in final volumes of 10 or 20lll.
Reactions were incubated either lhr at room temperature or over night at 4°C.
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2.2.2.4 LB cultures and LB Agar plates
Bacterial cells used in cloning were grown and maintained in LB (Luria
Bertani broth) and LB agar plates containing an appropriate selective antibiotic. Per
litre ofLB: 109 bacto-tryptone, Sg bacto-yeast extract, Sg NaCl, pH7.S, ISg bacto-
agar (for LB agar plates only). Autoclaved LBI LB agar plates were cooled to about
SSoC before the addition of the antibiotic (ampicillin: 100J.lg/ml, kanamycin:
2SJ.lg/ml, chloramphenicol: SOJ.lg/ml).
2.2.2.5 Preparation of competent cells for transformation
The E. coli strain DHSa. (genotype: supE44 L\/acU169 (<1>80lacZDM1S)
hsdR17 recAI endAI gyrA96 thi-) re/AI) was used routinely for amplification of
plasmid DNA. To generate cells competent for transformation with cloned DNA, the
following protocol was used (Hanahan, 1983).
A single colony from an LB agar plate was incubated in Sml of LB medium
(without antibiotic) at 37°C overnight with shaking (200rpm). The following day,
SOJ.llof this culture were used inoculate a fresh 25mls of LB. Cells were then grown
until the OD55oreached 0.3-0.4 (typically 3-Shours). Two fresh (pre-warmed to
37°C) 2S0ml LB cultures were then each inoculated with 12mls of the previous
culture and grown for a further 3-4hrs until the OD55ohad reached 0.4-0.S. The
cultures were then cooled rapidly in ice water and the cells harvested by
centrifugation at 2S00rpm in a Beckman J2-2IM/E centrifuge for lOmins at 4°C. The
supernatant was discarded and the pellet resuspended in lOOmis ice cold TFBI
(lOOmM RbCl, SOmMMnCh, 10mM CaCho 30mM CH3COOK, 19% (w/v) glycerol,
pHS.8 with acetic acid). Cells were again pelleted as before and resuspended in
lOmls ice cold TFBII (lOmM MOPS, 75mM CaCh, 10mM RbCI, 19% (w/v)
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glycerol, adjusted to pH7 with NaOH). 200-400J,11aliquots were then frozen on dry
ice and stored at -70°C.
2.2.2.6 Transformation of competent cells
100J,11aliquots of competent cells (2.2.2.5) were thawed on ice and incubated
on ice with 10J,11of ligation reaction (or I J,11of previously cloned plasmid) for 30-
60mins. Cells were then heat shocked at 42°C for 2mins and immediately placed on
ice for 15mins. Iml of non-selective LB was added and the cells incubated at 37°C
for Ihr. Cells were pelleted by briefly spinning at maximum speed in a microfuge,
resuspended in 100J,11of fresh LB, plated on the appropriate selective media (2.2.2.4)
and grown overnight at 37°C.
2.2.2.7 Production of glycerol stocks
A single colony of transformed bacteria was grown overnight in l Oml LB
containing the relevant antibiotic. Glycerol stocks were made by mixing 250J,11of
30% glycerol with 250J,11ofthe bacterial culture and freezing on dry ice. Glycerol
stocks were stored at -70°C.
2.2.2.8 Preparation of plasmid DNA
High quality plasmid DNA was prepared using the QIA miniprep and
maxiprep kits (Qiagen) following the manufacturers instructions. Cloned inserts and
plasmid DNA were checked by digestion with the appropriate restriction enzymes
and visualisation on an agarose gel (2.2.1).
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2.2.2.9 Colony PCR
Where low ligation efficiency was expected, bacterial colonies were screened
by PCR for the presence of a cloned insert. Single colonies were picked and
suspended in 50J..lIdH20. 10J..lIof the cells were transferred to a fresh tube and the
remaining cells boiled for 5mins, then pelleted by centrifuging at 13000rpm for
Imin. 5J..lIof the supernatant was used as template for a peR reaction (2.2.3).
2.2.3 Polymerase chain reaction (PCR)
2.2.3.1 Primer design
peR primers were designed using the Primer Designer program (Scientific
and Educational Software), and manufactured by TAGN or Invitrogen. Primers were
made up as 50ng/J..lIworking stocks in Tris-Hf'l (PH8) buffer.
2.2.3.2 Basic rca
peR was routinely carried out using Taq DNA polymerase (MBI Fermentas).
Standard reactions contained 10-500ng template DNA, 50ng of each primer, O.2mM
dNTP mix (MBI Fermentas), 2.5mM MgCh, lOX reaction buffer (IX in final
volume) and IV ofTaq DNA polymerase (5VIJ..lI stock), made up to final volume of
50J..lIwith dH20. A typical cycle of reactions were as follows:
Table 2.2: Typical PCR cycle
Stage 1: 1 cycle Stage 2: 35 cycles Stage 3: 1 cycle
step I 94°e Imin step 194°C 30secs step 1 72°e IOmins
step 255°C 30secs
step 3 72°e lmin
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2.2.3.3 PIu and Pwo peR
Pfu (MBI Fennentas) and Pwo (Roche) high fidelity DNA polymerases were
used on different occasions for PCR based cloning of DNA fragments. These
enzymes were used according to the manufacturer's instructions.
2.2.4 Isolation of genomic DNA from Drosophila
Drosophila genomic DNA was prepared using the DNeasy kit (Qiagen)
following the manufacturers instructions (isolation of genomic DNA from animal
tissues protocol).
Crude genomic DNA was prepared from single flies where a large number of
samples were to be screened by PCR. Individual flies were placed in 50J.llof
squishing buffer (lOmM Tris-HCI, pH8.2, ImM EDTA, pH8.0, 25mM NaCl,
200J.lg/ml freshly added proteinase K), and disrupted with a pipette tip before
incubating at 37°C for 20mins. Samples were then placed at 8SoC for 2mins to
inactivate the proteinase K, and centrifuged at 13,000rpm for 3mins. The supernatant
was removed and stored at 4°C or-20°C. lul of genomic was used as template in a
PCR.
2.2.5 DNA sequencing
Automatic sequencing was performed by the University of Warwick
Molecular Biology Service, using Applied Biosystems Big Dye Terminator Version
3.1 Chemistry, and run on the 3100 Genetic Analyser.
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2.2.6 In vitro mutagenesis
For the purposes of some cloning protocols, restriction sites were artificially
introduced into cloned DNA fragments by in vitro mutagenesis. This was achieved
using the QuikChange™ in vitro site directed mutagenesis kit (Stratagene) following
the manufacturer's instructions.
2.3 RNA manipulations
2.3.1 Maintenance of an RNase free environment
When handling RNA, RNase free water was routinely used to prevent
degradation. To produce RNase free water, sterile, deionised water was treated with
0.1% diethyl pyrocarbonate (DEPC), mixed well and left to stand overnight. The
water was then autoclaved for 20mins to remove the DEPC.
2.3.2 Whole mount in situ hybridisation
All washes were performed in 1.5ml Eppendorftubes on a rotator, and at
room temperature unless otherwise stated.
2.3.2.1 Preparation of Digoxygenin (DIG) labelled RNA probe
Template DNA was prepared (2.2.2.8) and linearised with the appropriate
restriction enzyme (2.2.2.1). lug of template was made up to l lul with RNase free
dH20. To this was added, 2JlI DIG labelling mix (Roche), IJ..lIof RNase inhibitor
(MH!), IJ..lIof either T3, T7 or SP6 RNA polymerase (Gibco), and 4JlI of the
appropriate 5X transcription buffer. The reaction was then incubated for 2hrs at
37°C. IJ..llwas then saved for later analysis. To the remaining reaction mix 2Jll of
RNase free DNase was added and this incubated for 15mins at 37°C. Another IJ..lI
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aliquot was removed for later analysis, and the DNase reaction was halted by the
addition of 2111EDTA (200mM, pH8).
Newly synthesised probe was precipitated by the addition of 80111of dH20,
20111of LiCI (4M) and 360111of 100% ethanol. The probe was incubated at -20°C for
20mins then pelleted by centrifugation at 13,00Orpm. The probe was then
resuspended in 100111of RNase free H20.
2.3.2.2 Acid hydrolysis of RNA probes
IOOIlI ofNaHC03 (0.2M) were added to the IOOIlI ofriboprobe prepared as
above, and the mixture heated for t mins as calculated by the following formula
(Sambrook et al., 1989):
t mins = La - Lr
0.11 (La) (Lr)
where La = initial length of probe in kb
Lf= desired length in kb (0.15kb for Drosophila embryos)
The probe was then precipitated again by adding 20111of 5% acetic acid, 20111of
sodium acetate, 500lli of 100% ethanol, incubated at -20°C for l5mins the pelleted
by centrifugation at 13,000rpm for 30mins. The pellet was then resuspended in 100111
of RNase free dH20. All probes were diluted both 1/100 and 1/50 in Hyb (50% (v/v)
de ionised formamide, 5X SSC, 0.1% (w/v) Tween-20, 2% (w/v) DIG blocking
reagent (Roche», and stored at -20°C as 100111aliquots.
2.3.2.3 Collection of embryos
Canton S flies were allowed to lay onto apple agar plates (2.1.1.2), which
were changed at 16 and 8hr intervals to ensure embryos were collected at a range of
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developmental stages. Embryos were harvested with a fine paintbrush and
dechorionated by washing in 50% (v/v) sodium hypochlorite (Fisher Scientific) for
2mins. Embryos were then washed and fixed for 20m ins (on a rotator) in a two-phase
solution containing 2mls 4% (w/v) paraformaldehyde (in PBS) and 2mls ofn-
heptane. The lower aqueous phase was then removed and Iml of methanol added.
Embryos were then devitellinised by vortexing at low speed for approximately
30secs. Devitellinised embryos (which sink to the bottom) could then be transferred
to an Eppendorf, washed in methanol, and stored at -20°C until needed.
2.3.2.4 Fixation
Embryos were removed from -20°C and washed for 3mins in a 1:1 PBT:
methanol mix, then twice for 3mins in PBT. Embryos were then fixed for 20mins in
4% paraformaldehyde (in PBT), washed twice for 5mins in PBT, and then treated for
5mins in proteinase K (Sug/ml in PBT) at room temperature. The proteinase reaction
was stopped by rinsing once in PBT then two 5min washes in 2mg/ml glycine (in
PBT).
2.3.2.5 Post-fixation
Embryos were fixed again for 20mins in 4% paraformaldehyde (in PBT)
followed by two 5min washes in PBT.
2.3.2.6 Pre-hybridisation
Embryos were washed for 15mins in a 1:1 PBT: Hyb mix (2.3.2.2).
Following this, embryos were incubated in Hyb solution in a 55°C water bath for
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20mins, transferred to a 65°C water bath for lhour, then back to 55°C for a further
20mins.
2.3.2.7 Hybridisation
The pre-hybridisation solution was removed and replaced with 100J.11of
riboprobe (diluted in Hyb, see section 2.3.2.2). Embryos were incubated with the
riboprobe overnight in a 55°C water bath. The following day, the probe was replaced
with fresh Hyb, and the embryos incubated at 60°C for 10mins. Embryos were then
subjected to a series of four 10min washes (all at 60°C) in 4: 1, 3:2, 2:3, 1:4 Hyb:
NTB (NTB: 150mM NaCl, 100mM Tris-HCl (pH7.5), 0.1% (w/v) Tween-20, 0.2%
(w/v) DIG blocking reagent), followed by a IOmins, 60°C wash in NTH.
2.3.2.8 Detection
Embryos were washed in 2% goat serum (in NTB) at 4°C for 4hrs on a
rotator. This solution was then replaced with fresh NTB 2% goat serum to which 5J.11
ofanti-DIG-AP Fab fragments (Roche) had been added, and left to wash at 4°C
overnight. The following day, embryos were washed three times in PBT for 30mins
at 4°C, followed by two IOmin, 4°C washes in freshly prepared NMTT (0.1M NaCl,
O.IM Tris-HCl (pH9.5), 50mM MgCh, 0.1% (w/v) Tween-20), and final IOmin wash
in NMTT at room temperature. Embryos were then transferred to a watch glass and
incubated in colouration solution (lml NMTT, 8111NBT/BCIP mix (Roche)) in the
dark to allow the colouration reaction to proceed (typically 30mins to overnight).
When complete, the reaction was stopped by washing in PBT.
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2.3.2.9 Mounting
Stained embryos were dehydrated via an ethanol series, cleared with Xylene
(Fisher) and mounted in DePeX mounting medium (BDH Laboratory Supplies).
2.3.3 Extraction of total RNA from Drosophila
Total RNAs from embryos, larvae, pupae and adult flies were isolated using
the QIA RNeasy kit (Qiagen), following the manufacturer's instructions. RNA
samples were visualised by agarose gel electrophoresis and quantified using an
Ultraspec III spectrophotometer (Pharmacia Biotech).
2.3.4 RT -peR
2.3.4.1 First strand cDNA synthesis
To prepare first strand eDNA, 100ng-Sllg of RNA (equal for each sample)
were added to 1III of 1X hexanueleotide mix (Roche), and made up to a volume of
1IIIIwith RNase free dH20. The mixture was then incubated at 65°C for 5mins, and
chilled on ice for 2mins. 4JlI of5X M-MuLV reaction buffer (MBI Fermentas), 2JlI
of 10mM dNTP mix, and 20U RNase inhibitor were then added and made up to a
final volume of 19111with RNase free dH20. The sample was then incubated at 25°C
for 5mins before the addition of IIII (200U) M-MuLV reverse transcriptase (MBI
Fermentas). The reaction mixture was next incubated at 2SoC for 10mins followed by
1hour at 42°C. The reaction was then halted by incubation at 65°C for 20mins.
Newly synthesised cDNAs were cooled on ice and stored at -20°C.
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2.3.4.2 Amplification of first strand cDNA
A modified peR protocol was used for optimal detection of specific
transcripts. Standard reactions contained l-Zug cDNA, SOng of each primer, 0.02mM
dNTP mix (MBl Fermentas), 1.2S-2.SmM MgCh (dependent on properties of primer
pair, see below), lOX reaction buffer (IX in final volume) and 2.SU ofTaq DNA
polymerase (MBl Fermentas), made up to fmal volume of SOlll with dH20. The basic
cycle of reactions presented in section 2.2.3.2 was followed, but was modified for
each primer pair in order to optimise the reaction (see below).
Table 2.3: Primers for RT-PCR
Stage2 Annealing MgCh
Transcript Primer Sequence Cycle No. Temp. cone.
RpL32 5'-aagatgaccatcc gcccagcatac- 3' 30 55°C 1.2SmM
5'-ctcgttcttcttgagacgcagg- 3'
prel 5'-gcagaaggatggtagtactc-3 ' 35 S2.3°C 2.SmM
5'-gagagctccttggttgttga-3 '
retm 5'-ctggtgatgaaggcctatga-3 ' 35 54.4°C 2.5mM
5'-gtagcgacaccgctcgaaga-3 '
2.3.4.3 Semi-quantitative analysis
"Semi-quantitative" RT-PCR was used to estimate relative levels of transcript
expression. To allow for small variations in the initial quantity of template eDNA,
RpL32, a well characterized housekeeping gene, was used as a control for
quantification. Equal volumes (usually 5J..ll)of each of the samples to be compared
were loaded and run on an agarose gel. For each sample, the corresponding RpL32
PCR product (i.e. amplified from the same cDNA) was also run out on the same gel.
All PCR products were quantified using GelDoc software (Bio-Rad). Arbitrary
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values were generated for relative fluorescence, which were expressed as a
percentage of the corresponding RpL32 product.
2.4 Protein manipulations
2.4.1 Preparation of Drosophila protein
Twenty adult flies were collected and disrupted in 100)..l1of homogenization
buffer (lOmM Tris-HCI, pH8, 60mM NaCI, 10mM EOTA, pH8, 0.15mM
spermidine, 0.5% (v/v) Triton X-I00). The sample was then pelleted by
centrifugation at 13,000rpm for 5mins and the supernatant transferred to a fresh tube.
This was mixed with 20)..l1of2X SOS loading buffer (250mM Tris-Hel, pH6.8, 2%
SOS, 10% glycerol, 20mM OTT, 10% ~-mercaptoethanol, 0.01% bromophenol
blue), before boiling the sample for 5mins and storing at -20°C. Protein samples
were re-boiled for 5mins before loading 5-1O)..llon an SOS-PAGE gel (2.4.4).
2.4.2 Preparation of S. cerevisiae protein
A 2.5ml culture of selective YPO medium (2.8.1) was inoculated with a
single colony and grown overnight at 30°C. The following day, cells were pelleted by
centrifugation at 2500rpm in a Centra MP4R centrifuge (International Equipment
Company) for 10mins at room temperature, and the pellet resuspended in 1ml of
0.25M NaOH, 1% ~-mercaptoethanol solution. The sample was then incubated on
ice for IOmins prior to the addition of 160)..l150% (w/v) Tri-chloroacetic acid (TCA).
The sample was mixed, placed back on ice for a further 10mins then centrifuged at
13,000rpm for 10mins. The pellet was resuspended in 1ml of ice cold acetone by
vortexing vigorously, then centrifuged again at 13,OOOrpmfor lOmins. The pellet
was air dried, resuspended in 300)..l1of IX SOS loading buffer, and boiled for 5mins
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before storage at -20°C. Protein samples were re-boiled for 5mins before loading
25~1 on an SOS-PAGE gel (2.4.4).
2.4.3 SDS-polyacrylamide gel (SDS-PAGE) analysis
SOS-PAGE gels were prepared using the Protein Mini-Gel kit (Bio-Rad)
according to the manufacturers instructions. To prepare the resolving gel (12.5%),
4.28ml of 30% acryl-bis stock (29: 1 w/w of acrylamide to bis-acrylamide, Fisher
Scientific), were mixed with 2.85ml of Solution B (I.57M Tris-HCl, pH8.8, 0.4%
(w/v) SOS), 2.87ml dH20, 150~1 of 10% (w/v) APS (ammonium per-sulphate) and
15~1 ofTEMEO (Sigma). To prepare the stacking gel, 1.3ml ofacryl-bis stock were
mixed with 2.5ml of solution C (0.5M Tris-HCl, pH6.8, 0.4% (w/v) SOS), 6.3ml
dH20, 150~11O% APS and 15~1 ofTEMED.
Electrophoresis was carried out in IX running buffer (3.03g/l Tris-HCl
pH8.3, 14.4g/1 glycine and 0.01% (w/v) SDS). Pre-stained size markers (MBI
Fermentas) were loaded on all gels for comparison. Protein samples were run on
sos-PAGE at 100V until reaching the edge of the resolving gel, then at 130V for 1-
2hrs.
2.4.4 Staining of SDS-PAGE gels
Proteins were visualized by staining with Coomassie blue staining solution
(0.1% (w/v) Coomassie brilliant blue, 40% (v/v) methanol, 10% (v/v) acetic acid) for
1hr at room temperature with agitation. Staining solution was then removed and
replaced with destaining solution (10% (v/v) methanol, 10% (v/v) acetic acid) for 2-
4hrs. The gel was then left in fresh destaining solution overnight (without agitation)
to completely remove background.
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2.4.5 Western blotting
2.4.5.1 Transfer of protein to nitrocellulose membrane
Following electrophoresis the gel was soaked in western blot transfer buffer
(39mM glycine, 48mM Tris base, 0.037% (w/v) SDS, 20% methanol). The gel was
placed, with a nitrocellulose membrane, in a gel transfer kit (Bio-Rad) according to
the manufacturers instructions, and the transfer carried out for 1hr at 1OOV.
2.4.5.2 Immunodetection of membrane bound antigens
To reduce non-specific binding of the antibody, the membrane was incubated
for 2hrs at room temperature in 5% (w/v) powdered milk (Tesco) in PBS. The
membrane was then incubated in the relevant primary antibody (diluted in 2% (w/v)
powdered milk in PBS) overnight at 4°C.
Primary antibodies: Rabbit polyclonal anti-OFP 290 at I: 2000 (AbCam), Rabbit
polyclonal anti-LexA (Invitrogen) at 1:5000.
The following day, the membrane was given five 10min washes in PBT
before incubating at room temperature in the secondary antibody (goat anti-rabbit
IgO AP conjugate, Bio-Rad), diluted 1/2000 in 2% (w/v) powdered milk. The
membrane was then washed a further five times for IOmins in PBT.
2.4.5.3 Colour development
The membrane was given two lOmin washes in NMTT (lOOmM Tris-HCI,
pH9.5, 100mM NaCI, 5mM MgCh, 0.1% (w/v) Tween-20), before transferring it to a
Petri dish and treating it with colouration solution (80J,l1NBT IBCIP mix (Roche) in
10mi NMTT). The colour was then allowed to develop in the dark (1Omins to
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overnight). Colouration reaction was halted by washing twice in PBS for 15mins.
The membrane was air dried on filter paper.
2.4.6 In vitro transcription - translation
Reactions were performed using the TNT Coupled Reticulocyte Lysate
System (Promega). Double stranded plasmid DNA was transcribed and translated as
described in manufacturer's instructions, in the presence of35S methionine.
Translation product was then run on an SDS-PAGE gel (2.4.4). The gel was then
exposed to X-ray film (Fuji Photo Film Co.) overnight to visualise the protein.
2.5 Whole mount antibody staining
2.5.1 Dissection of Drosphila eNS
Embryos were collected from overnight lays, and dechorionated in 50%
sodium hypochlorite solution (Fisher Scientific). Early stage 16 embryos
(Hartenstein, 1993), were identified by the presence of three disk-like contractions of
the gut. Late stage 17 embryos (Hartenstein, 1993) were readily identifiable by the
presence of inflated trachea. 18t instar larvae could be readily collected from aged
laying plates. Dissections were carried out under either PBS or dissection saline
(135mM NaCl, 5mM KCl, 2mM MgCh, 0.5mM CaCh, 5mM N-
Tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid (TES), and 36mM sucrose)
using sharp tungsten dissecting needles. Embryos were removed from their vitelline
membranes by hand. Devitellinised stage 16 embryos readily adhered to polylysine
(Sigmaj-coated coverslips. Stage 17 embryos and 18t instar larvae were fixed at their
anterior and posterior ends to a Sylgard (DOW Comingj-coated coverslip by mouth
pipetting cyanoacrylate glue (Histoacryl; Braun, Melsungen, Germany). Embryos
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and larvae were then opened dorsally and stuck flat to the polylysine, or glued to the
Sylgard. Gut and fat bodies were removed to fully expose the brain and ventral nerve
cord.
Adult brains were dissected in PBT by pinning the fly to a Sylgard coated
Petri dish and using fine forceps. The dissection was carried out essentially as
described in Allen et al., 1998.
2.5.2 Antibody staining
Dissected embryos were fixed on covers lips with 4% paraforrnaldehyde in
PBS at room temperature for either lhr (stage 16 embryos) or 30mins (stage 17
embryos). Embryos were then washed several times in PBTx (PBS + 0.1% (w/v)
Triton X-lOO) before blocking for 1 hour in PBTx + 3%BSA (bovine serum
albumen, Sigma). Primary antibodies were then incubated overnight at 4°C diluted in
PAT (PBTx + I%BSA). The following day, samples were washed 5 times in PAT,
and incubated in secondary antibody (diluted in PAT) for 1hr at room temperature.
Embryos were then washed several times in PBTx, and finally mounted in PBTx
using nail varnish to seal the slides. Samples were visualised using a Leica confocal
microscope, with LCS lite software.
Primary antibodies: Rabbit polyclonal anti-GFP 290 at 1:2000 (AbCam), mouse
monoclonal anti-Eve 3C 10 at 1:250 (Doe et al., 1988), mouse monoclonal anti-
Futsch 22C 10 at 1:250 (Hummel et al., 2000), mouse monoclonal anti-Acj6 9C52 at
1:2 (Certel et al., 2000), mouse anti-Repo 8012 at 1:300 (Developmental Studies
Hybridoma Bank), rabbit polyclonal anti-Synaptotagmin at 1:500 (Littleton et al.,
1993).
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Secondary antibodies: The Molecular Probes fluorescent secondaries Alexa Fluor
488 (goat anti-mouse and goat anti-rabbit), and Alexa Fluor 594 (goat anti-mouse
and goat anti-rabbit) were used in this study.
2.6 Cell culture techniques
2.6.1 Maintenance
NIH 3T3 fibroblast cells were seeded in flasks and grown in a monolayer in
growth medium (Dulbecco's modified Eagle's medium (DMEM) supplemented with
10% heat-inactivated fetal calf serum (FCS), 2mM glutamine, 20units/ml penicillin
and 150units/ml streptomycin). Cultures were kept at 37°C in a humidified
atmosphere containing 5% C02 in air, and maintained in logarithmic growth by
harvesting with trypsin solution (0.25% (v/v) trypsinllmM EDTA in PBS) and re-
plating before the cells reached confluence.
2.6.2 Liquid nitrogen stocks
Cells were detached from flasks by incubating in trypsin solution (2.6.1) and
transferred to fresh media. This was then pelleted by centrifugation at 1200rpm for
5mins, and the pellet re-suspended in media containing 10% (v/v) DMSO and an
additional 10% (v/v) FCS. Aliquots were left on ice for 30mins, and frozen to -80°C
before finally being transferred to liquid nitrogen for long-term storage.
2.6.3 Transfection and staining
NIH-3T3 fibroblasts were cultured on coverslips in 23mm dishes in lml of
growth medium (2.6.1). When the culture reached 50-80% confluence, the cells were
transfected with 0.5Jlg of plasmid under growth conditions, for --48hours, using
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GeneJuice (Novagen) according to the manufacturers instructions. The medium was
then replaced with fresh medium containing 25nM MitoTracker Red CMXRos
(Molecular Probes, Incorporated) and incubated in growth conditions for 30mins.
Cells were then washed with PBS and fixed in 4% paraforrnaldehyde for lOmins,
washed three times in PBS then incubated in DAPI (I ug/ml in PBS) at room temp
for IOmins. Cells were again washed in PBS then mounted in Vectorshield mounting
medium (Vector Labs, Inc.).
2.6.4 Fluorescence microscopy
Cells were viewed under a Zeiss Axioskop fluorescence microscope equipped
with FITC, Texas Red and DAPI filters. Images were captured digitally using the
Quips Smartcapture (Vysis, Ltd.) software and processed using Adobe Photoshop.
2.6.5 Confocal microscopy
Cells were viewed as optical sections under a Leica confocal microscope.
2.7 Production of transgenic Drosophila
2.7.1 Preparation of DNA for injection
High quality transgene construct DNA was prepared using the QIA Maxiprep
kit (Qiagen), and 1Jlg/JlI mixed with 250ng/JlI of helper plasmid (p7t~2-3, Roberts,
1986). This plasmid mix was then ethanol precipitated and resuspended in injection
buffer (Sambrook, 1989).
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2.7.2 Fly transformation
yw embryos (2.1.2) were collected hourly from apple agar plates (2.1.1.2).
Embryos were dechorionated by hand and injected as previously described (Roberts,
1986). Following injection embryos were incubated at 18°C for 16-48hrs. Hatched
larvae were collected, transferred to standard fly food (2.1.1.1) and incubated at 25°C
until adulthood.
2.7.3 Mapping of inserts
All inserts were mapped genetically to a particular chromosome, and
subsequently maintained over an appropriate balancer chromosome (2.1.2). Where
inserts were homozygous viable, stocks were maintained without a balancer
chromosome.
2.8 Yeast manipulations
Yeast protocols were primarily adapted from the DupLEX-A yeast two-
hybrid system (OriGene Technologies) manual.
2.8.1 Yeast media
The yeast strain EGY48 (genotype: MATa trpJ his3 ura3Ieu2::6 LexAop-
LEU2) was cultured in YPD (rich medium) or on YPD plates. Per litre ofYPD: 20g
peptone, 109 yeast extract, 20g glucose, 20g agar (plates only). Transformed yeast
strains were cultured and maintained in selective YNB (glu) dropout media or YNB
(glu) plates. Per litre YNB(-ura-his-leu-trp): 1.7g yeast nitrogen base without amino
acids (QBIOgene), 5g ammonium sulphate, O.6g-his-leu-trp-ura dropout mix
(QBIOgene), 20g glucose, 20g agar (plates only). The appropriate selective media
50
was produced by adding tryptophan (0.04mglml), uracil (0.02mglml), leucine
(O.06mglml) and histidine (0.02mglml) as required.
When screening for activation of LexAop-LEU2 and lacZ reporters, YNB
(gal) selective media was used. This was prepared in the same way as standard YNB
media, but used 20g galactose and 109 raffinose instead of the normal 20g glucose
per litre. All media was autoc1aved for lSmins before use. Per litre of X-gal indicator
medium, 100ml was added of7% (w/v) sodium phosphate (dibasic) and 3% (w/v)
sodium phosphate (monobasic) solution (prepared using sterile water autoclaved),
and 0.8ml of 100mglmi X-gal (in N, N-dimethyl formamide).
2.8.2 Yeast Transformation
A large yeast colony was used to inoculate 10ml of the appropriate media
(2.8.1) and incubated overnight at 30°C with shaking (200rpm). The overnight
culture was then used to inoculate a 100mi culture to an OD6oo ofO.2-0.3, and
incubated at 30°C with shaking for 3hrs. The cells were then pelleted at 2S00rpm in a
bench top centrifuge (Centra MP4R, International Equipment Company) for Smins at
room temperature, and resuspended in sterile TE (O.OIM Tris-HCI, pH7.S, ImM
EDTA, pH8). Cells were then pelleted again as before and resuspended in I.Sml of
sterile, freshly prepared TE/lithium acetate solution (0.1M lithium acetate in TE).
100JlI of yeast suspension was then mixed with I-SJlg of plasmid DNA and SOJlgof
salmon testes carrier DNA (Sigma) prior to the addition of 600Jll sterile PEG/LiAc
solution (40%polyethylene glycol (PEG) 33S0, 0.1M lithium acetate in TE). This
was mixed by vortexing, and incubated at 30°C for 30mins before heat shocking at
42°C for lSmins and then chilling on ice for 2mins. Cells were then spun at
13,000rpm in a bench top microfuge for Ssecs and the pellet resuspended in TE. The
SI
cells could then be plated on the relevant selective media and incubated at 30°C for
3-4days to allow colonies to appear.
2.8.3 Large Scale Transformation
For transformation of the library, the transformation protocol described above
was scaled up in size. A colony of an EGY48 strain containing the bait and lacZ
reporter plasmids was used to inoculate 50ml of selective YNB and incubated
overnight at 30°C with shaking (200rpm). The following day, 30ml of the overnight
culture were used to inoculate 300ml of selective YNB and incubated at 30°C for
3hrs to an OD6oo ofO.4-0.6. The cells were then centrifuged at 2500rpm in a Centra
MP4R bench top centrifuge (International Equipment Company) for 5mins at room
temperature, the pellet resuspended in sterile TE, recentrifuged as before and finally
resuspended in 1.5ml TE/lithium acetate solution (2.8.2). Thirty 50J..Llaliquots of
yeast suspension were each mixed with 6-10J..Lgof plasmid DNA and 50J..Lgof salmon
testes carrier DNA (Sigma) prior to the addition of 300J..LlPEG/lithium acetate
solution (2.8.2) to each tube. Samples were incubated at 30°C for 30mins, heat
shocked at 42°C for 15mins, then chilled on ice for 2mins. Cells were next
centrifuged at 13,OOOrpmin a bench top microfuge for 5secs and resuspended in
500J..LIof TE before plating on the relevant selective medium and incubating at 30°C
for 3-4 days. Transformed colonies were harvested from the plates by washing them
from the surface in TE with the aid of a sterile glass spreader. The resulting slurry
was then pipetted into a fresh tube. Transformants were pelleted by centrifuging at
2500rpm in a bench top centrifuge (Centra MP4R, International Equipment
Company) for 5mins, washed in TE, repelleted and then resuspended in an equal
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volume ofTE. The yeast suspension was then mixed with an equal volume of sterile
50% glycerol and stored at -70°C as lml aliquots.
2.9 Electron Microscopy
To expose the CNS, 1SI instar larvae were dissected in dissection saline
(2.5.1) as flat preparations by gluing to a Sylgard (DOW-Coming)-coated coverslip
as described in 2.5.1. Dissected larvae were washed in PBS, fixed in EM fixative
(3% glutaraldehyde, 4% formaldehyde, 0.1M PIPES in PBS) and removed from the
Sylgard using a razor blade. Sample were processed for electron microscopy
according to published methods (Baines et al., 2002) and analysed using a JEOL-
1200EX transmission electron microscope.
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Chapter 3: Analysis of slmo Function in the
Drosophila Central Nervous System
3.1 Introduction
The locomotor behaviour of Drosophila larvae represents a particularly
robust and relatively simple motor behaviour, and provides a useful model with
which to screen for mutations that perturb motor output. The isolation of mutations
in Drosophila that cause paralytic phenotypes have led to the identification of many
of the components required for neuronal signalling. For example, ion channel genes
such as para (Loughney et al., 1989; Suzuki et al., 1971) and cacophony (Kawasaki
et al., 2000), and synaptic vesicle components such as syntaxin (Littleton et al.,
1998) and synaptobrevin (Deitcher et al., 1998). Mutations that disrupt larval
locomotion have also led to the identification of a variety of factors required for the
development ofa functional motor circuit. For example, the role of the POU
transcription factor encoded by acj6 in regulating neuronal connectivity and synapse
formation (Certel et al., 2000), and hikaru genki, which has been shown to encode a
cell adhesion protein (Hoshino et al., 1999; Hoshino et al., 1996). Screens in larvae
have also identified genes involved in related behaviours such as foraging and
wandering (Shaver et al., 2000). However, there is a paucity of genetic loci identified
as being involved in the early stages of locomotor peristalsis, and very little is known
of how the circuitry that underlies this behaviour develops or is regulated.
The availability ofP(GAL4) enhancer trap strains expressed in specific
subsets of neurons (Brand and Perrimon, 1993) has provided a means to begin
unravelling the function of neurons, as behaviour can be analysed in parallel with
genetic misexpression (Ferveur et al., 1995; Hidalgo and Brand, 1997; Sweeney et
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al., 1995). Suster et al. (2003) applied this genetic approach in an attempt to identify
specific neurons required for the spatial and temporal pattern of larval locomotion. A
small screen was performed of about 150 P(GAL4) enhancer traps by looking for
abnormal larval behaviour after crossing each of these to a UAS-TeTxLC strain. A
small number of GAL4 lines were isolated which generated defects specifically in
the "decision making" phase of locomotory behaviour, such as abnormal turning and
pausing. The ideal would be to characterise genes that correspond to interesting
enhancer trap lines and identify molecules involved in regulating locomotor
behaviour.
Previous research on the slmo locus had focused on the involvement of this
gene in survival of the germline, but evidence had been reported that the gene is
expressed in the nervous system, and that loss of slmo function results in defective
motor control (Carhan, 1999; Reeve, 2002). The research presented in this chapter
focuses on the role of slmo within the nervous system. The slmo mutant phenotype,
and the corresponding enhancer trap line P(GAL4)c682, are consistent with this
locus as a candidate for regulating the motor output required for normal locomotory
peristalsis. Possible causes of the phenotype are explored and discussed.
3.2 Results
3.2.1 slmo mutant lethality and behavioural phenotype
Initial observations showed that while null mutant embryos were capable of
hatching they were clearly compromised in their motor function. Whilst it was
originally proposed that mutant 1st instars are completely paralysed (Carhan, 1999),
closer inspection revealed that newly hatched larvae have some motor function
(Reeve, 2002). Mutant larvae were tested for the ability to perform a simple "twist-
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and-roll" righting reflex when placed in an inverted position (Reeve, 2002). This
represents a relatively complex behavioural response requiring coordinated motor
control, and had previously been used to show the requirement for the gene turtle
(which encodes a neurally expressed member of the Ig superfamily) in executing
complex coordinated movements (Bodily et al., 2001). As with turtle null mutant
larvae, it was found that newly hatched slmo'~69mlhomozygotes were able to perform
the reflex, and right themselves from an inverted position, but were clearly defective
in this behaviour, taking a substantially longer time to perform the reflex than wild-
type animals. By the end of the 1st instar stage (-20hrs), mutants were totally unable
to perform this behaviour and remained stranded in an inverted position.
In the case of the turtle gene, mutant 3rd instar larvae were found to be
defective in the righting reflex behaviour, and other coordinated movements such as
response to tactile stimulation, turning behaviour during locomotion, and flying in
adults, whilst being able to execute basal locomotory peristalsis in a manner
comparable to wild-type (Bodily et al., 2001). In this case the authors argued that the
turtle gene fulfils a specific role in regulating complex coordinated behaviours, and
that the inversion assay provides an example of such behaviour. In the case of slmo,
this behavioural assay demonstrated that these mutants have defective motor
function, and that this defect is progressive. However, a more thorough consideration
of slmo mutant behaviour might suggest that the defect reported for this complex
behaviour, was in this case secondary to a more general disruption of motor function.
Observation suggested that the slmo null mutation, which causes lethality at
an earlier stage than turtle, results in a much more severe impairment of motor
control, with animals exhibiting severely sluggish locomotor behaviour immediately
after hatching. Newly hatched larvae performed visibly slow and weak waves of
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peristaltic contraction that drives larval locomotion, and incomplete contraction
waves were often performed. It therefore follows that mutant larvae would perform
badly in the righting reflex assay performed by Reeve (2002), as this movement
requires coordinated bilateral motor control involving the innervation of body wall
muscles in a specific pattern (Bodily et al., 2001). Interestingly, slmo null mutants
were still capable of moving their head and mouth parts during pauses. Given that
slmo expression in the embryo had been reported previously to be specific to the
CNS, it seemed reasonable to postulate that the locus might be involved in regulating
the control of locomotor behaviour.
A detailed analysis of the locomotor defect is presented in Figure 3.1 (2.1.3).
Mutant and heterozygous larvae were genotyped by selection for, or against the CyO
[kruppeIGAL4, UASGFP] balancer chromosome, which causes bright fluorescence
of the Bolvic's organs (Casso et al., 2000). At 0-2hrs post-hatching, slmo~69ml
homozygotes exhibit an approximately 12-fold reduction in the number of peristaltic
contraction waves executed in a 3min time period when compared to the wild type
control line Canton S (CS) or the heterozygous siblings (Figure 3.1A). The same
phenotype is also observed with larvae carrying the slmo~69mI mutation hemizygous
with a deficiency for the chromosome region (Df(2L)BSC5). As expected, the
phenotype becomes more severe with age, and by 18-20hrs post-hatching larvae
homozygous or hemizygous for the slmo'~69mlallele were unable to perform a full
body peristaltic contraction wave (Figure 3.1B). However, aged mutant larvae were
still able to move their head and mouth parts in response to tactile stimulation. In
addition, raising the larvae on coloured food demonstrated that null mutants do not
feed and grow (Figure 3.1E), and by 18-20hrs post-hatching have developed a flaccid
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Figure 3.1: slmo mutants exhibit
defects in locomotor behaviour. A-D.
Locomotor activity was measured as
the number of fu II body peristaltic
contraction waves performed by Ll
larvae in a 3min time period. For all
lines in A-D n = 15. Error bars indicate
standard error. A. At 0-2 hrs post-
hatching (PH), slmolJ.69mJ null mutants,
and slmd~69mlfDf(2L)BSC5
hemizygotes perform badly in the
locomotor assay as compared to wild-
type (Canton-S, CS) and
slmolJ.69mJ/CyO controls. B. By 18-20
hrs PH, no peristaltic contraction
waves are performed by slmoll69ml
homozygotes or hemizygotes. C-D.
Homozygotes for the hypermorphic
allele sfmoc682 and slmoc682/slmo!J.69mJ
transheterozygotes perform locomotor
peristalsis at a rate comparable to wild-
type at both 0-2hrs (C. P-value=O.305)
and 18-20hrs (D. P-value=O.184) PH.
E. slmo!l69ml and sfmo!l69mJ/CyO larvae
were fed coloured food and aged for 20
hrs. Control heterozygous siblings
grow to more than double their original
size, and the red-dyed food is clearly
visible in the gut (arrow). In contrast,
mutant larvae do not grow, and do not
appear to have ingested the coloured
food.
E.
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appearance. This raises the possibility that the lethality may ultimately be due to lack
of food or hydration, rather than as a direct result of a defect in the nervous system.
To examine whether the phenotype is dosage dependent, the original slmoc682
allele was also examined. Northern and western blot analysis had previously shown
the slmoc682 mutation, which carries the P(GAL4)c682 enhancer trap, to be a
hypermorphic allele of slmo (Carhan, 1999; Reeve, 2002). Expression of the gene is
greatly reduced, but homozygotes survive to adulthood with no apparent behavioural
phenotypes. Over time, homozygous adults had become increasingly rare within the
stock (which was maintained over a CyO balancer), suggesting that the line had
acquired a lethal mutation on the slmoc682 chromosome. Before any behavioural
analysis could be performed, single flies of the slmoc682 line were out-crossed to
WCS flies over 7 generations to allow any linked mutations to be lost by
recombination (the P-element insertion could be followed by its white+ marker), and
then balanced over the CyO [kruppeIGAL4, UASGFP] chromosome. As expected,
the genetically "Cantonised" slmoc682 stock returned to a 2: 1 ratio of curly wing to
straight wing flies.
Locomotor activity was analysed as before for slmoc682 homozygotes,
slmoc682/slmot.69ml transheterozygotes and slmoC682/CyO heterozygous siblings. No
significant differences (2.1.3) were observed between control flies or either of the
mutant genotypes (Figure 3.1C, D), suggesting that the slmo phenotype is not dosage
dependent.
3.2.2 Expression analysis of the P(GAL4)c682 enhancer trap
The enhancer trap P(GAL4)c682 had previously been subjected to very
limited analysis in the developing embryo. Using UAS-lacZ as a reporter, expression
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of the enhancer trap was reported in the ventral nerve cord (VNC) of stage 16
embryos (Carhan, 1999). No expression was observed outside the CNS, except in the
salivary glands, which was dismissed as a common artefact of enhancer traps.
Interestingly, reporter expression appeared to be restricted to a very limited group of
cell bodies in the midline of the VNC. Following cloning of the gene, in situ
hybridisation to Drosophila embryos using a Digoxygenin labelled DNA probe
appeared to show the enhancer trap expression to be an accurate representation of the
expression of the endogenous gene. The slmo gene is expressed only in the CNS and
the salivary glands, and is not ubiquitous within the CNS. It was proposed that the
cells expressing P(OAL4)c682 and slmo mRNA are identified as the longitudinal
glia, based purely on morphology (Carhan, 1999). However, the glial identity of
these cells was never proven, and no attempt was made to explore the expression of
the enhancer trap at later stages of development, which might be more directly
relevant to the mutant phenotype (which is first apparent after hatching). Attempts to
use several antisera against Slmo have failed to work on whole mount preparations,
which would accurately report the expression of the protein, although western blot
analysis confirmed that Slmo is expressed at low levels in embryos and larvae
(Carhan, 1999; Reeve, 2002). I attempted to address these issues by utilising the
fluorescent reporters UAS-mCD8GFP (Lee and Luo, 1999), UAS-OFP (Yeh et al.,
1995) and UAS-OFPn (nuclear OFP; Martin-Blanco et al., 2000) of enhancer trap
expression, allowing for greater resolution of the expression pattern within the CNS.
3.2.2.1 Expression in the embryonic CNS
Expression of the enhancer trap was initially determined using the reporter
UAS-mCD8GFP (Lee and Luo, 1999), which expresses a version of the green
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fluorescent protein that becomes anchored to the cell membrane. This provides a
brightly fluorescent reporter with the important advantage that neuronal projections
can be visualised. In addition, UAS-GFP (Yeh et al., 1995; GFP remains in the
cytosol and nucleus) was also employed, but detected and visualised using
immunofluorescence (2.5.2), allowing the cell bodies to be resolved more clearly.
Importantly, the pattern of expression is similar with both reporters, suggesting that
all the cells expressing GAL4 at significant levels are labelled. The embryonic CNS
was viewed in filleted preparations using confocal microscopy (2.5.1).
As previously reported, the enhancer trap is not expressed until early in stage
16 of embryonic development, at around the time at which muscle contractions first
become apparent (Broadie and Bate, 1993). Expression at this stage is found in a
small group of 8 cell bodies per segment (Figure 3.2). To establish the identity of
these cell bodies, CNS preparations were fixed and double labelled with the glial
marker anti-Repo 8D12 (Developmental Studies Hybridoma Bank), and the neuronal
markers anti-Evenskipped (Eve) 3CI0 (Doe et al., 1988), anti-Futsch 22CI0
(Hummel et al., 2000) and anti-Acj6 9C52 (Certel et al., 2000) (Figure 3.2). At stage
16, Eve is expressed in the identified motoneurons aCC and RP2, plus the pCC
interneurons (Doe, 1992). Futsch expression also labels motoneurons, and some
intemeurons at this stage including aCC, MP 1, dMP2, vMP2, SP 1, VUMs and their
neuronal extensions (Grenningloh et al., 1991), whilst Acj6 labels only intemeurons
thought to be involved in motor control (Certel et al., 2000). The cell bodies marked
by P(GAL4)c682 at stage 16 clearly co-localise with a subset of the midline glial
cells labelled by anti-Repo, whilst not co-localising with any of the neuronal
markers, confirming previous observations made by Carhan (1999).
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Figure 3.2: Expression of
P(GAL4)c682 in stage 16 embryos. A.
Expression in the ventral nerve cord as
reported by both UAS-GFP and UAS-
mCD8GFP. The enhancer trap is
expressed in a small group of about 8
cell bodies per segment in the ventral
midline. B. Enhancer trap expression
reported by UAS-GFP (green), does not
co-localise with neuronal markers anti-
Eve, anti-Futsch, or anti-ACJ6 (red). C.
The cell bodies marked by
P(GAL4)c682 (green) co-localise with a
subset of midline glia labelled by anti-
Repo (red). All images were captured at
63X magnification and are orientated
with anterior as upwards.
By stage 17, reporter expression has expanded and can be seen in a group of
medially positioned neurons as well as a second set of neurons more peripheral
within the eNS. The enhancer trap is also expressed in a limited subset of neurons in
the brain lobes (Figure 3.3A). Double labelling the stage 17 eNS with anti-Repo
suggests that at this later stage of development there is no glial expression of the
enhancer trap (Figure 3.3B), noting that a small number of midline glial cells are not
labelled by Repo expression.
3.2.2.2 Expression in the larval eNS
Given the severe defect in locomotor activity observed in slmo null mutant I st
instars, it seemed important to examine enhancer trap expression at this stage. The
expression ofP(GAL4)c682 was visualised in filleted preparations using UAS-
meD8GFP as the reporter and imaging with confocal microscopy. The reporter is
expressed strongly in a limited group of midline cell bodies located in the dorsal half
of the VNe, and weakly in a small group oflateral neurons most of which are
located in ventral and intermediate positions (Figure 3.4). The reporter is expressed
strongly in the neuropil and commissures, and neurons are seen to project along the
segmental nerves. The dorsal position of the midline cells suggests that these are
likely to represent motoneurons which are sending axons out to the muscles, whilst
the lateral cell bodies may belong to intemeurons projecting into the neuropil (Certel
et al., 2000; Odden et al., 2002). In the brain lobes, the enhancer trap labels a
restricted group of cell bodies in the cortex, which can be seen to project into the
dorsal neuropil region (Younossi-Hartenstein et al., 2003). In addition, strong
expression is seen in the basoanterior compartment of the neuropil, which forms part
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Figure 3.3: Expression of the P(GAL4)c682 in stage 17 embryos. A. Expression in the VNC
and left brain lobe as reported by VAS-OFP and UAS-mCD80FP. The enhancer trap is
expressed in a population of neurons positioned medially as well as a second set of neurons
more peripheral within the VNC. Expression is also reported in a subset of neurons in the
cortex of the brain lobe, including a small group of strongly labelled cells projecting towards
the VNC (white arrow). B. Enhancer trap expression reported by VAS-OFP (green) does not
co-localise with the glial marker anti-Repo (red) at stage 17, indicating that all expression is
neuronal at this stage. All images were captured at 63X magnification and are orientated with
anterior as upwards.
Figure 3.4: Expression of P(GAL4)c682
in the I" instar larva. In all cases
expression is reported by UAS-mCD8GFP,
and anterior is up. A-C. Expression is
reported in a restricted population of cells
in the VNC. A. Projection of 5 optical
sections from the dorsal layer of the VNC,
each lum in thickness, showing a restricted
set of midline cell bodies, and projections in
the neuropil and segmental nerves. B.
Projection of 10 optical sections (Ium
thickness) from the intermediate and ventral
layers of the VNC. Strong expression can
be seen in the neuropil, commissural
neurons, and segmental nerves. A group of
weakly labelled celJ bodies can be seen in
the peripheral region ofthe CNS. C. Merge
of A and B. D. Expression in the left brain
lobe. A limited group of cell bodies in the
cortex project into the dorsal neuropil (DN)
region, and the basoanterior neuropil (BA)
compartment. Scale bar is 25J..lm.
of a transitional region between the brain and VNC (Younossi-Hartenstein et al.,
2003).
The CNS was also dissected from 3rd instar larvae carrying the enhancer trap
and the UAS-mCD8GFP reporter (Figure 3.5). At this stage of development a similar
expression pattern was observed to that seen in 1si instars. A group of dorsally
located cell bodies are labelled in the midline of the VNC, and very strong
expression can again be seen in the neuropil, commissures and segmental nerves
(Figure 3.SA-C). The neurons marked by the enhancer trap at this stage are
presumably the same as those seen at the first instar stage, as the CNS undergoes
little reorganisation between these stages (Younossi-Hartenstein et al., 2003). In the
brain lobes, expression is tightly restricted to a group of neurons, which again appear
to correspond to those seen in the much smaller brain lobes of the first instar larva by
projecting into the dorsal neuropil region (Figure 3.SD,E).
3.2.2.3 Expression in the adult CNS
The P(GAL4)c682 line was originally isolated for its expression in the adult
giant fibres. To explore expression in the adult CNS, whole brains were dissected
from flies carrying the enhancer trap and the UAS-mCD8GFP reporter (2.5.1). These
were mounted in PBS and analysed by confocal microscopy (Figure 3.6A,B).
Expression in the adult brain, although not ubiquitous, is seen to be widespread
within the neuropil. An alternative reporter, UAS-GFPn, expresses GFP fused to a
nuclear localisation signal (Martin-Blanco et al., 2000), and was used to specifically
label GAL4 expressing cell bodies. Expression is reported within a large number of
cell bodies in the cortex of the adult brain.
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Figure 3.5: Expression of P(GAL4)c682 in the 3rd instar larva. In all
cases expression is reported by UAS-mCD8GFP and anterior is up. A.
Projection of 3 optical sections (Ium thickness) from the dorsal layer of
the VNC. A small set of dorsally located cell bodies can be seen, which
may correspond to those seen in the 1st instar VNC (see Figure 3.4A). B. A
projection of 16 optical sections (1~ thickness) from the ventral and
intermediate layers ofthe VNC shows expression in neuropil, commissural
neurons, and segmental nerves. C. Merge of A and B. D. Expression in the
left brain lobe may also correspond to that seen at the 1st instar stage (see
Figure 3.4D). A small group of neurons can be seen to project into the
dorsal neuropil region (DN). The perimeter of the brain lobe is indicated
by white arrowheads. E. Close up ofD. Scale bar is A-D: 50~m, E:
25~m.
Figure 3.6: Expression of
P(GAL4)c682 in the adult brain. A.
UAS-mCD8GFP reports widespread
expression in the adult brain. A merge
of25 optical sections (6.4llm
thickness) reveals diffuse expression
in the central neuropil, and
fluorescence also observed in the
lamina (arrow). Brain is viewed from
the posterior with dorsal to the top. B.
A single 6.4J.1ffioptical section from
the posterior region of the adult brain
demonstrates that expression is not
ubiquitous. Viewed from the posterior
with dorsal to the top. C. Merge of 25
optical sections (1.21lm thickness).
UAS-GFPn reports expression of the
enhancer trap in a large number of cell
bodies within the cortex. Brain is
viewed from the anterior with dorsal to
the top. Scale bar is 75J.lm.
3.2.2 Inactivation of marked neurons with UAS- TeTxLC
To further characterise the subset of neurons marked by P(GAL4)c682, the
neurons were inactivated using UAS- TeTxLC, which is sufficient to eliminate all
evoked release of synaptic neurotransmitter (Sweeney et al., 1995). Resultant
embryos appeared to develop normally, but ultimately were unable to hatch. Closer
inspection revealed that, like slmo mutant larvae, embryos expressing the toxin were
not completely paralysed. The vigorous head swinging movements characteristic of
the hatching process were still commonly observed, whilst peristaltic contraction
waves were seen only very rarely. The phenotype generated by expression of
TeTxLC in this population of neurons therefore appears to reflect that of slmo
mutants, but with increased severity. Locomotor peristalsis is seemingly affected
more severely than other movements such as head swinging.
To further investigate the neuronal basis of this phenotype, an
electrophysiological analysis was performed in collaboration with Richard Baines
(University of Warwick). In order to compare the activity of central synapses, a
previously described preparation of the Drosophila embryo was used to record the
synaptic drive in motoneurons (Baines and Bate, 1998; Baines et al., 1999). The
patterned synaptic excitation exhibited by this preparation is known to reflect the
maximum rate of peristaltic contraction in an intact wandering larva (Baines and
Bate, 1998). This is presumably because the damage necessarily done to the CNS in
order to access and record from the motoneurons initiates a near maximal output of
the underlying CPG circuitry. In a late stage 17 wild type embryo or larva, the
centrally generated rhythmic pattern of motor output can clearly be seen as bursts of
action potentials. Analysis of the synaptic drive to motoneurons in embryos
expressing the toxin reveals the normal pattern of synaptic excitation to be severely
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disrupted (Figure 3.7). Synaptic excitation is almost completely abolished, however,
it is clear that the motoneurons do have some input, and some residual rhythmicity
can still be observed. Inactivation of the neurons marked by the enhancer trap does
appear to prevent the CPG from firing normally. The sporadic and weakened
excitation that persists in the motoneurons indicates that the immediate presynaptic
intemeurons have retained the ability to release neurotransmitter, and therefore do
not express GAL4. However, these intemeurons have seemingly lost their own
synaptic drive, suggesting that the enhancer trap labels neurons presynaptic to this
subset of neurons.
3.2.4 Analysis of sectioned mutant eNS
Neurodegeneration is a pathological condition known to occur in diverse
organisms, including humans and flies. Neurodegenerative phenotypes have often
been ascribed to single gene defects (Muqit and Feany, 2002), and in model
organisms such as Drosophila, a variety of mutations have been isolated that cause
degeneration of the nervous system and manifest as behavioural phenotypes (Driscoll
and Gerstbrein, 2003). In many cases, neuronal cell death is the consequence of
mutations that cause aberrant neuronal signalling properties (Driscoll and Gerstbrein,
2003). For example, the mouse neurodegenerative mutants Lurcher, tottering and
weaver, which were initially isolated on the basis of defective locomotor behaviour
phenotypes, have now been shown to encode ion channels and neurotransmitter
receptors (Fletcher et al., 1996; Patil et al., 1995; Zuo et al., 1997). Likewise,
mutation in C. elegans ion channel genes such as deg-3, deg-l and mec-4, have also
been shown to cause neurodegeneration (Hall et al., 1997; Yassin et al., 2001). In
Drosophila, mutations in Adar, which encodes an RNA editing enzyme that operates
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Figure 3.7: Synaptic excitation of motoneurons in TeTxLC
expressing embryos. A. In a wild-type embryo, whole cell current clamp
recordings from either aCC or RP2 motoneurons reveal the presence of
rhythmic synaptic depolarisations that result from the activity of
presynaptic cholinergic intemeurons. B. Expression of UAS- TeTxLC,
using the driver P(GAL4)c682, causes disruption of patterned synaptic
excitation in the motoneurons aCC/RP2. The residual activity that can be
recorded in these embryos suggests that the immediately presynaptic
interneurons have maintained the ability to release neurotransmitter.
on transcripts encoding several ion channels (Palladino et al., 2000), and vacuous, a
mutation that results in hyperexcitability of young neurons (Palladino et al., 2002),
both result in extensive loss of neurons in the adult brain. In several cases,
degeneration of neurons appears to result from defects in the glial cells required for
neuronal maintenance. For example, drop-dead (Buchanan and Benzer, 1993), repo
(Xiong and Montell, 1995; Xiong et al., 1994) and swiss cheese (Kretzschmar et al.,
1997). Alternatively, neurodegeneration can be caused by direct interference with the
mechanisms controlling apoptotic cell death (Nakano et al., 2001).
Despite the severity of the locomotor phenotype observed in s/mo''!.69ml
mutants (Figure 3.1), all available evidence suggests that the nervous system of the
Slm0t.69ml mutant initially develops normally (Carhan, 1999; Reeve, 2002). However,
the progressive nature of the phenotype presented the possibility that neuronal
circuitry was degenerating at a later stage. Certainly, the marked reduction of slmo
expression caused by the original P(GAL4)c682 enhancer trap insertion had been
shown to cause dramatic degeneration of the male germ line in a manner suggestive
of apoptosis (Carhan, 1999; also see Figure 1.3). To address this possibility, slmo
mutant larvae were sectioned and the CNS examined under the transmission electron
microscope (TEM). This approach allowed the presence or absence of cellular
degeneration within the CNS to be assessed directly, and also provides an
opportunity to look for any obvious abnormalities in the structure of the
mitochondria, to which the function of slmo has now been linked (see chapter 4).
In preparation for the TEM, slmoM9ml homozygous larvae were selected
immediately after hatching and aged for 18-20hrs. Aged larvae were then dissected
to expose the CNS, fixed, stained, and embedded in Araldite resin (2.9). Embryos
were sectioned by Anton Page (University of Southampton). Ultrathin sections were
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taken from the posterior region of the larval brain and viewed under the TEM (Figure
3.8). Heterozygous siblings were prepared in an identical manner as a negative
control. Examination of several sections from multiple samples revealed no evidence
of cellular degeneration. No vacuolisations can be seen in either the neuropil or
cortex of mutant larvae. In addition, no obvious differences were observed in cell
morphology, and the mitochondria also appeared indistinguishable from those of the
heterozygous controls. Small vacuolisations could sometimes be identified in the
cytoplasm of both neurons and glia, but these were also present in the control
samples. The eNS of aged slmo null mutant larvae therefore appears to be intact,
suggesting that cellular degeneration is not the cause of the motor phenotype.
3.2.5 Examination of axon transport in mutant larvae
The considerable distances that can separate a synapse from its cell body
places special demands on the mechanisms of cytoplasmic motility. The axon itself
supports little synthesis of proteins, making it necessary for newly synthesised
components to be continually transported from the cytoplasm of the cell body to the
presynaptic point of action (Martin et al., 1999). In addition, this anterograde
transport must be supported by a system of retrograde transport, which returns
materials back to the cell body for recycling (Schnapp, 1997). Axonal transport is
critical for the ability of a neuron to transmit signals to postsynaptic cells, and is
therefore essential for both the development and maintenance of a functional
neuronal circuit.
Intracellular transport requires the action of molecular motors that bind cargo
and generate movement coupled to ATP hydrolysis along cytoskeletal filaments.
Kinesin-I is a microtubule motor protein that facilitates the ATP dependent
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Figure 3.8: Analysis of sectioned slmoA69mlmutant eNS. Aged (l8-20hrs) simotJ.69ml
homozygotes (left column) were compared to their heterozygous siblings (right column).
Sections were taken from the posterior region of the larval brain lobes. A. Low
magnification view of the neuropil showing a complete lack of cellular degeneration in the
mutant, which is indistinguishable from the heterozygote controls. B. Mitochondria in the
neuropil exhibit no obvious morphological defects. C, D. Small vacuolisations (arrows)
can sometimes be identified in the cytoplasm of neuronal cell bodies (C) and glia (D), but
these are also present in the control larvae. Scale bar is A: 2~m, B: O.5~m, C: O.75~m (left
column), O.5~m (right column), D: O.75~m (left column), O.5~m (right COlumn).
movement of membrane bound vesicles and organelles. This protein is necessary for
intracellular transport in a variety of cellular contexts, but is particularly important in
morphologically specialised cell types, such as neurons, where cargos must be
transported over long distances (Goldstein, 2001). Native kinesin- I is a
heterotetramer composed of two heavy chains (KHC) and two light chains (KLC)
(Goldstein and Philp, 1999). Loss of function of either of these subunits results in
transport related defects of neuronal function, which manifests as a phenotype with
striking similarities to that of sima. Mutants of the khc or klc genes exhibit
progressive lethargy and locomotory defects during the second instar larval stage
(Gindhart et al., 1998; Hurd and Saxton, 1996). This leads to paralysis and eventual
lethality prior to the transition to the third instar stage. In addition, several proteins
that have been shown to interact with kinesin-I, such as Appl (Gunawardena and
Goldstein, 2001), Unc76 (Gindhart et al., 2003) and Sunday driver (Bowman et al.,
2000), exhibit similar loss of function phenotypes. These factors are thought to form
part of the mechanisms that allow kinesin-I to bind particular cargos and regulate the
response of the system to the needs of the axon and synapse. This raised the
intriguing possibility that the Slmo protein might also playa role in axon transport.
Mutations that disrupt the function of fast axonal transport motor complexes
such as kinesin-I result in defects in the trafficking of axonal cargos. These
trafficking defects include the formation of axon "clogs", which are aggregates of
membrane bound transport cargos such as synaptic vesicle precursors, prelysosomal
vesicles and mitochondria (Bowman et al., 2000; Gindhart et al., 1998). Axon clogs
can be visualised in the segmental nerves of an affected larva, and the sima enhancer
trap reports strong expression in cells that send axonal projections along these fibres
(Figure 3.9A). Given that the sima null mutation causes behavioural defects similar
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Figure 3.9: The slmo gene
product is not required for
normal axonal transport.
Segmental nerves are viewed by
confocal microscopy in
neuromuscular preparations of
aged (18-20hrs) pt instar larvae.
In all images anterior is upwards.
A. UAS-mCD8GFP reports strong
expression of the P(GAL4)c682
enhancer trap in the segmental
nerves. B. The segmental nerves
of slmo null mutant and control
(heterozygous sibling) larvae
were stained with the synaptic
vesicle marker, anti-Syt. Diffuse,
punctate staining is observed for
both genotypes. No axon clogging
is observed, indicating that axonal
transport of synaptic vesicles is
not affected by mutation in slmo.
C. The mitochondria of slmo null
mutant and control larvae are
labelled by UAS-GFP driven by
D42-GAL4. Distribution of the
mitochondria in the segmental
nerves is unaffected by slmo loss
of function. Scale bar is 50J..lm.
to those observed when axonal microtubule motor function is disrupted,
neuromuscular preparations of slmo mutant and control larvae were examined for
disruption of axonal transport. Synaptic vesicle components such as synaptotagmin
(Syt) and cysteine string protein (Csp) undergo high levels of microtubule based
axonal transport, and can be detected strongly in the axon clogs of mutants that
disrupt this function (Gindhart et al., 1998; Littleton et al., 1993). Aged 18-20hours
slmo null mutants and control heterozygous siblings were immunostained with
antisera to Syt (2.5). This revealed a diffuse, punctate staining pattern for both
genotypes, and axon clogs are not seen randomly distributed in the nerve fibres
(Figure 3.9B). Although mutations in khc, klc and unc-76 result in many large axon
clogs, the cellular phenotype of appl mutants is less dramatic, resulting instead in a
quantifiable increase of small axon clogs (Gunawardena and Goldstein, 2001). A
milder phenotype of this type cannot be formally discounted for slmo from the data
presented here. However, experience with the various kinesin related genes suggests
that the degree of axon clogging is directly related to the severity of the phenotype
(Hurd and Saxton, 1996). Indeed, appl null mutants have detectable locomotory
defects as larvae, but are viable and survive to adulthood (Gunawardena and
Goldstein, 2001). It therefore seems very unlikely to apply to the very severe
phenotype of slmo mutants.
Whilst all synaptic vesicles are exported to the nerve terminal, only a
proportion of the mitochondria are transported down the axon. However,
mitochondria are a necessity at synaptic terminals where they are not only required to
meet the energetic demands of neuronal signalling, but are also thought to play an
important role in buffering local Ca2+ concentrations (Berridge, 1998; Meldolesi,
200 I). The kinesin associated protein Milton has been shown to playa role
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specifically in the transport of mitochondria (Stowers et al., 2002). Mutation causing
milton loss of function results in axons and synaptic terminals that lack mitochondria,
whilst transport of synaptic vesicles is found to be unaffected. As a result, Milton has
been suggested as an adaptor protein, or part of an adaptor complex, that links the
appropriate kinesin motor to mitochondria. Given the association of Slmo with the
mitochondria (see chapter 4), it was important to test whether the slmo mutant
phenotype might result from a mitochondria specific transport defect. To achieve
this, the mitochondria were labelled using a GFP fusion protein that is targeted to the
mitochodria by a well characterised localisation sequence. This reporter fusion,
referred to as mitoGFP, was expressed under VAS control driven by D42-GAL4,
which causes expression of the VAS construct in (almost) all motor neurons (A.
Pilling, pers. comm.). The D42-GAL4 and VAS-mitoGFP transgenes were
conveniently recombined together on the third chromosome resulting in permanently
maintained expression (A. Pilling, pers. comm.). Viewed under confocal microscopy,
mitochondria can be clearly seen distributed along the segmental nerves. When
VAS-mitoGFP is expressed in a slmo mutant background, the distribution of the
mitochondria is indistinguishable from wild type (Figure 3.9C). From these data, it is
possible to eliminate defective axon transport as a possible cause for the slmo mutant
phenotype.
3.3 Discussion
This chapter describes a mutant phenotype demonstrating the requirement for
slmo in normal larval locomotor activity. Newly hatched slmo null mutants are
mobile, but their ability to generate rhythmic locomotory peristaltic contraction
waves is severely impaired. This phenotype subsequently progresses towards total
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inactivity, although the ability to move the head and mouth parts is retained. In
addition, I have reported an expression pattern that strongly suggests slmo operates
primarily in the CNS throughout early development. Taken together, these data
implicate slmo as a candidate for regulating the patterned motor output that drives
basal locomotor activity in larvae.
A number of mutations defective in larval motor function have been isolated,
and these are involved in a variety of developmental processes. For example,
mutations in acj6 result in larval locomotory phenotypes as a result of defects in
axon pathfinding and synaptic connectivity of specific neurons, which is regulated by
the POU transcription factor that the gene encodes (Certel et al., 2000). Likewise,
various mutant alleles of hikaru genki (hig) result in locomotory defects at both
larval and adult stages, and in this case appears to encode a synaptic adhesion
protein, as observed by abnormal synapse development in the mutant (Hoshino et al.,
1999; Hoshino et al., 1996). Previously reported data on slmo suggest that this
phenotype does not result from a gross defect in the development of the nervous
system. Various preparations stained with markers ofCNS morphology, combined
with electrophysiological analysis, suggest that CNS morphology is normal, the
neuromuscular junctions are intact, and all axonal processes are visible (Carhan,
1999; Reeve, 2002; R. Baines, pers. comm.). Although subtle abnormalities in
central or peripheral nervous system development cannot be formally eliminated, the
evidence available suggests that the basic circuitry required for larval locomotion is
initially established. The disruption of motor output observed in slmo mutants would
therefore appear to be the result of a defect at the functional stage of neuronal
circuitry development or the modulation of an intact circuit's output. Alternatively,
the circuit might have developed, but then degenerated at a later stage.
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The data presented here addresses two possible hypotheses for the cause of
the slmo phenotype. Firstly, examination of sections from the slmo mutant CNS
established that there was no visible degeneration of the mutant eNS. In addition,
examination of sections under the transmission electron microscope revealed no
obvious abnormalities in the structure of neurons, glia or mitochondria (Figure 3.6).
Secondly, analysis of neuromuscular preparations with markers of synaptic vesicles
and mitochondria demonstrated that the phenotype was not caused by an impairment
of the axonal transport machinery.
Given the highly restricted expression pattern initially observed in stage 16
embryos, I had initially hoped that a very discrete neuronal population could be
identified that was critical in driving larval locomotion. This would then provide a
starting point to begin unravelling the cellular basis of this patterned motor output.
By stage 17 of embryogenesis, expression of the enhancer trap has expanded to a
limited, but much larger population of cells, which are probably of heterogeneous
neuronal cell types (Manseau et al., 1997). Expression ofTeTxLC in this neuronal
subset results in a phenotype, which is superficially similar to that observed in slmo
mutants, but with an increased severity that prevents the embryos from hatching. In
this case the severe impairment of peristaltic movement is accompanied by a clear
decrease in the synaptic drive to motoneurons. The fact that the motoneurons of toxin
expressing embryos have some synaptic input indicates that expression is not found
in the immediately presynaptic population of cholinergic interneurons (Baines et al.,
2002). This suggests that the enhancer trap does in fact mark a poorly defined
population of neurons that includes interneurons presynaptic to those that directly
synaptically drive the motoneurons. Initially it would be desirable to gain more
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information on the identity of the neurons marked by P(GAL4 )c682 at this stage and
look for overlapping enhancer trap patterns that generate similar phenotypes.
Interestingly, after hatching, at the time when the slmo mutant phenotype first
becomes apparent, reporter expression becomes markedly more refined. In the VNC,
strong reporter expression marks a very discrete set of dorsally positioned neuronal
cell bodies. which may represent motoneurons (Figure 3.4). Certainly, neuronal
projections are clearly visible along the segmental nerves as well as in the neuropil.
In the brain lobes, a small group of cell bodies are labelled in the cortex which
project into specific regions defined as the dorsal neuropil and basoanterior neuropil
compartments (Younossi-Hartenstein et al., 2003). In addition, this concise pattern of
expression appears to persist into later larval stages (Figure 3.5). Enhancer traps will
often report incomplete or extraneous expression that does not accurately represent
the corresponding endogenous gene. However, whilst the limitations of the enhancer
trap as a reporter of endogenous gene expression should be acknowledged. the
expression pattern described here is compelling with regards to the potential function
of slmo in the nervous system. The implication is that slmo plays a critical role in
modulating the functional output of only a small set of CNS neurons that are
essential for a stereotyped motor output. It would be interesting to inactivate the
neurons expressing GAL4 at the larval stages using a conditional effector gene such
as UAS-shibiretsl (Kitamoto, 2001), and look for a locomotor phenotype comparable
to that caused by slmo loss of function.
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Chapter 4: Subcellular Localisation of Slmo
4.1 Introduction
The severe behavioural phenotype and subsequent lethality caused by loss of
slmo function suggests a vital role for the Slmo protein. However, very little is
known about the biochemical function of Slmo, which contains no characterised
domains and no defined localisation signals. Establishing the localisation of the
protein within the cell is an important step towards establishing the cellular processes
that involve Slmo. Several unsuccessful attempts have been made in our lab to raise
an antibody to Slmo, which could be used to label the protein and determine its
localisation at both the cellular and subcellular level (Carhan, 1999; Reeve, 2002).
Most recently, Reeve (2002) was able to produce an antibody that could be used to
detect Slmo on western blots, but did not work in whole mount preparations.
Although very little information was available about the nature of the Slmo
protein, it was known that the S. cerevisiae homologue MSFlp' had been linked to
the mitochondria. Researchers in Toshia Endo's lab (Nagoya University) had
identified MSFl' while cloning the YAP19 gene (Nakai et al., 1993). Deletion of this
gene is not lethal, but a myc-tagged fusion was reported to localise to the inner
mitochondrial membrane. In addition, over-expression of the gene was reported to
alter the location of a reporter directed to the mitochondrial intermembrane space (T.
Endo, pers. comm.). Following this, it was shown that the antibody raised by Reeve
(2002) was occasionally able to detect Slmo in the cytoplasm of the Drosophila
Schneider 2 (S2) cell line. A punctate pattern was observed throughout the cytosol,
as would be expected for the mitochondria (Reeve, 2002), although this staining was
inconsistent and not reproducible.
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An alternative approach is to engineer and express a version of the
Drosophila Slmo protein which carries an easily detectable molecular tag. The green
fluorescent protein (GFP) of Aequorea victoria is now used widely for this purpose,
as its unique fluorescent properties provide a convenient way of visualising the target
protein (Chalfie, 1998). GFP generates a strongly fluorescent signal in heterologous
cell types, without the addition of any extrinsic factors. Importantly, it can be fused
to other proteins without disrupting its fluorescent properties, and the resulting
chimera will often retain the normal functions and localisations of the host protein.
GFP fusions have now been successfully targeted to virtually every major organelle,
including plasma membrane, nucleus, endoplasmic reticulum, Golgi apparatus,
secretory vesicles, peroxisomes and the mitochondria (Chalfie, 1998). The range of
applications of GFP have also been expanded by the isolation of mutant variants with
altered spectral properties, such as the enhanced fluorescence of EGFP (enhanced
GFP) and S65T, and the shifted excitation and emission spectra ofBFP (blue), YFP
(yellow), RFP (red) and CFP (cyan) (Chalfie, 1998).
This chapter documents attempts to gain further insight into the function of
the Slmo protein by expressing GFP fusions in mammalian cell culture, and also in
transgenic flies. There is considerable precedent for both these approaches (Rizzuto
et al., 1995; Wang and Hazelrigg, 1994). Although the Slmo protein is expressed in
the D. melanogaster S2 cell line (Reeve, 2002), analysis of a Drosophila fusion
protein in a well established mammalian fibroblast cell line has a number of
important practical advantages. In particular, these cells are morphologically large
and flat, providing an excellent system in which to study a cytoplasmic protein, and
are also relatively easy to manipulate and transfect. GFP is often used in transgenic
organisms to study complex phenomena such as the regulation of gene expression,
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dynamics of organelles or protein sorting (e.g. chapter 3; Rizzuto et al., 1995; Yeh et
al., 1995). The production of transgenic flies, which express GFP tagged Slmo under
the control of the endogenous promoter and is able to rescue the mutant phenotype,
would present a means to confidently assess the spatial and temporal expression of
Slmo. In addition, a commercially available antibody could be used to label the
protein in fixed Drosophila tissues and refine the localisation of the protein under the
electron microscope. For example, if Slmo were indeed a mitochondrial protein, it
would be possible to determine in which compartment(s) of the organelle the protein
operates.
4.2 Results
4.2.1 Production of slmo-GFP and GFP-slmo fusion constructs
The expression of tagged protein constructs in mammalian cell lines is a
commonly employed method for studying the relationship of the target protein with
the cell. As a result, a variety of useful expression vectors are now commercially
available for this purpose. Tagging a protein with GFP is often successful in
generating a fusion that maintains all or some of the normal functions and
localisation of the target protein. Certainly, it is not uncommon that the fusion ofa
GFP tag to the N-terminus of the target protein results in success, whilst the
equivalent C-tenninal fusion will result in failure, or vice versa (Chalfie, 1998). It
has therefore become common practice to engineer both types of fusion protein and
analyse the results in parallel. The vectors pEGFP-NI and pEGFP-CI (Clontech)
provide a convenient means for the construction and expression of both N- and C-
terminal GFP fusion proteins. The protein coding sequence of interest can readily be
cloned in frame either upstream (EGFP-NI) or downstream (EGFP-CI) of an EGFP
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coding sequence. When these constructs are transiently transfected into a cultured
mammalian cell line, such as the NIH-3T3 fibroblast line used here, fusions are
expressed under the control of the human cytomegalovirus (CMV-E1) promoter.
4.2.1.1 Cloning of slmo coding sequence into mammalian expression vectors
Three constructs, based on the mammalian expression vectors EGFP-N 1 and
EGFP-Cl, were designed to express Slmo-GFP fusion proteins in mammalian cell
culture. An N-terminal fusion ofGFP (GFP-slmo), a C-terminal fusion (slmo-GFP),
in which the slmo ORF is preceded by 20bps of endogenous 5'UTR, and a second C-
terminal fusion (slmo-GFP') in which the slmo ORF is preceded by the vertebrate
Kozak consensus sequence, GCCACC (Kozak, 2000). In all three cases PCR primers
were designed to add both an EcoRI site upstream of the ORF, and a downstream
KpnI site to enable cloning into the expression vectors. For the construction ofGFP-
slmo, the primers used were 5'- aagcttgaattcgATGAAAATCT GGACATCG-3' and
5' -aagcttggtaccGTCGACACCT ACGT AATG-3'. For slmo-GFP, the primers were
5' -aagcttgaattcCGACAACGGCGCTTGCA T-3' and 5' -aagcttggtaccCCCGT AATG
TGCATCGCCTT-3', and for slmo-GFP', the primers were 5'-aagcttgaattcGCCACC
ATGAAAATCTGGACATCG-3' and 5' -aagcttggtaccCCCGT AATGTGCATCGCC
TT-3' (EcoRI and KpnI sites are underlined). For slmo-GFP and slmo-GFP' the
primer pairs were designed to delete the endogenous slmo UAG stop codon.
With each primer pair the slmo coding sequence was amplified using a
standard protocol for Pwo DNA polymerase (2.2.3.3), an enzyme with a high fidelity
of synthesis. The slmo cDNA (referred to as 2A7) previously isolated by Carhan
(1999), was used as the template for all three PCR reactions. Figure 4.1 shows the
three amplified PCR products at the expected size for slmo. The PCR fragments were
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1018bp
506/517bp
Figure 4.1: peR amplification of the slmo coding region. Three
different primer pairs were used to amplify and modify the slmo
coding sequence for the construction of GFP-slmo, slmo-GFP and
slmo-GFP'. Following amplification, all three products were
resolved on an agarose gel, and single bands found to migrate
between lOl8bp and 506/517bp standard markers consistent with the
expected size of 648bp.
then cloned (2.2.2) into corresponding restriction sites in the EGFP-Cl (for GFP-
slmo) or EGFP-Nl (for slmo-GFP and slmo-GFP') vectors. Plasmid DNA was
isolated (2.2.2.8) and the presence of the inserts confirmed by digestion with EcoRI
and KpnI restriction enzymes (Figure 4.2).
4.2.1.2 Confirmation of fusions by in vitro transcription/translation
In order to confirm that the three fusions are translated, in vitro coupled
transcription-translation reactions were performed (2.4.6). The system used to
perform these reactions requires standard T7, SP6 or T3 promoters for the
transcription step, none of which are present in the EGFP- N I or -C 1 vectors. For this
reason all three fusion coding sequences were subcloned into the pBluescriptIIKS
(pBKS) vector which carries both T7 and T3 promoters. The slmo-GFP and slmo-
GFP' ORFs were released from the EGFP-Nl vector by digestion with NotI and Sad
restriction enzymes, whilst GFP-slmo was excised using KpnI and Nhel. These
fragments were then purified from an agarose gel and ligated into the corresponding
restriction sites in pBKS (2.2.2). In the case of GFP-slmo the NheI site was ligated
into the compatible XbaI site in the pBKS polylinker. Cloned plasmid DNA was
digested with restriction enzymes to confirm the presence of the correctly sized
inserts in all three constructs (Figure 4.3A). In each case the fusion coding fragments
were orientated so that transcription can be initiated from the upstream T7 promoter
(Figure 4.3B).
The in vitro transcription-translation reactions were performed in the
presence of 35Smethionine and a fraction of each reaction was resolved by SDS-
PAGE (2.4.4). An autoradiograph of this gel is shown in Figure 4.3C, and indicates
that both slmo-GFP and slmo-GFP' are translated in vitro. The size of both these
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Figure 4.2: Production of GFP fusion constructs. Three constructs were
engineered to express Slmo fused to GFP. The N-terminal fusion, GFP-
slmo, was produced by cloning the slmo ORF into the pEGFP-Cl vector.
The C-terminal fusions, slmo-GFP (slmo ORF is preceded by 20bps of
endogenous 5'UTR), and slmo-GFP' (slmo ORF is preceded by the
vertebrate Kozak consensus sequence, GCCACC) are based on pEGFP-Nl.
A. Gel showing diagnostic EeoRI and KpnI double digests. The presence of
the slmo insert (arrow) is confmned in all three constructs. B. Schematic
plasmid maps of GFP-slmo and slmo-GFP (identical to the slmo-GFP' map),
showing relative positions of the EeoRI and KpnI sites.
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Figure 4.3: Expression of fusion proteins in vitro. A. The GFP-slmo, slmo-GFP and slmo-GFP'
ORFs were subcloned into the vector pBluescript (pBKS). The presence of the inserts was
confmned by digestion with either Sad and KpnI (for GFP-slmo) or EcoRI (for slmo-GFP and
slmo-GFP'). The GFP-slmo insert is released as two fragments of approximately 730bp and 650bp
as Sad cuts in between the EGFP and slmo coding sequences. The slmo-GFP and slmo-GFP'
ORFs are both released as single fragments at approximately 1.4kb. B. Schematic plasmid maps
showing the position of the GFP-slmo and slmo-GFP inserts (identical to slmo-GFP') relative to
the relevant restriction sites and the T7 promoter. C. Autoradiograph of an SDS-PAGE gel
showing the products of in vitro transcription-translation reactions using the above plasmids as
templates. For Simo-GFP and Slmo-GFP' product is detected at the predicted size of 52kDa (blue
arrow). The GFP-Slmo clone is not translated in this system.
fusion proteins is consistent with the predicted size of 52kDa (Slmo alone is 25kDa,
GFP alone is 27kDa). Surprisingly, no product is apparently translated from the
GFP-slmo construct, which was subsequently sequenced to confirm the integrity of
the open reading frame. It is true that the rabbit reticulocyte lysate system used to
perform the transcription-translation reaction is prone to substantial variation in
efficiency (D. Murphy, pers. comm.), or it may simply be that the GFP-slmo
fragment subcloned into pBKS is missing upstream sequences that are important for
translation of the EGFP coding sequence.
4.2.1.3 Localisation of fusion proteins to the mitochondria
NIH-3T3 fibroblasts were cultured on coverslips and transiently transfected
with the pEGFP-Nl and -Cl based expression constructs slmo-GFP, slmo-GFP' and
GFP-slmo (2.6.3). The vector plasmid pEGFP-NI was also used as a positive control
for the transfection, as lone EGFP should be expressed strongly in transfected cells.
In addition, the absence of any localisation signals means that EGFP should be
expressed ubiquitously within the cell, and therefore also acts as a negative control
for the subcellular localisation of the fusion proteins. Following transfection, cells
were treated with MitoTracker Red CMXRos (Molecular Probes, see methods 2.6.3);
a red fluorescent die that stains the mitochondria of live cells and is resistant to
fixation. The cells were then fixed briefly in paraformaldehyde before labelling the
nucleus by OAPI staining (2.6.3). Cells were mounted on slides and analysed by
fluorescence microscopy.
All three fusion proteins were expressed in cell culture and could be
visualised by their green fluorescence, including GFP-Slmo, which was not
successfully expressed in vitro. In each case, the tagged Slmo protein was found
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exclusively in the cytoplasm in a punctate pattern. Consistent with observations in
the S. cerevisiae system (T. Endo, pers. comm.), all three fusion proteins were seen
to co-localise with the mitochondrial marker MitoTracker Red (Figure 4.4A-C),
confirming that the Drosophila Slmo protein is indeed associated with the
mitochondria. As expected, EGFP was found to be ubiquitous within the cell when
expressed alone as a control, and does not co-localise with MitoTracker Red (Figure
4.4D).
4.2.2 Production of Drosophila GFP fusion transgenics
Transgenic Drosophila lines containing slmo based transgenes have been
produced on two previous occasions. Carhan (1999) isolated a 2kb genomic Psti
fragment, which contains the entire sima gene (Figure 4.5), and cloned this into the
pCaSpeR-hs P-element vector. In this way transgenic lines were established that
express sima under the control ofa heat shock inducible promoter. No
overexpression phenotypes were observed, but the transgene was able to rescue the
mutant phenotype even without the need for a heat shock regime, suggesting that the
construct contains all the endogenous regulatory sequences required for normal slmo
function. In this case, a promoter within the first exon and intron, which drives the
2021 transcript (see Figure 1.1), would therefore seem to be both necessary and
sufficient for essential sima expression.
As a method for studying the expression of sima, Reeve (2002) chose to
analyse the activity of the putative promoters. Arbitrarily chosen fragments
containing presumptive promoter sequences (referred to as the "short" and "long"
promoters, see Figure 4.5) were cloned into the pCaSpeR-AUG-~gal vector, which
facilitates the analysis of promoters by allowing them to drive the expression of a
93
GFP
A.
B.
c.
D.
MitoTracker
Red Merge
Figure 4.4: Localisation ofN- and C-terminal GFP-tagged Slmo in NIH-3T3
fibroblasts. NIH-3T3 fibroblasts were transiently transfected with the expression
constructs GFP-slmo, slmo-GFP and slmo-GFP'. After 24 hours, cells were fixed and
labelled with the red fluorescent mitochondrial marker MitoTracker Red (centre column),
and the nuclear marker DAPI (blue), before analysis by fluorescence microscopy at lOOx
magnification. The green fluorescent fusion proteins (left column) GFP-Slmo (A), Slmo-
GFP (B) and Slmo-GFP' (C) are cytoplasmic, and co-localise with MitoTracker Red (right
column). D. EGFP expressed alone is present in both the cytoplasm and the nucleus, and
does not co-localise with MitoTracker Red. Scale bar: 5)lm.
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Figure 4.5: Schematic map showing the genomic fragment used to generate
GFP-slmo and slmo-GFP transgenes. PCR primers were designed to amplify
and clone a 3.6kb genomic fragment using the genomic 6kb BamHI fragment
cloned by Carhan (1999) as a template for the reaction. All numbers on the map
refer to the original 6kb fragment (appendix l ). The transcripts 2A7 (green
blocks) and 2021 (grey blocks) are mapped relative to the 3.6kb fragment, and
sequences previously included in Drosophila transgenes. The "2kb" PstI
fragment had been introduced into transgenic flies under the control of a heat-
shock inducible promoter, but was found to be sufficient to completely rescue the
slmo null mutation without requiring a heat-shock regime (Carhan, 1999). The
"short" promoter was shown to drive expression of a lacZ reporter gene in the
larval nervous system and both larval and adult gonads, and is presumably
responsible for regulating the 2021 transcript. The fragment labelled "long"
promoter was included in a similar trans gene and shown to have only weak
promoter activity. Schematic is for reference and is not to scale.
lacZ reporter gene. As expected, reporter expression was observed from both
constructs in the larval CNS, and the larval and adult gonads, although these
constructs did not report any expression in the embryo. Interestingly, it was noted
that the short promoter, which is thought to drive expression of the 2021 transcript,
produced considerably stronger expression of the reporter gene than the long
promoter thought to drive 2A7. This provides further evidence that the regulatory
sequences important for slmo expression are contained within the 2kb Pstl fragment
cloned by Carhan (1999).
The promoter analysis provides a study of the expressional activity of isolated
genomic sequences, but its value as a reporter of endogenous slmo gene expression is
questionable. Endogenous promoters form only one component of the process of
regulating gene expression, and their activity is often modulated by interaction with
other regulatory sequences such as enhancer or suppressor elements. In addition,
expression reported from these constructs does not take into account regulation in the
post-transcriptional phase, and are therefore not a satisfactory substitute for a Slmo
specific antibody. However, given that the putative promoter sequences have been
shown to have activity (Reeve, 2002), and that only a portion of these sequences was
required for rescue of the phenotype (Carhan, 1999) I reasoned that presumptive
promoters could be employed to drive the expression of Slmo-GFP and GFP-Slmo
fusion proteins. Ideally, these fusions would be functional in vivo, and would rescue
the mutant phenotype. This approach would therefore have important advantages
over the promoter constructs, as rescue of the mutant by a functional gene product
proves that no important regulatory sequences are absent. In addition, the dynamics
of the functional protein could be readily observed within the cell by GFP
fluorescence or immunohistochemistry.
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4.2.2.1 Construction of slmo-GFP and GFP-slmo transgenes
PCR primers were designed to amplify a 3.6kb genomic fragment containing
the entire sequence which had previously been shown to rescue the slmo mutant
(Carhan, 1999), and 1.6kb of additional upstream genomic sequence which had been
shown to have weak promoter activity (Reeve, 2002; Figure 4.5). A previously
cloned 6kb genomic BamHI fragment (Carhan, 1999) was used as a template for the
reaction. The primers were 5' -gcggccgcggatccGGCGTTCCGCTGGGGCTTCC-3'
and 5' -gcggccgcggatccTTT ATACACAGAA TGCTT AA-3'. These primers add
BamHI sites (underlined) to each end of the PCR fragment, which were used to clone
the fragment into the corresponding sites in the pBluescript vector (Figure 4.6A).
To generate N- and C-terminal GFP fusions, it was necessary to introduce
restriction sites either immediately upstream or downstream of the slmo open reading
frame to facilitate cloning of the GFP coding sequence in frame with the slmo coding
sequence. This was achieved using the QuikChange ™ in vitro site directed
mutagenesis kit from Stratagene (2.2.6). A pair of oligonucleotide primers was
designed, each complementary to opposite strands of the target vector, and
containing the desired mutation. These were extended during thermal cycling by
PfuTurbo DNA polymerase, which replicates both strands with high fidelity.
Incorporation of the primers generates mutated copies of the plasmid containing
staggered nicks. The parental DNA is removed by digestion with DpnI, an
endonuclease which specifically cuts methylated and hemimethylated DNA (such as
the dam methylated template isolated from E.coli strains). The nicked, mutated
plasmid DNA was then transformed into the supercompetant cell line XLI-Blue
where the nicks were repaired. For the production ofGFP-slmo, a BstEII site was
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Figure 4.6: Introduction of the EGFP coding sequence into the slmo gene. A. A 3.6kb genomic
DNA fragment, containing the slmo gene and putative promoter sequences, was cloned into the
BamBI sites of the vector pBKS. The presence of the 3.6kb insert was confirmed by digestion with
BamHl. B,C. To generate N- and C- terminal fusions site directed mutagenesis was used to introduce
estEll or Sphl restriction sites either immediately upstream (for EstEH) or immediately downstream
(for SphI) of the slmo ORF to facilitate the in frame cloning of the EGFP coding sequence. B. The
introduction of the new restriction sites was confirmed by linearisation of the plasm ids by digestion
with either estEll or Sphl. C. Schematic showing the positions of the site directed mutagenesis
primers (black arrows) and the introduced restriction sites to the original 3.6kb genomic fragment,
the slmo gene (green/grey blocks), and the slmo ORF (black blocks). Numbers refer to the sequence
in appendix 1. Schematic is for reference and is not to scale. D. The EGFP coding sequence was
cloned into the estEll and SphT sites. The presence of the insert was confirmed in both constructs by
digestion with the relevant enzyme.
introduced immediately upstream of the endogenous sima start (AUG) codon using
the following HPLC purified complementary primers: 5'-
GACAACGGCGCTTGCA TAggtcaccATGAAAA TCTGGACA TCGGAGC-3' and
5' -GCTCCGA TGTCCAGA TTTTCATggtcaccT ATGCAAGCGCCGTTGTC-3'. For
the production of slma-GFP, an SphI site was introduced immediately 5' of the
endogenous sima stop (TAG) codon using the primers 5'-
GAAGGCGA TGCACATT ACGgcatgcT AGGTGTCGACAAGGCGACAG-3' and
5' -CTGTCGCCTTGTCGACACCTAgcatgcCGT AATGTGCATCGCCTTC-3'
(enzyme sites are in lower case). Mutated clones were isolated from bacterial culture
(2.2.2.8) and the DNA cut with BstEII or SphI to confirm the introduction of the new
restriction site (Figure 4.68).
The EGFP coding sequence was amplified from the EGFP-Nl vector plasmid
using two different pairs of primers which add either BstEII or SphI sites to the ends
of the amplified fragments. The primers used to amplify with BstEII sites
(underlined) were 5' -gcggccgcggtcaccATGGTGAGCAAGGGCGAG-3' and 5'-
gcggccgcggtcacCTTGTACAGCTCGTCCAT-3' and for the addition of SphI sites
(underlined) the primers were 5'-gcggccgcgcatgcATGGTGAGCAAGGGCGAG-3'
and 5' -gcggccgcgcatgcCTTGT ACAGCTCGTCCA T-3'. The amplified fragments
were then ligated into the corresponding restriction sites in the mutated 3.6kb BamHI
fragment clones to generate GFP-slma and slma-GFP. Twelve individual BstEII
clones and eleven SphI clones were isolated and screened for clones in which the
EGFP insert was in the correct orientation (i.e. the same orientation as the sima
coding sequence) by sequencing across the linkers using the primers 5'-
CCATCTATCGGAGCCACTGTCATC-3' (for sequencing across the BstEII linker
in GFP-slma) and 5'-AGGACCTGCTCACCTCGACCATTA-3' (for sequencing
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across the SphI linker in slmo-GFP). The EGFP coding sequence was found to have
inserted in the correct orientation in eight of the GFP-slmo (BstEII) clones and nine
of the slmo-GFP (SphI) clones. Figure 4.60 shows examples of these GFP-slmo and
slmo-GFP clones with the EGFP insert released from the plasmid by digestion with
BstEII or Sphl.
Sequencing of the clones revealed that an error had been introduced
specifically in the slmo-GFP clones, presumably during the mutagenesis process. A
single thymine residue had been deleted from position 3117 (appendix 1) near the
end of the slmo coding sequence. This presented a problem, as any coding sequence
downstream of this point mutation (including the entire EGFP coding sequence) will
have been shifted out of frame. This was solved by performing in vitro mutagenesis
(2.2.6) on a slmo-GFP clone for a second time using a complementary primer pair
designed to reintroduce the deleted residue. In addition, the primers were purified by
polyacrylamide gel electrophoresis (PAGE) rather than HPLC to increase the purity
and hopefully the efficiency. The primers used were 5' -GAAGGCGA TGCACA TTA
CGgcatgcA TGGTG-3' and 5' -CACCA TgcatgcCGT AATGTGCA TCCCTC-3' (the
reintroduced residue is underlined in bold, the EGFP "start" codon is in bold, and the
SphI restriction site is in lower case). "Reverted" slmo-GFP clones were isolated, cut
with SphI to release the EGFP coding sequence and confirm their identity, and then
resequenced across the linker to confirm the reintroduction of the missing thymine
residue (and the absence of any additional errors).
In order to generate transgenic Drosophila, it was necessary to subclone the
entire GFP-slmo and slmo-GFP gene constructs (including putative regulatory
sequences) into a P-element transformation vector. The entire GFP-slmo and slmo-
GFP inserts were excised from the pBluescript vector by double digestion with
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BamHI, which releases the insert from the vector and Seal, which cuts within
pBluescript and allows easier resolution of the fragments on an agarose gel. The
inserts were excised and purified from the gel then ligated into the BamHI site of
pCaSpeR3 (Thummel, 1992) a P-element vector which contains the inverted repeat
sequences, and selectable marker genes (white+) required for transformation, but
does not contain any additional promoter or enhancer sequences (Figure 4.7). These
constructs are referred to as pGFP-slmo and pslmo-GFP.
4.2.2.2 Generation of transgenic Drosophila
The plasmids pGFP-slmo and pslmo-GFP were each co-precipitated with the
helper plasmid p1t~-3 and injected into yw embryos (2.7.1). The helper plasmid
codes for the P-transposase enzyme needed for the integration of the trans gene into
the Drosophila genome. The helper plasmid itself is unable to integrate into the
genome and is lost during cell division, whilst the integrated trans gene becomes
stable.
2403 yw embryos were injected with the plasmid pGFP-slmo, just 124 (5.2%)
of which hatched into larvae and 34 (1.4%) eclosed as adults. 1734 yw embryos were
injected with the plasmid pslmo-GFP, of which 50 (2.9%) hatched and only 8
(0.46%) eclosed as adults (2.7.2). The adults were crossed individually to flies of the
genotype w; CyO/Sp and the progeny screened for the red-eyed phenotype that would
indicate the fly was carrying the white+ marker gene carried by the P-element. Many
of the adults proved to be sterile (20% of those injected with pGFP-slmo, and 12.5%
of those injected with pslmo-GFP) as is common following the injection process.
Three of the adults injected with pGFP-slmo generated red-eyed progeny, and a total
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Figure 4.7: Production of the GFP fusion transgenes. The entire GFP-
slmo and slmo-GFP gene constructs (see Figure 4.6) were subcloned into
the P-element transformation vector pCaSpeR3 to generate the transgene
constructs pGFP-slmo and pslmo-GFP. A. Constructs were cut
diagnostically with the enzymes BamHI (releases the entire gene from the
pCaSpeR3 vector), EcoRI and HindIll (which cut at sites in the vector
allowing orientation to be determined, and either BstEll (for pGFP-slmo)
or SphI (for pslmo-GFP) to release the EGFP coding sequence. B.
Schematic plasmid maps showing the position of the GFP-slmo and slmo-
GFP insets (identical to slmo-GFP') relative to the relevant restriction sites.
of 7 transgenic individuals were obtained. No transgenic flies were obtained from the
injection with pslmo-GFP.
For each transgenic individual, the transgene was genetically mapped by
crossing to flies of the genotype w; CyOllj; TM68/MKRS (2.7.3). Out of the 7
pGFP-slmo transgenic flies obtained, 6 (designated 2Ft, 3MI, 3F2, 4M2, 4F2, 4F3)
were found to have inserted on the third chromosome, whilst the remaining I
(designated 4MI) was located on the second chromosome. In addition, two of the
transgenic lines, 3MI and 4F2, are not homozygous viable and have to be genetically
maintained over the TM68 balancer chromosome. From this it could be determined
that at least 6 independent trans gene insertions have been isolated, whilst the lines
4M2 and 4F3 may represent the same insertion event. The seven transgenic lines are
summarised in Table 4.1.
Table 4.1 Summary of transgenic lines.
Chromosome Homozygous viable Notes
2F1 3rd Yes
3F2 3rd Yes
3M1 3rd No Maintained over TM6B balancer
4M1 2nd No Maintained over CyO balancer
4M2 3rd Yes Maybe same insertion as 4F3
4F2 3rd No Maintained over TM6B balancer
4F3 3rd Yes Ma_y_besame insertion as 4M2
4.2.2.3 Analysis of transgenic lines
Having obtained stable transgenic lines it was initially important to confirm
the presence of the insert in the genome by molecular analysis. To accomplish this,
genomic DNA was prepared from the six third chromosome lines 2F I, 3M I/TM6B,
3F2, 4M2, 4F2/TM6B and 4F3 (2.2.4). The second chromosome line 4M 1 proved to
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be a very sick stock which was maintained with difficulty as a population of less than
15 flies, making it impractical to remove flies for genomic DNA extraction. Genomic
DNA extracts were used as the template for PCR reactions using the primers 5'-
gcggccgcgcatgcA TGGTGAGCAAGGGCGAG-3' and 5' -gcggccgcgcatgcCTTGT A
CAGCTCGTCCAT-3' which amplify the entire EGFP coding sequence (without the
"stop" codon), a sequence not found in the yw line originally injected). In all six
lines, a fragment of the predicted size was amplified, thereby proving that these lines
carry the pGFP-slmo transgene (Figure 4.8A).
To determine whether the fusion protein is expressed in these transgenic
lines, total fly protein was extracted from each of the six 3rd chromosome lines
(2.4.1), and a western blot analysis (2.4.5) was performed using a commercially
produced rabbit polyclonal antibody to GFP (Ab290, AbCam). In addition, the
western blot was also performed on protein extracted from line known to be
expressing GFP strongly (Cha-GAL4; UAS-GFP, see Table 2.1) as a positive
control, and the wild type line CS as a negative control (Figure 4.88). No bands were
detected at the expected size for the fusion protein (57kDa) in any of the six
transgenic lines analysed, suggesting that the fusion protein is not expressed.
Examination of dissected adult, embryonic and larval CNS, and both adult testes and
ovaries revealed no fluorescence confirming that GFP-Slmo fusion protein, under the
control of putative endogenous regulatory sequences, is not expressed in any of the
transgenic lines produced here.
4.3 Discussion
The data presented in this chapter demonstrates an association of Slmo with
the mitochondria. When expressed in a mammalian fibroblast cell line, both N- and
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Figure 4.8: Analysis of pGFP-slmo transgenic lines. A. PCR for the detection of the EOFP
coding sequence in Drosophila genomic DNA. Genomic DNA was extracted from six
putative transgenic lines. In all six lines a fragment was amplified at the predicted size of
7l7bp confirming the presence of the trans gene. No band was detected for the wild-type line
Canton S (CS). B. Homogenates were prepared from the six transgenic lines, and subjected to
western immunoblotting using a commercially available polyclonal antibody to OFP (Ab290,
AbCam). A fly line known to be expressing OFP strongly (Cha-GaI4; UAS-OFP, lane 7),
were included as a positive control, and a strong band is detected at approximately 27 kDa as
expected for OFP. CS flies were also included as a negative control (lane 8). The fusion
protein OFP-Slmo is predicted to run at 57kDa (OFP is 27kDa, Slrno runs a 30kDa, see
Reeve, 2002). No band is detected at this size in any of the six transgenic lines. Bands at
approximately 30, 36 and 50kDa are present in all lanes including the controls, and are
presumably the result of non-specific binding of the antibody. C. Coomasie stained gel run in
concert with A to show equivalence of loading.
C-tenninal GFP fusions of Slmo co-localise with the mitochondrial marker
MitoTracker Red. This finding is consistent with subcellular localisation reported for
the yeast homologue MSFlp' (Huh et al., 2003; T. Endo, pers. comm.), and is now
complemented by biochemical data reported by Reeve (2002). In this case it was
shown that the Slmo protein co-localises with the mitochondrial markers succinate
dehydrogenase and cytochrome-C in a sucrose gradient fractionation of adult
Drosophila cells. Slmo therefore appears to represent a completely novel class of
conserved mitochondrial proteins. Although the nature of the association with the
mitochondria has not yet been defined, the lethality exhibited by Slmo mutants
(chapter 3) combined with the observation that the protein is highly conserved in
evolution (chapter 5), suggests that Slmo fulfils a critical function. However, Slmo is
the first of this protein class to be analysed for loss of function.
What precisely is the functional relationship of Slmo with mitochondria, and
how might this affect the functional characteristics of Slmo expressing neurons?
Several genes encoding mitochondrial proteins generate behavioural phenotypes
when mutated, although their biochemical functions are diverse. For example,
mutation of the lamas gene, which encodes the catalytic subunit of mitochondrial
DNA polymerase, leads to impaired movement at the third instar larval stage and
eventual lethality and is also required for normal development of the larval visual
system (Iyengar et al., 1999). sluggish-A encodes mitochondrial proline oxidase, an
enzyme involved in glutamate biosynthesis and is expressed primarily in the
embryonic CNS, although loss of function has only been shown to cause impaired
locomotor behaviour in adult flies (Hayward et al., 1993). Mutations of the stress-
sensitive B gene, which encodes an inner mitochondrial membrane ATP/ADP
antiporter, have also been reported to cause abnormal adult locomotor behaviour
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(Homyk et al., 1980; Zhang et al., 1999), whilst mutants of technical knockout, a
gene encoding the mitochondrial ribosomal protein S12, have various defects
including deafuess and "bang sensitivity" and larval lethality (Toivonen et al., 2001).
The disparity of the mutant phenotypes observed suggests that these are unlikely to
be informative with regards to Slmo function.
Researchers in T. Endo's lab have suggested that the S. cerevisiae homologue
MSFlp' is localised to the inner mitochondrial membrane, and that the protein might
be involved in intercompartmental protein sorting (Nakai et al., 1993). However, we
currently have no data to infer this in Drosophila. It is for this reason that the failure
of the OFP fusion trans genies is particularly unsatisfactory. The expression of
functional OFP-tagged Slmo proteins under the control of endogenous regulatory
elements would have provided the opportunity to localise the fusion to a particular
mitochondrial compartment by irnmunogold labelling and electron microscopy. It is
possible that expression of pOFP-slmo trans gene has been silenced by the position of
insertion within the genome, although at least five independent insertion lines have
been analysed for expression of the fusion protein. Alternatively, the putative
promoter sequences used in the construction of this trans gene may not have been as
complete as was originally proposed. Certainly, reporter expression driven by the
promoter constructs described in Reeve (2002) was notably weak in tissues other
than the germline. Carhan (1999) described rescue of the slmo mutant phenotype by
a transgene containing only a portion of the sequences included in the pOFP-slmo
construct (see above). Carhan' s trans gene had been engineered under the control of a
heat shock inducible promoter, but was able to rescue both slmo mutant alleles
without the need for a heat shock regime. This suggested that the pOFP-slmo
trans gene contained all the regulatory sequences required for slmo gene function. It is
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possible the functional rescue observed for the heat shock trans gene was the result of
leaky expression from the heat shock inducible promoter at purportedly restrictive
temperatures.
An alternative approach would be to generate transgenes that express GFP
fusions ofSlmo under the control of the GAL4-UAS system (Brand and Perrimon,
1993). Under this system, expression of the fusion proteins would not provide any
direct information on the endogenous expression of Slmo protein, but significant
questions on the functional requirement of the protein could be answered by testing
which GAL4lines are sufficient to rescue the slmo null mutation. For example,
rescue of the locomotor phenotype induced by elaV-GAL4 (Lin and Goodman,
1994), a driver expressed only in neurons, would strongly support the hypothesis that
slmo function is specifically neuronal during early larval development. Likewise,
expression with drivers such as Cha-GAL4, which is expressed specifically in
cholinergic neurons (Baines et al., 2002), or TH-GAL4, which is expressed
specifically in dopaminergic neurons (Friggi-Grelin et al., 2003), might offer an
insight into the particular neuronal populations that require Slmo.
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Chapter 5: Bioinformatic Analysis of the Simo
Family
5.1 Introduction
The observation that the sima mutant phenotype is caused by the loss of a
novel class of non-ubiquitous mitochondrial protein is of considerable cell biological
interest. At the beginning of this project, it was clear that the Slmo protein was
conserved, as similar sequences had been reported from a wide variety of eukaryotic
organisms including human (Guzman-Rojas et al., 2000; Lai et al., 2000), chicken
(Niu et al., 1996), S. cerevisiae (Nakai et al., 1993), C. elegans and S. pombe
(Carhan, 1999). However, the extent of this evolutionary conservation had not been
fully explored, and the rapidly expanding databases facilitated a more thorough
analysis of this entirely new, and poorly characterised family of proteins.
Reported in this chapter are the results of an extensive database search and
the identification of a highly conserved and widely spread family of SImo related
proteins. The relationships between the various members of this family are described
and the existence of two predicted sima related Drosophila genes is discussed.
5.2 Results
5.2.1 Conservation
An initial BLASTp (Altschul et al., 1990) search of the Swiss-Prot database
identified several Simo related protein sequences, some of which had been described
previously. These were the chick protein px 19 (N iu et ai, 1996), the human protein
PRELl (Guzman-Rojas et al., 2000), the human predicted protein CGI-I07 (also
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called CT45) (Lai et al., 2000) and the S. cerevisiae protein MSFlp' (Nakai et al.,
1993). In addition, the predicted protein products of two further Drosophila genes,
designated CG8806 and CG9528 were found to exhibit sequence similarity with
Slmo. A total of three different slmo related genes were also identified in both C.
elegans and S. cerevisiae, whilst the fission yeast S. pombe was found to contain only
two such loci. A further tBLASTn search of the Genbank EST database identified
similar sequences from a wide range of eukaryotic taxa including vertebrate model
organisms such as the mouse Mus musculus and Xenopus laevis, parasitic worms
(Ancylostoma caminum and Strongyloides stercoralis) and several plant species,
with both angiosperms (A. thalianay and gymnosperms (Pinus taeda) represented. A
full list of the identified EST sequences is presented in appendix 2. A more recent
search of the sequence databases, in the light of more complete genome sequencing
projects for several model organisms, reveals the complete sequences of some of the
proteins originally identified as translated ESTs. In addition, further members of the
Slmo family can now be identified. In particular, it is now possible to find a total of
four slmo related genes in both mouse and human. A list of identified Slmo related
proteins/ genes from selected model organisms is presented in Table 5.1 including
amino-acid sequence identities and similarities to the Slmo protein.
5.2.2 Phylogenetic analysis
The high degree of conservation of protein sequences from a broad range of
species is illustrated by an amino acid sequence alignment generated using Clustal X
(Thompson et al., 1997) (Figure 5.1). The conserved domain appears to comprise an
approximately 170 amino-acid region at the N-terminus of all the proteins identified.
To further clarify the relationships between Slmo and the other members
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Table 5.1A: Slmo related sequences identified in 2000
Organism Gene/EST Protein SwissProt GenBank Identity Similarity
Name Accession Accession (%) l%\
D.melanogsster slmo Simo 09V3U9
C.elegsns F15D3.6 F15D3.6 062173 42 58
H.sapiens C200RF45 CGI-107 09Y3B1 54 71
M.musculus C200RF45 CGI-107 09CYY7 53 70
X.lsevis BC047977 BC047977 49 69
S.cerevisiae MSF1' MSF1p' P35200 34 54
S.cerevisiae YDR185C 004006 33 51
S.pombe SPBC36.10 059707 37 55
D.melsnogater CG8806 095RE6 26 42
C.elegans B0334.4 B0334.4 017476 24 41
H.sapiens PREll PREll 09Y255 25 46
M.musculus Preli Preli 08R107 25 46
X.laevis Preli-like AAH44981 22 44
Gallus gallus Px19 Px19 090673 27 45
S.cerevisiae YLR193C 005776 26 44
S.pombe SPAP8A3.10 09UT07 29 48
D.melanogaster CG9528 09VMD6 24 44
C.elegans T23G5.2 T23G5.2 003606 26 43
A.thslisna T19L5_30 09FYA3 26 49
L.esculentum EST303596 AW216413 29 50
(Tomato)
Pinustaeda RTCNT1_73_B06 CF672720 31 47
Ceretopteris ricardii Cri2 8 P09 SP6 BE643491 31 50
Table 5.1H: Slmo related sequences identified in 2004
Organism Gene/EST Protein SwissProt GenBank Identity Similarity
Name Accession Accession l%\ l%\
H.sspiens KlAA0420 KlAA0420 043304 22 47
1200017E04
M.musculus SEC14L 1 Rlk 09DBOO 22 46
H.sapien MGC21644 MGC21644 MGC21644 21 43
C330006K14
M.musculus C330006K 14Rik Rlk 09CRD6 21 46
S.tuberosum EST504505 BG599610 27 46
(Potato)
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Figure 5.1: Multiple sequence alignment of the Slmo protein family. Full length (2] 5
amino-acid) Drosophila Slmo was aligned to related proteins from selected model
organisms using Clustal X. A conserved domain is identified that extends for
approximately 170 amino-acids at the N-terminus. In this region a high degree of
evolutionary conservation is observed between eukaryotic taxa as widely diverged as
human (CGT-l07, PRELl), S. cerevisiae (MSFlp', YDRI85C, YLR 193C) and
Arabadopsis thaliana (T 19L5_30). Universally conserved residues are highlighted in
blue, widely conserved residues are in green.
of this protein family, a phylogenetic analysis was performed using the maximum
likelihood (ML) program TreePuzzle (Schmidt et al., 2002). Figure 5.2 shows the
phylogenetic tree resulting from an analysis of the protein sequences identified in the
original search (2000, see Table 5.1A). The basic topology of this tree is consistent
with that produced using a Neighbour-Joining method (appendix 3). The group of
plant proteins were used as an outgroup with which to root the tree (Figure 5.2A).
Most of the animal and yeast sequences then fall into a single major clade, which
excludes only the predicted products of the Drosophila gene CG9528, and C. elegans
T23G5.2. The remaining animal proteins are then further grouped into two main
monophyletic clades. The first of these contains Slmo, C. elegans FI5D3.6, the
human CGI-I07 and closely related proteins from mouse and Xenopus laevis (Figure
5.2B). A second clade constitutes the human protein PREll, chick px19 and similar
proteins from mouse (Preli) and X. laevis (Preli-like), plus Drosophila CG8806, C.
elegans B0334.4 and proteins from S. cerevisiae (YLR 193C) and S. pombe
(SPAP8A3.1O) (Figure 5.2D). The remaining S. cerevisiae proteins MSFlp' and
YDR 185C form a distinct clade with the second S. pombe protein SPBC36.1 0
(Figure 5.2C), although these exhibit more sequence similarity to the proteins of the
Simo group than the PREll group (see Table 5.1). The close relationship ofMSFlp'
and YDR 185C suggests that these proteins diverged from a relatively recent gene
duplication event.
The predicted proteins of the Drosophila CG9528 and C. elegans T23G5.2
form a separate group that appears to have diverged significantly from the other
proteins (Figure 5.2E). In particular it was clear that this C. elegans protein was
much larger, comprising 743 amino acids, than any other identified member of the
family (the second largest identified protein being the 236 amino-acid product of
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Figure 5.2: Phylogeny of the Simo family of proteins (2000). Phylogeny was generated from a
ClustalX protein sequence alignment using the maximum likelihood program TreePuzzle (Schmidt
et a/., 2002), with 10,000 puzzling steps and a uniform rate of substitution. The phylogeny was
rooted using the plant sequences as an outgroup and branching nodes are labelled with maximum
likelihood support values. Proteins are grouped into five major clades corresponding to A. plant
proteins B. sequences most closely related to Slmo, C. MSF lp' and closely related yeast proteins,
D. sequences most closely related to the human PRELl protein, and E. predicted proteins that
contain a C-terminal CRAL-TRIO domain.
CG8806). Analysis of the T23G5.2 protein sequence using the PFAM database of
protein families (Bateman et al., 2000) revealed the presence of a C-terminal CRAL-
TRIO (cellular retinaldehyde binding protein! triple function) domain (PFAM entry:
PF00650), a conserved module thought to be involved in the binding and delivery of
small lipophilic molecules. Closer inspection of the Drosophila genome sequence
suggested CG9528 was also likely to contain such a domain, and that the predicted
gene sequence was simply incomplete at the time, an observation that is confirmed
by the current annotation of the Drosophila genome (http://fly.ebi.ac.uk).ltis now
possible to identify both human and mouse proteins carrying an N-terminal Slmo-
like module (Slmo/MSFl p' domain), and a CRAL- TRIO domain (Table 5.1B). In
addition, this group of proteins has also been shown to be associated with the GOLD
domain, thought to be involved in mediating protein-protein interactions
(Anantharaman and Aravind, 2002). The domain structure of these proteins is
illustrated in Figure 5.3B. The CRAL-TRIO domain is also highly conserved as
demonstrated by an amino acid sequence alignment of these proteins (Figure 5.3A).
Figure 5.4 shows a phylogenetic analysis of the Slmo protein family
including protein sequences identified from a recent (2004) database search. The
same basic branching pattern is observed, although a single branching node is
missing which was previously seen to group most of the animal sequences together
into a single major clade (Figure 5.2). It should be noted that the ML statistical
confidence value applied to this node in Figure 5.2 was not very high (79). As
expected, the CRAL- TRIO domain containing proteins identified in mouse and
human form a single clade with those previously identified in Drosophila and C.
elegans (Figure 5.4E). A fourth Slmo related protein can also be identified in both
mouse and human and these proteins also fall together with the CRAL- TRIO domain
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Figure 5.3: Slmo related proteins containing the CRAL- TRIO domain. Predicted proteins
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of these proteins. Conserved residues are illustrated in green, whilst universally conserved
residues are shown in blue. B. Schematic comparing the domain structures of the three
Drosophila proteins Slmo, CG8806 and CG9528. As is the case for most proteins in the family,
Slmo and CG8806 exist as stand alone PRELl/MSF lp' domains (green). The CRAL- TRTO
domain (blue) exists in conjunction with the CRAL-TRlO-N domain (red) and is believed to be
involved in the binding small hydrophobic ligands (Li et al., 2000). The C-terminal GOLD
domain is suggested to mediate protein-protein interactions (Anantharaman and Aravind, 2002).
Limits of all domains were determined from the PFAM database except the GOLD domain
which is described in Anantharaman and Aravind (2002).
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Figure 5.4: Phylogeny of the Simo family of proteins (2004). Phylogeny was generated from a
ClustalX protein sequence alignment using the maximum likelihood program TreePuzzle (Schmidt
et al., 2002), with 10,000 puzzling steps and a uniform rate of substitution. The phylogeny was
rooted using the plant sequences as an outgroup and branching nodes are labelled with maximum
likelihood support values. Proteins are grouped into five major clades corresponding to those
described in Figure 5.2 (A-E). Clade E includes two additional sequences from human and mouse
containing the CRAL- TRIO motif (12000 17E04Rik and KIAA0420) and two less closely related
sequences that do not appear to contain this domain (C330008K 14Rik and MGC21644).
group in a single larger clade (Figure 5.4E), although neither of these proteins appear
to contain either the CRAL-TRIO or GOLD domains.
5.3 Discussion
The identification of Slmo related proteins from organisms as diverse as
yeast, plants, worms, flies and mammals may suggest that these proteins are a
requirement in all eukaryotic organisms. Whilst the biochemical function of these
proteins remains unknown, such widespread conservation would point to an ancient
and vital role that has yet to be established. In animal species, the existence of
multiple sima-like genes appears to be the norm, with the invertebrates Drosophila
and C. elegans containing three such genes, whilst mouse and human are found to
possess at least four. Phylogenetic analysis indicates that the animal proteins of this
family form three major groups. The first subgroup is composed of proteins
apparently directly homologous to Slmo, which includes the CGI-I 07 proteins from
human and mouse, F15D3.6 from C. elegans and may also include the previously
identified yeast protein MSF 1p'. It is currently unclear whether these proteins are
related as true functional homologues, although the human CGI-l 07 is reportedly
expressed in the adult central nervous system (BodyMap project; Sese et al., 2001).
Knockouts of these genes in yeast (T. Endo pers. comm., Nagoya University) and C.
elegans (http://www.wormbase.org, release WS115, date 15/01/04) do not result in
lethality. However, it is interesting to note that C. elegans lacking F15D3.6
expression exhibit a post-embryonic "slow growth" defect.
The second subgroup is comprised of apparent homologues of the previously
reported human gene PRELl (Guzman-Rojas et al., 2000), and includes the closely
related pxl 9 from chick (Niu et al., 1996), and the Drosophila computed gene
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designated CG8806. These proteins have not been assigned to any particular
biological role, although expression of PRELl and px19 has been reported in a
variety of tissues. In particular, expression of the px19 gene was reported to be strong
in the major sites ofhaematopoiesis, the blood islands of the area opaca during early
development, and the blood cells of the liver during later embryonic development
(Niu et al., 1996). In the human foetus, PRELl is expressed predominantly in the
liver, which also represents the major foetal haematopoietic organ, and the most
important site for B-celllymphopoiesis (Guzman-Rojas et al., 2000). This has been
interpreted as evidence of an important role for PRELl in these stem cell systems,
however it should be noted that this protein is highly expressed in a variety of adult
tissues including brain, lung, spleen and kidney and may be involved in the postnatal
maturation of these organs. Previous reports on px 19 and PRELl noted the presence
of the LEA (Late Embryogenesis Abundant) motif (Guzman-Rojas et al., 2000; Niu
et al., 1996), a consensus sequence previously reported only in plants (Puupponen-
Pimia et al., 1993). However, this motif is not found in any of the other family
members including those proteins identified from plants and its functional
significance is unclear.
Perhaps the most significant result of this analysis is the discovery of a third
subgroup in which the Slmo/MSFlp' domain is not found as a "stand alone" protein,
but rather as the N-terminal portion of a larger protein featuring a functionally
characterised protein module known as the CRAL- TRIO domain. This conserved
motifhas been shown to constitute a hydrophobic lipid binding pocket, and is
common to several proteins with established roles in mediating the transfer of small
hydrophobic molecules through the aqueous phase. These include proteins involved
in a variety of biological processes. For example, CRALBP (cellular retinaldehyde
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binding protein) is a critical component of visual cycle, where it is responsible for the
transport of the physiological ligands II-cis-retinol and II-cis-retinaldehyde and
modulates interaction of these retinoids with visual cycle enzymes (Crabb et al.,
1998). Another example is the a-tocopherol transfer protein (a- TTP), a mammalian
protein shown to mediate the recognition, binding and transport of vitamin E (a-
tocopherol) (Arita et al., 1995). The mammalian supernatant protein factor (SPF) on
the other hand, has been linked to the metabolism of another hydrophobic substrate,
squalene, where it has been suggested to regulate the availability of this molecule to
the enzymes of the sterol biosynthetic pathway and ultimately the maintenance of
cholesterol homeostasis (Shibata et al., 2001).
The yeast phosphatidylinositol transfer protein, SEC 14p, an example of an
isolated CRAL- TRIO domain, mediates the binding and transfer of either
phosphatidylinositol (PI) or phosphotidylcholine (PC), an activity which is essential
for many cellular processes (Li et al., 2000). By controlling the availability of these
molecules, the transfer protein forms an integral part of the machinery regulating
downstream signalling and membrane transport events. In S. cerevisiae, the protein
operates specifically in the Golgi apparatus, and plays an essential role in regulating
the efficient production of exocytotic vesicles (Li et al., 2000). However,
homologous SECJ4 genes can control distinct physiological processes, even though
the underlying biochemical function is likely to be the same. For example, in the
budding yeast species Yarrowia Iipolytica, SEC 14p is not required in the Golgi, but
instead plays a role at the plasma membrane related to the dimorphic transition from
the yeast to the mycelial form (Lopez et al., 1994). In addition, proteins with similar
activity in higher eukaryotes have been shown to playa variety of complex roles
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including signal transduction and membrane transport (Cockcroft, 1998; Cockcroft
and De Matteis, 2001).
Significantly, all of the three major subgroups of the Simo family are
represented by a Drosophila gene, these being slmo, CG8806 and CG9528. The two
computed genes, which have been namedprelil (PRELl-like) and real-time (see
chapter 6) respectively, offer an opportunity to further explore the possible functions
of the proteins of this new family.
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Chapter 6: Analysis of the slmo Related Drosophila
Genes prelil and real-time
6.1 Introduction
Phylogenetic analysis demonstrated the existence of three diverged subgroups
within the Slmo protein family, which may be functionally diverged. The three
related Drosophila genes, slmo, prelil (pre!) and real-time (retm) are each
representative of one of these subgroups, and therefore provide an opportunity to
gain insight into the function of the various factors within this new class of proteins.
The gene structures of pre! (CG8806), which maps to the 45D5 region of
chromosome 2, and re/m (CG9528), which maps to 26D4-5 of chromosome 2, are
presented in Figure 6.1. Neither pre! nor retm had been reported previously in any
molecular or biochemical studies, though the presence of a CRAL- TRIO domain
within the Retm protein suggests an undefined role for this factor in the transport of
small hydrophobic molecules (Allen-Baume et al., 2002). This chapter presents the
first analysis of pre! and retm function, including localisation, expression and the
consequences of loss-of- function.
6.2 Results
6.2.1 Subcellular localisation of Prel and Retm
The knowledge that both Slmo and the S. cerevisiae MSFlp' are
mitochondrial proteins, suggests that this is likely to be true of closely related
homologous proteins such as vertebrate CGI-} 07 and S. pombe SPBC36.} O.
However, an association with either the mitochondria, or any other cellular
compartment had never been demonstrated for any of the more distantly related
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Figure 6.1 : Schematic representation of the prel and retm gene structures. The intron exon
structure of the prel (A) and retm (B) genes is presented based on gene region and mRNA
sequences obtained from the GadFly database [gene rDs: FBgn0033413 (pre!) and FBgn0031814
(relm)]. Exons are represented by coloured blocks. ORFs are represented by black blocks. All
numbers refer to the gene region sequences presented in appendix 4 (pref) and appendix 5 (relm).
Schematic is for reference and is not to scale.
proteins. This was particularly pertinent in the case of those proteins shown to
contain the CRAL-TRIO and GOLD domains, which are both known to be
associated with the Golgi apparatus in a variety of other proteins (Anantharaman and
Aravind, 2002; Li et al., 2000). The expression of GFP-tagged Slmo fusion proteins
in cell culture proved an effective method by which to demonstrate the association of
this protein with mitochondria (chapter 4). In order to determine whether this was the
case for proteins throughout the Slmo family, this same approach was applied to the
Prel and Retm proteins.
6.2.1.1 Production of GFP fusion constructs
Constructs were designed to express both N- and C-tenninal GFP fusions of
the prel and retm gene products, based on the mammalian expression vectors EGFP-
NI and EGFP-Cl. For bothprel constructs, PCR primers were designed to amplify
the prel ORF with the addition ofan upstream EcoRI site and a downstream KpnI
site to facilitate cloning into the expression vector. For the two retm constructs, the
primers were designed to include an upstream XhoI site and a downstream KpnI site.
In the case of the C-tenninal fusions prel-GFP and retm-GFP, the primers were
designed to introduce the vertebrate Kozak consensus sequence (GCCACC) (Kozak,
2000) immediately upstream of the ORF. For the construction ofGFP-prel, the
primers were 5' -gcaagcttgaattcgATGGTCGTGGCAGCATCCAC-5' and 5'-
gcaagcttggtaccTCAGTTCTTGACAGAAAACA-3', and for prel-GFP, the primers
were 5' -aagcttgaattcGCCACCATGGTCGTGGCAGCA TCCAC-3' and 5'-
gcaagcttggtaccccGTTCTTGACAGAAAACAGTT -3'. For GFP-retm the primers
were 5' -gcaagcttctcgagctATGGTGCAAAAA TTCCAGTC-3' and 5'-
gcaagcttggtaccTCAT CGACTCTGCACCGAGC-3' and for retm-GFP the primers
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were 5' -aagcttctcgaGCCACCATGGTGCAAAAA TTCCAGTC-3' and 5'-
gcaagcttggtaccccTCGACTCTGCACCGAGCTGG-3' (EcoRI, XhoI and KpnI sites
are underlined, start and stop codons are in bold). For prel-GFP and retm-GFP the
primers were designed to delete the endogenous UGA stop codons.
The prel and retm coding sequences were then amplified with the above
primer pairs using the high fidelity enzyme Piu DNA polymerase (2.2.3.3). As
templates for these PCR reactions, full length cDNAs were obtained for prel
(LD36516, GenBank Ace. AI456484) and retm (GH05975, GenBank Ace.
AI517941) as IMAGE clones (www.hgmp.rnrc.ac.uk). These amplified fragments
were found to run at the expected sizes for prel and retm on an agarose gel (Figure
6.2), and were cloned into to the relevant restriction sites in the EGFP-Cl (for GFP-
prel and GFP-relm) or EGFP-Nl (for prel-GFP and relm-GFP) vectors. Plasmid
clones were isolated, and the presence of the inserts confirmed by double digestion
with KpnI and either EcoRI (for GFP-prel and prel-GFP) or XhoI (for GFP-relm and
relm-GFP) restriction enzymes (Figure 6.3). All constructs were sequenced to
confirm the integrity of the fusions.
6.2.1.2 Expression of GFP fusions in cell culture
NIH-3T3 fibroblasts were cultured on covers lips and transiently transfected
with each of the four expression constructs GFP-prel, prel-GFP, GFP-retm and retm-
GFP (2.6.3), with the expression vector pEGFP-N 1 used as a positive control for the
transfection. After transfection, cells were treated with the red fluorescent
mitochondrial marker MitoTracker Red CMXRos (Molecular Probes, see 2.6.3).
Cells were then fixed briefly in parafonnaldehyde, mounted on slides and analysed
by confocal microscopy (2.6.5). Fusion ofGFP to the N-tenninus of Pre I (GFP-Prel)
127
710bp
GFP-prel prel-GFP
2000bp_f'!I!!!!I!I!II'
1500bp 1979bp
GFP-retm retm-GFP
Figure 6.2: peR amplification of the pre/ and retm coding
regions. The prel and retm coding sequences were each amplified
using two different primer pairs for the construction of GFP-prel,
prel-GFP, GFP-retm and retm-GFP. Following amplification all
for products were resolved on an agarose gel, and single bands
were found to migrate at the expected sizes for both prel (71Obps)
and retm (l979bps).
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Figure 6.3: Production of Prel and Retm GFP fusion constructs. Constructs
were engineered to express GFP fused to the N- and C- termini ofPrel and
Retm. The N-terminal fusion constructs GFP-prel and GFP-retm, were
produced by cloning the prel and retm ORFs into the pEGFP-Cl vector. The C-
terminal fusions prel-GFP and retm-GFP utilised the vector pEGFP-Nl. A. All
four constructs were cut diagnostically with restriction enzymes KpnI and either
EcoRI (for GFP-prel and prel-GFP) or XhoI (for GFP-retm and retm-GFP) and
resolved on an agarose gel. The presence of the insert is confirmed in all
constructs at the expected sizes for the prel (710bps, white arrow) and retm
(1979bps, black arrow). B. Schematic plasmid maps of the four constructs
showing the relative positions of the relevant restrictions sites.
resulted in a pattern of fluorescence that coincided with that observed upon staining
the cells with MitoTracker Red CMXRos (Figure 6.4, left column), indicating that
Prel is found in the mitochondria. However, expression of the C-terminal fusion,
Prel-OFP resulted in diffuse cytoplasmic staining (Figure 6.4, right column),
suggesting that an important mitochondrial targeting signal might be located at the
C-terminus of the protein. In the case of Retm, the reverse was found to be true with
the N-terminal fusion, OFP-Retm showing only diffuse cytoplasmic staining (Figure
6.5, left column). Importantly however, expression of the C-terminal fusion, Retm-
OFP, resulted in a pattern of fluorescence that co-localised with that of MitoTracker
Red CMXRos (Figure 6.5, right column). This study therefore represents the first
direct evidence that the Retm-like subclass ofCRAL-TRIO domain proteins (see
chapter 5) is likely to be associated with the mitochondria. The observation that
fusion ofOFP to the N-terminal of Retm disrupts the mitochondrial localisation
suggests that this is determined by a signal within the Slmo/MSF 1p' domain.
6.2.2 Endogenous expression of pre/ and retm
An examination of the expression profile of an mRNA through a series of
developmental stages can provide an insight into the possible role of the encoded
protein. The slmo gene is known to be expressed throughout development, although
the transcript appears to be restricted to the CNS during embryonic development
(Carhan, 1999), and analysis of the enhancer trap suggests this is also the case during
larval stages (see chapter 3). An obvious question is whether the related genes prel
and retm are also associated with the developing nervous system, or perhaps fulfil a
similar biochemical function in different tissues or developmental stages. To
establish the expression of these genes during embryonic development, Digoxygenin
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GFP-Prel Prel-GFP
Figure 6.4: Localisation of N- and C-terminal GFP-tagged Prel in NIH-3T3
fibroblasts. NIH-3T3 fibroblasts were transiently transfected with the
expression constructs GFP-prel and prel-GFP. Cells were also stained with the
red fluorescent mitochondrial marker MitoTracker Red CMXRos and analysed
by confocal microscopy. Expression of the GFP-Prel fusion results in a pattern
of fluorescence (green) that co-localises with that of the mitochondrial marker
(red), indicating that Prel is a mitochondrial protein. Expression of the C-
terminal fusion, Prel-GFP, results only in diffuse cytoplasmic staining. Scale
bars represent 5urn.
GFP-Retm Retm-GFP
Figure 6.5: Localisation of N- and C-terminal GFP-tagged Retm in NIH-
3T3 fibroblasts. NIH-3T3 fibroblasts were transiently transfected with the
expression constructs GFP-retm and retm-GFP.The mitochondria were labelled
by staining the cells with the red fluorescent dye MitoTracker Red CMXRos.
Expression of the N-terminal fusion protein, GFP-Retm (left column), results
in a diffuse pattern of fluorescence in the cytoplasm (green). Expression of the
C-terminal fusion, Retm-GFP (right column), results in a pattern of
fluorescence (green) that co-localises with the red fluorescence of the
mitochondrial marker. Scale bars represent SJ.lm.
(DIG) labelled riboprobes, specific to the pre! and retm transcripts, were
manufactured as described in 2.3.2, using the full length cDNA IMAGE clones (see
6.2.1.1) as templates. The expression of pre! and retm mRNA was then detected by
in situ hybridisation to Canton S embryos (2.3.2).
The embryonic expression of pre! is presented in Figure 6.6. Transcription of
pre! begins at the earliest stages of development, and is Ubiquitous throughout
embryonic development. At stage 16,pre! expression appears to be upregulated
significantly in the developing brain lobes, although, interestingly, this is not true of
the ventral nerve cord. In addition, an increased level of expression can also be seen
in specific regions of the midgut. Expression of the retm gene is considerably more
dynamic (Figure 6.7). The retm message is first transcribed at stage 7, where it is
expressed in the early germ band. By stage 11, when the germ band is fully extended,
the gene is expressed strongly in the ventral neuroectoderm, which represents the
progenitor of the central nervous system (Goodman, 1993). At this time, a small
region of particularly strong staining is visible at the tip of the extended genu band
marking the proctodeum (the primordial hindgut) and expression is also visible in the
anterior midgut and the foregut primordial region known as the stomodeum (Skaer,
1993). Expression then persists in both the emerging gut and nervous system during
the next three developmental stages (12-14). At stage 15, retm is no longer expressed
in the newly formed midgut, but staining continues in the hindgut as it continues to
develop by projecting towards the antero-dorsal region of the embryo and is also
evident in differentiating components of the foregut, which might include the
stomatogastric nervous system (Hartenstein, 1993). Interestingly, retm expression is
detected strongly throughout the developing eNS and the intensity of this staining is
maintained through stage 16, whilst the expression in regions of the gut is rapidly
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Stage 2
Stage 10
Stage 14
Stage 16
Figure 6.6: Expression of prel during
embryonic development. Expression
of prei mRNA was detected by in situ
hybridisation using a DIG-labelled
RNA probe. prel is expressed
ubiquitously throughout embryonic
development. At stage 16 expression is
seen to be upregulated in specific
regions of the midgut (mg), and in the
developing brain lobes (bl) (although
not in the ventral nerve cord). A sense
control probe detects no staining at any
stage (not shown). All embryos are
orientated with anterior to the left and
lateral view. Scale bar is 100J..lm.
Stage 5
Stage 7
Stage 10
(dorsal view)
Stagell
Stage 12
amg
Stage 17
vnc
Stage 14
(dorsal view)
Stage 14
Stage 15
Stage 16
Stage 16
(dorsal view)
Figure 6.7: Expression of retm during embryonic development. Expression of retm mRNA was
detected using a DIG-labelled riboprobe. retm is expre sed in the developing gut and central nervous
system. (amg) anterior midgut; (bl) brain lobes; (ens) central nervous system; (fg) foregut; (gb) germ
band; (hg) hindgut; (mg) midgut; (pmg) posterior midgut; (pr) proctodeum; (sg) salivary glands; (st)
stomodeum; (t) trachea; (vnc) ventral nerve cord; (vne) ventral neuroectoderm. A sense control probe
detects no staining at any stage except stage 17, when non-specific staining is seen in the salivary
glands and trachea, but not the eNS. All embryos are orientated with anterior to the left and lateral
view unless otherwise stated. Scale bar is 1OO~m.
vne
ens
downregulated. Expression continues in the CNS late into stage 17, but is also
downregulated prior to hatching. At stage 17, strong staining can also be seen in the
salivary glands and trachea, a common artefact of in situ hybridisation resulting from
the probe becoming trapped in these tissues.
To further explore the developmental expression of these genes, prel and
retm specific primers were designed for the purposes of RT-PCR, a sensitive method
for identifying the presence or absence of a particular transcript (2.3.4). This
technique also provides a means by which to estimate the relative levels of
transcriptional expression at various developmental stages. For the identification of
the prel transcript, the primers were 5' -GCAGAAGGA TGGT AGTACTC-3'
(position 1206-1225, appendix 4) and 5'-GAGAGCTCCTTGGTTGTTGA-3'
(position 1491-1472, appendix 4) which amplify a 285bp fragment. For retm the
primers were 5'-CTGGTGA TGAAGGCCT ATGA-3' (positions 389-401 and 2879-
2885, sequence is split by the first intron in appendix 5, see Figure 6.1) and 5'-
GTAGCGACACCGCTCGAAGA-3' (position 3156-3137, appendix 5) which
amplify a 290bp fragment. Using the wild-type strain Canton S, embryos, Ist instar
larvae, 3rd instar larvae, pupae and adult males and females were individually
homogenised and total RNA extracted from the samples (2.3.3). RT-PCR was then
used to analyse the transcriptional expression of the prel and retm genes at each of
these developmental stages (Figure 6.8A,B). As expected, both genes are shown to
be expressed in the developing embryo. In addition, expression of prel and retm was
detected during all the subsequent developmental stages from I sI instar larvae
through to adulthood.
For estimation of relative levels of expression between stages, primers
specific to the ubiquitously expressed housekeeping gene RpL32 (2.3.4.2), which
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Figure 6.8: Developmental expression of pre/ and retm. Semi-quantitative RT -peR was
performed on total RNA extracted from embryos (E), )St instar larvae CLl), 3rd instar larvae
(L3), pupae (P), adult males (M) and adult females (F). The housekeeping gene RpL32 was used
as a control recognised as a 456bp band. Each peR set includes 2 negative controls to show
there is no contamination with exogenous DNA (-RT and -RNA), and 3 linearity controls, in
which the cDNA template is diluted 112, 114 and 1/8 (labelled by triangle), to demonstrate peRs
were in exponential phase. RT-peR using primers specific to prel CA), retm CB)demonstrate
expression of both these genes at all developmental stages. C. Developmental expression
profiles of prel and retm. All peR products were optically quantified using GelDoc software
(Bio-Rad), and the arbitrary "relative fluorescence" values generated are expressed as a
percentage of the corresponding RpL32 product.
encodes the L32 ribosomal protein (O'Connell and Rosbash, 1984), were used for
control PCR reactions to allow for small variations in the initial quantity of template
cDNA (2.3.4.3). These primers were 5'-AAGATGACCATCCGCCCAGCA TAC-3'
(position 417-440, GenBank accession: X00848) and 5'_
CTCGTTCTTCTTGAGACGCAGG-3' (position 876-855, GenBank accession:
X00848) and had been shown previously to recognise a specific 459bp product
(Hodges et al., 2002). PCR products were optically quantified using GelDoc
software (Bio-Rad, methods), and arbitrary values were generated to represent the
relative fluorescence of each band. These relative fluorescence values were then
expressed as a percentage of the corresponding (amplified from the same cDNA
sample) RpL32 product. This method allows for a qualitative (sometimes referred to
as "semi-quantitative") assessment of relative levels of expression between samples,
and can be used to look for large differences or general trends in expression. From
the developmental profiles generated (Figure 6.8C) it can be seen that prel
transcription, which is ubiquitous in the embryo, shows a general increase during
development with expression at a maximum in the pupa and adult. In the case of
retm, a large discrepancy is observed between transcriptional expression in adult
male and female, with expression in the female less than half that observed in the
male. This might suggest a male specific function for retm.
6.2.3 Characterisation of the P-element insertion lines 1(2)k12402 and KG05639
Analysis of the expression pattern of a gene provides valuable insight into its
function. The ubiquitous expression suggests a general requirement for prel in all cell
types, whilst the more restricted distribution of the retm transcript would appear to
indicate a more specific role in the development of the gut and central nervous
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fly strains carrying single P-element insertions are readily available for many of the
system. An essential step in establishing the functional requirement of any gene is an
analysis of a loss of function mutant. In Drosophila, many large scale screens have
been carried out to search for mutations disrupting gene function, notably by the
BDGP gene disruption project (Spradling et al., 1999; Spradling et al., 1995) which
has employed P-element mutagenesis to disrupt large numbers of genes. As a result,
genes identified by the genome project. This is fortunately true for both prel and
retm.
The P-inserts designated 1(2)k12402 and KG05639 were reported by the
database (http://fly.ebi.ac.uk) to map to the prel and retm genes respectively. These
alleles, herein referred to as prel'(2)kI2402 and retmKG05639,were obtained as
independent strains from the Bloomington stock centre. Flanking sequence recovered
by inverse peR is available for both P-elements [GenBank accession numbers
AQ026044 (l(2)k12402) and BH759618 (KG05639)] and was used to map the
precise position of both insertions (Figure 6.9). In the case ofbothprel'(2)kI2402 and
retmKG05639, the P-elements are inserted within the transcribed region of the gene.
The 1(2)k12402 P-element has inserted in theprel5' UTR, 266bp upstream of the
translational start codon (Figure 6.9A). In addition, the prei(2)kI2402 allele, which was
genetically maintained over a CyO balancer, was found to be homozygous lethal,
suggesting that the insertion has disrupted the function of this gene. Prior to any
analysis of the mutant line, it was important to first prove that the 1(2)k12402
insertion is indeed the cause of the lethality. For this reason the line was subjected to
an excision screen. The chromosome carrying the 1(2)k12402 insertion was brought
together with a transposase source located on the third chromosome (Figure 6.10).
Fifty-seven crosses were set up and produced seven independent excision events.
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Figure 6.9: Position of the 1(2)k12402 and KG05639 P-elements. A. The 1(2)k 12402
insertion (black triangle) is located within the second exon of the prel gene, 266bps
upstream of the translational start codon . .B. The KG05639 insertion is located within the
first intron of the re/m gene, 7bps from the end of the first exon. Coding sequences are
represented by black blocks. All numbers refer to the sequences in appendix 4 (pre£) or
appendix 5 (retm). Schematic is for reference and is not to scale.
The system of nomenclature used for excisions is based simply on the vial number
the excision line was produced from and the sex of the original fly. For example, line
~5Fl represents the first excision event produced as a female from vial number 5.
The excision lines were ~5Fl, ~9Ml, ~13MI, ~14F2, ~34Fl, ~46Ml and ~52Ml.
If the P-element is the cause of the lethal phenotype, precise excision of the p,
element should restore the viability of the 1(2)kI2402 homozygote. All seven of the
excision lines produced by the screen were able to generate viable ~1(2)kI2402
homozygotes.
To establish the earliest lethal phase of the mutant, 300 embryos collected
from the prei(2)k12402/CyO stock were laid out on an agar plate and aged for 26hours.
Of these, 97% hatched indicating that the prei(2)k12402 homozygotes do not die during
embryonic development. To allow the homozygotes to be selected from
heterozygous siblings, the prei(2)k12402 allele was balanced over the CyO
[kruppelGAL4 UASGFP] balancer chromosome, which causes bright fluorescence of
the larval Bolvic's organs (Casso et al., 2000). Fifty homozygous 1st instar larvae
were selected and aged on apple agar medium (2.1.1.2). By 26hrs post-hatching, all
of the larvae progressed to the 2nd instar stage, as identified by the morphology of the
mouthparts (Ashbumer, 1989), and dug downwards into the food. None of the
mutant larvae ever progressed to the wandering 3rd instar or pupal stages, suggesting
that lethality occurs during the 2nd instar or early 3rd instar stages. Upon closer
observation, it was clear that prei(2)k12402 1sI instars do not exhibit an impaired
locomotor phenotype similar to that described in slmo mutants (see section 3.2.1). In
addition, mutant larvae are able to grow and feed, although growth appears to have
slowed in the mutant (Figure 6.11).
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Figure 6.10: Crossing scheme for 1(2)k12402 excision screen. Figure shows the excision
of the lethal P-element insertion 1(2)k12402 in the presence ofa transposase source (Dril2-
3) located on the third chromosome. The generation of7 independent, homozygous viable
excision lines is shown in step 5, and demonstrates the P-element is the cause of the
lethality.
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Figure 6.11: Growth of pref(2)kI2402
homozygous larvae. Newly hatched
pre/1(2)kI2402 and pre/1(2)kI2402/CyO larvae were
fed coloured food and aged for 18 and 26 hour
time periods. A. By 18 hours po t-hatching (PH),
shortly before the transition to the 2nd instar
stage, 1st instar larvae have undergone a
substantial period of feeding and growth during
which they more than double in size. At this time
mutant homozygotes exhibit a slight reduction in
size when compared to the control heterozygous
siblings, suggestive of slowed rate of growth. B.
By 26 hours PH, mutant and control 2nd instars
exhibit a marked difference in size. At both 18
and 26hours, the red-dyed food is visible in the
gut (arrows) indicating that mutant larvae are
able to feed. Scale bars are equal to 0.5mm.
The KG05639 P-element has also inserted into the transcribed region of the
retm gene, although in this case the insertion site is located within the first intron
(Figure 6.98). Initially it was observed that retmKG05639 homozygotes are both viable
and fertile. Although the insertion site within the first intron does not physically
disrupt the coding sequence, the KG05639 belongs to a class of specially modified P-
elements which carry copies of the suppressor of Hairy-wing (su(Hw) binding
sequences (Roseman et al., 1995). The Su(Hw) protein acts to alter gene expression
by disrupting the normal interactions between endogenous regulatory sequences and
has been shown to improve the mutagenic properties of the P-element. However, it
should be noted that P-elements of this type do not suppress gene expression with
100% efficiency, a notion supported by previous experience in our lab (Liu, 2002).
In addition, it is well established that P-elements located in intronic regions are often
spliced out of the resulting transcript and therefore do not fully disrupt expression of
the protein (Horowitz and 8erg, 1995). To establish whether expression of the gene
is blocked by the P-element, retmKG05639 homozygotes were subjected to analysis by
RT-PCR using retm specific primers (Figure 6.12, see 2.3.4). A weak band was
detected at the expected size of290bps, suggesting that transcription of the retm gene
persists despite the presence of the P-element.
An excision screen was carried out on the retmKG05639 line in the hope that
imprecise excision of the P-element would generate deletions of the flanking DNA
that physically disrupt the retm coding sequence. Excisions were generated
essentially as described in Figure 6.10. The chromosome carrying the KG05639
insertion was brought together with a transposase source (in this case Sb~-3)
located on the third chromosome. A total of 200 crosses were set up and 95
independent excision lines were produced (Table 6.1). 13 excision lines were found
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Figure 6.12: Expression of retm in the retmKGOS639 mutant. RT -PCR was performed on
total RNA extracted from adult retmKG05639 homozygotes. A weak band is detected at the
expected size of 290bps, indicating that the retm gene is still transcribed in the presence
of the P-insert. Canton S (CS) flies were used as a positive control.
Table 6.1: List of KG05639 excision strains.
A. The viable excisions
No. Strain No. Strain No. Strain
1 61 29 6064 57 60136
2 M 30 665
- 58- -6138
3 65 31 -6fi'f" -59 • 6140-:32"" - 669-- 60-1- 61~4 66
5 67 33 6070 61 - 614"6
6 68 34 672 62 6149
7 69 35 675 -63 --6150
8 612 36 678 64 60151
9 615 37 687 65 6152
10 616 38 689 66 6155
11 617 39 692 -e;r 6156
12 620 40 6100 68 6158
13 622 41 6105 -s9- 6160
14 623 42 6107 70 6163
15 628 43 6110 71 6165-
16 633 44 6111
--72- ~68
17 641 45 60114 73 6170
18 6043 46 6~!g_ I-~ 6~
19 M5 47 6117 75
-';:;76-
20 650 48 6120 76 6177
21 652 49 6122 77 6,180
-
22 6,53 50 6124 78 -60183
23 L\55 51 6125
--- 1-~18679
24 656 52 6,127 Bb- =- i187_
25 658 53 L\129 -81- 1_6,~
26 L\59 54 6,131 82 - ~196
27 6,61 -55- ~134
28 L\63 56 6,139
-- - -
B. The lethal excisions
No. Strain No. Strain
1 6,10 8 _E3_
2 6,57 9 6164
3 666 10 6175
4 681 --n-- 6191
5 683 12 6,194 -
6 684 13
-
- 6197
7 6119
to be lethal, although these were later found to genetically compliment each other,
indicating that the lethality of these strains resulted from independent events
unrelated to the retm locus. To screen the remaining 82 lines for deletion of the retm
coding sequence, PCR primers were designed to amplify fragments from exon I and
exon 2 (Figure 6.13A) and reactions performed on genomic DNA extracted from
single adult flies (2.2.4). For exon I the primers were 5'-
ACGCTAGGAGCCAACGGAT A-3' and 5' -CTTCATCACCAGCTCAAAAG-3'.
For exon 2 the primers were 5'-AGGCCTATGAGCGGCGGTTT-3' and 5'-
ACATGCGTGA TGCCTTCCTC-3'. A single excision line, designated retmM9 was
found to carry a deletion which includes part of exon 2 and disrupts the retm coding
sequence (Figure 6.13C). In addition, primers were designed to amplify fragments
from the predicted genes CG16947 and CG9527 that directly flank retm on
chromosome 2 to demonstrate that the deletion did not represent a large deficiency
removing multiple genes. For CGl6947 the primers were 5'-
ATGAAGAACCGCCAGCGAAC-3' (position 1-20, FlyBase gene region:
FBgn0031816) and 5'-GTGCGCTGGATGATACTTGC-3' (position 284-303,
FlyBase gene region: FBgn0031816), whilst for CG9527 the primers were 5'-
TCGCGCCT AGCATTCGAAGC-3' (position 4-23, FlyBase gene region:
FBgn0031813) and 5'-AAGGTCCGCTACGGAAGTCG-3' (position 308-327,
FlyBase gene region: FBgn0031813). The gene was named real-time due to the
initial observation that mutation does not result in a larval slow motion phenotype
comparable to that seen in slmo mutants. The fact that retmM9 homozygotes survive
to adulthood suggests that retm is likely not an essential gene. Loss of retm function
may result in more subtle defects which have yet to be determined, although
preliminary analysis suggests that adult retmM9 homozygotes perform normally in
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Figure 6.13: Identification of a retm deletion allele. A. Schematic to show the relative positions
of PCR primers designed to amplify fragments from exon I and exon2. The original position of
the KG05639 P-e1ement is indicated (black triangle). The protein coding sequence is indicated
by black blocks. All numbers refer to the retm gene region sequence obtained from FlyBase
(appendix 5) Schematic is for reference and is not to scale. B. The primers recognise bands of
320bps (exonl) and 471bps (exon2) in the putative precise excision lines /17, /143 and /152. C. In
the excision line /169, no peR product is recognised for exon 2 indicating that part of this exon
has been deleted by imprecise excision of the P-element. The consequent disruption of the coding
sequence means that the /169 excision represents an additional retm mutant allele. Exon I and the
neighbouring genes ca 16947 and CG9527 are still intact.
assays of locomotor activity, and the ability to right themselves from an inverted
position (appendix 6).
6.3 Discussion
The long term objective must be to define a functional role for the
Slmo/MSFI p' motif. The demonstration that all three Drosophila proteins, Slmo,
Prel and Retm are localised to the mitochondria strongly suggests that this is true of
all proteins that contain this domain and indicates a biochemical function for the
proteins of this family that is specific to the mitochondria. This observation is now
supported by a recent report describing the mitochondrial localisation of the mouse
Preli protein (Fox et al., 2004) as determined using a Preli specific antisera. In this
study the authors also described a putative mitochondrial-targeting signal located
within the N-terminal 35 amino acids of the Preli protein. Fusion of GFP to the N-
terminus of Preli was consequently found to disrupt the mitochondrial localisation of
the protein, whilst the reciprocal C-terminal fusion was directed to the mitochondria
as expected. This does not appear to be the case for the Drosophila Prel protein. In
this case a fusion of GFP to the N-terminus of Prel is still targeted to the
mitochondria, whilst a fusion to the C-terminus is found to be diffuse within the
cytoplasm (Figure 6.4). The various targeting signals that are used to direct newly
synthesised proteins to the mitochondria are diverse in nature, and these can be
located at the N- or C-terminus, or distributed internally within the protein (Truscott
et al., 2003). These observations would suggest that the signals used to target the
various proteins of the Slmo/MSFI p' family to the mitochondria are not universal.
Certainly, the N-terminal 35 amino acid region of the mammalian Preli proteins does
not appear to be particularly well conserved in the fly (see Figure 5.1). This notion is
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also supported by the finding that fusions to either terminus of the Slmo protein are
successfully directed to the mitochondria (see chapter 4) and that Retm is directed to
the mitochondria only by a C-tenninal fusion (Figure 6.5).
The prel gene is expressed ubiquitously during embryonic development
(Figure 6.6) and the transcript is present during all later developmental stages (Figure
6.8A), suggestive of a general requirement for the Prel protein in the mitochondria of
all cells. This is in contrast to the restricted expression observed with both sima and
retm, but consistent with the reported expression of the human PRELl gene in a wide
variety of tissues including brain, liver, lung, spleen and kidney (Guzman-Rojas et
al., 2000). Certainly, the lethality resulting from prelloss of function indicates that
the function of this gene is essential. The survival of prel mutants to larval stages
may simply be the result of maternal contribution. The PRELl subgroup of
Slmo/MSFl p' proteins may ultimately come to be regarded as the archetypal
members of the family, fulfilling an as yet to be defined, but generally required
biochemical function within the mitochondria, whilst those proteins more closely
related to Slmo or Retm have diverged to fulfil more specialised roles in specific cell
types.
Whilst the ubiquitous transcription of prel would appear to indicate a general
requirement for the gene product, the spatially dynamic expression of retm appears to
suggest a specific developmental function. Expression of retm is limited to the
developing gut and CNS, but is also temporally restricted to developmentally crucial
stages for these organs (Figure 6.7). For example, strong expression in the primordial
midgut is rapidly down regulated prior to stage 15, by when the presumptive midgut
has closed both ventrally and dorsally and is largely established. Expression persists
in the hindgut as it continues to develop by projecting towards the antero-dorsal
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region of the embryo, and is itself only down regulated during stage 16. Likewise,
the retm transcript is detected strongly in the CNS at stages 15 and 16, during periods
of major developmental reorganisation (Goodman, 1993), but is clearly reduced by
the end of stage 17 immediately prior to hatching.
Like both prel and slmo (Reeve, 2002), retm expression persists through later
stages of development through to adult. Despite this, the viability of flies
homozygous for a re/m deletion allele, retmtJ.69,indicates that this gene does not
perform an essential function in Drosophila. The fact that retm is conserved between
flies and mammals (see chapter 5) might suggest that loss of function has more
subtle consequences that confer a selective disadvantage, or that the Retm subclass of
CRAL- TRIO domain proteins play important roles in other organisms.
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Chapter 7: Yeast-2-Hybrid Screen
7.1 Introduction
Specific interactions between proteins form the basis of many essential
biological processes. Consequently, considerable effort has been made to identify
those proteins that bind to proteins of interest. It also follows that a major step in
elucidating the function of an uncharacterised protein is to understand the
interactions it makes with previously identified proteins. The advent of large scale
sequencing projects has identified large numbers of novel proteins. For many of
these new proteins, like those of the Slmo family, the sequence alone sheds little or
no light on their function.
The yeast-Z-hybrid approach provides a sensitive and versatile method for
identifying proteins that interact with a protein of interest, and can be applied to
most, if not all, proteins for which the coding sequence is known. The system takes
advantage of the fact that many eukaryotic transcription factors are modular, with
distinct and separable functional domains directing the binding to specific DNA
sequences and the activation of transcription (Brent and Ptashne, 1985). Neither is
capable of activating transcription alone, but the DNA binding and activation
domains of different transcription factors can often be interchanged to form
functional hybrid proteins. For example, when the transcriptional activation domain
of GAL4 is combined with the DNA binding domain of the bacterial repressor LexA,
the resulting chimera is a functional transcriptional activator in yeast (Brent and
Ptashne, 1985). Importantly, the DNA binding and activation domains do not have to
be covalently bonded to each other in order for transcription to be activated. Fields
and Song (1989) first demonstrated the usefulness of this property by showing that
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the activation of transcription in yeast could be used to assay the interaction between
two proteins if one of them was fused to a DNA-binding domain and the other to an
activation domain. When both fusions are expressed together in yeast, a positive
interaction results in the reconstitution of a functional transcription factor. This
results in the expression of one or more reporter genes, which ultimately generate a
phenotypic signal (Figure 7.1). In this way, a protein of interest fused to a DNA-
binding domain can be used to hunt for possible interactions by screening large
numbers of activation domain fusion proteins expressed from a cDNA library (Chien
et al., 1991). Selection of yeast which are positive in the 2-hybrid assay therefore
provides a means by which to isolate and identify those interactors by rescue of the
corresponding cDNAs.
Based on this concept, a number of yeast-2-hybrid systems have been
developed independently, all of which utilise the DNA-binding domains of either the
yeast GAL4 or the E. coli protein LexA (Toby and Golemis, 2001). This approach
has been used widely, and has often proven successful in ascribing functions to
previously uncharacterised molecules (Vidal and Legrain, 1999). Indeed, the 2-
hybrid system has much wider applications than this and has been further developed
for the proteomic dissection of entire protein networks (Giot et al., 2003). This
chapter describes the use of a LexA based 2-hybrid system, the interaction trap, to
look for proteins that interact with the Slmo protein with the purpose of gaining some
insight into the biochemical role of this molecule.
7.2 Results
A major factor in the success of a yeast-2-hybrid screen is the availability of a
high quality cDNA library. Given what we knew of the expression and function of
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Reporter Gene
B.
Reporter Gene
Figure 7.1: Schematic representation of the yeast-2-hybrid system
assay. An interaction between two proteins is detected by the activation
of one or more reporter genes. A. Protein of interest X is fused to a DNA-
binding domain (DB) that binds specifically to sequences in the promoter
of the reporter gene. Protein Y is fused to a transcriptional activation
domain (AD) that recruits the transcription machinery. B. Expression of
the reporter gene will only occur if proteins X and Y interact.
Slmo, either an embryonic or ovarian library was acceptable for the purposes of this
screen. The Drosophila ovary library RFLY3 was originally manufactured in Roger
Brent's lab (Finley et al., 1996) and had been used successfully to identify
interacting partners in a number of screens (Finley et al., 1996; Granderath et al.,
1999). The selection of this library (gift from Cahir Q'Kane, University of
Cambridge) required the adoption of the LexA based "interaction trap" 2-hybrid
system developed in the Brent lab (Gyuris et al., 1993). For this scheme, the Slmo
protein was expressed as a fusion with the LexA DNA-binding domain (referred to
as the "bait"). The screen was carried out in the yeast strain EGY48, containing a
selectable marker gene derived from the yeast gene LEU2 with upstream LexA
binding sites in place of the endogenous upstream activating sequences. Expression
of the LexA operator LEU2 gene (LexAop-LEU2) was easily assayed by the ability
of the yeast strain to grow on media deficient in leucine (2.8.1), a function which
requires the LEU2 gene product. In EGY 48 the LexAop-LEU2 reporter replaces the
endogenous LEU2 gene and is integrated into the chromosome ensuring it is
genetically stable. The system also incorporates a second, less sensitive LexA
activated reporter based on the lacZ gene. This provides a secondary assay of
activation that will eliminate many of the false positives that arise due to cis and
trans-acting mutations that cause activation of the LEU2 reporter. To prepare the
selection strain for the interaction trap, EGY48 was transformed (2.8.2) with the lacZ
reporter plasmid pSH 18-34, which carries the URA3 selectable marker that permits
growth on media lacking uracil (2.8.1). The library cDNAs are contained in the
"prey" vector pJG4-5, which directs the expression of the cDNA-encoded protein
fused at the N-terminal to a moiety containing the SV40 nuclear localisation signal,
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and the transcriptional activation domain 842. The plasmid also carries the selectable
marker TRP 1, which permits growth in the absence of tryptophan.
7.2.1 Construction of LexA-slmo bait plasmid
The purpose of using the interaction trap is to identify any protein that
interacts with any part of Slmo. In addition, the lack of any characterised domains
within the predicted Slmo sequence provided no basis for the exclusion or inclusion
of any region of the protein. Therefore, for the purposes of this investigation. the
entire Simo coding sequence was included in the bait construct. The bait vector,
pEG202, contains the entire coding sequence of the E. coli LexA protein (including
the DNA binding domain and the dimerisation domain), and will maintain strong and
constitutive expression of the bait as regulated by the yeast alcohol dehydrogenase 1
(ADHl) promoter. The LexA coding sequence is followed by a polylinker, which
facilitates cloning of the coding sequence of interest to generate in frame fusions to
LexA. In addition, the plasmid contains the HIS3 selectable marker, which allows
yeast transformants to grow on media lacking histidine (2.8.1), and the E. coli
ampicillin resistance gene (amp) for selection of the plasmid during cloning. The
LexA protein does not contain a yeast nuclear localisation sequence, but almost all
fusion proteins become equally partitioned between the cytoplasm and the nucleus
and will therefore bind LexA operators in the yeast nucleus (Golemis and Brent,
1992; Toby and Golemis, 2001).
For the construction of the bait plasmid, PCR primers were designed to
amplify the slmo coding sequence adding both an upstream EcoRI restriction site and
a downstream XhoI site to facilitate cloning of the fragment into the pEG202
polylinker. The primers were 5' -gcggccgcgaattcA TGAAAATCTGGACA TCGGA-
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3' and 5' -gcggccgcctcgagCT ACGT AATGTGCA TCGC-3' (restriction sites are
underlined, "start" and "stop" codons are in bold). The sequence was amplified with
Piu polymerase (2.2.3.3), using the slmo 2A7 cDNA (Carhan, 1999; see Figure 1.1)
as a template for the reaction (Figure 7.2A). The PCR fragment was then cloned into
the EcoRI andXhoI sites of the pEG202 vector and the presence of the insert
confirmed by digestion with the corresponding enzymes (Figure 7.2B). The
production of an in frame LexA-slmo fusion construct was confirmed by sequencing.
7.2.2 Testing the bait for auto activation of reporters
Some bait proteins can activate transcription of the reporter genes alone. To
be useful in an interactor screen, it is important that the bait fusion does not activate
transcription independently. Screens involving proteins that have transcriptional
activity require only portions of the protein to be cloned into the bait vector. It is
important not to have a high background of false positive colonies arising from
activation of the lacZ or LexAop-LEU2 reporter genes by the bait alone. To test
whether the bait autoactivates transcription of the reporters, an EGY48 strain
containing the reporter plasmid pSH 18-34 was transformed (2.8.2) with the LexA-
slmo bait construct. In parallel with this, the reporter strain was also transformed with
two HIS3+ control plasmids. The first of these, pSH 17-4 directs the expression of a
LexA-GAL4 fusion that activates transcription strongly and acts as a positive control
for the activation assay. The second, pRFHM 1 expresses LexA fused with a
transcriptionally inert fragment of the Drosophila Bicoid homeoprotein, and
therefore acts as a negative control. Transformed colonies were then patched onto X-
gal indicator media (2.8.1) then incubated at 30°C for 3 days. As expected, the
positive control yeast strain containing pSH 17-4 went dark blue, indicating strong
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Figure 7.2: Construction ofthe bait plasmid. A. peR
amplification of slmo coding region. The product was resolved on
an agarose gel, and a single band found to migrate between 1018bp
and 506/517bp standard markers consistent with the expected size
of 648bp. This fragment was therefore cloned into the bait vector
pEG202. B. Gel showing diagnostic EcoRI single digest and
EcoRI/ XhoI double digests, confirming the presence of the insert
(arrow). C. Schematic plasmid map of the bait construct showing
the relative positions of the LexA-slmo ORF, the ADH promoter
and the HIS3 gene.
activation of the lacZ reporter gene. In contrast, neither the bait strain nor the
negative control responded in this assay (Figure 7.3A).
For some baits, the LexAop-LEU2 reporter ofEGY48 is more sensitive than
the lacZ reporter on pSH18-34 (DupLEX-A User Manual, OriGene Technologies). It
was therefore also necessary to test the ability of the bait to autoactivate the LcxAop-
LEU2 reporter. A single colony of EGY48 containing the bait plasmid (and pSH 18-
34) was transferred into 0.5ml of sterile distilled water and vortexed to disperse the
cells. This suspension was then further diluted I: 10, I: 100 and 1:1000 before plating
all four concentrations onto media deficient in leucine (2.8.1). In addition, dilutions
were also plated onto media containing leucine as a positive control. Plates were then
incubated at 30°C for 3 days. As expected, many colonies developed on leucine
containing media (Figure 7.3B). However, yeast containing the bait plasmid were
unable to grow in the absence of exogenous leucine, and no colonies were visible for
any of the dilutions, confirming that the bait fusion does not autoactivate either of the
reporters (Figure 7.3C).
7.2.3 Test that the bait fusion is expressed in the yeast system
Before the bait construct could be employed in a large scale screen, it was
important to confirm that the bait fusion protein is expressed in the yeast host. A
single colony of the bait strain (EGY 48 transformed with pSH 18-34 and the bait
construct) was used to inoculate an overnight culture. The culture was then lysed
(2.4.2) and the sample run on an SDS-PAGE gel (2.4.3). As controls, yeast
transformed with the pEG202 vector alone, and the pSH 18-34 reporter plasmid alone
were prepared in the same way, and a western blot was carried out on all three
samples using an anti-LexA antibody (Figure 7.4). A band was detected at
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Figure 7.3: Test to determine
whether the bait can autoactivate
reporters. A. An EOY 48 strain
carrying the lacZ reporter plasmid
pSH18-34 was transformed
individually with the slmo bait
plasmid, the positive control plasmid
pSH17-4 and the negative control
plasmid pRFHM I before plating on
selective media containing X-gal. The
Lex-OAL4 fusion protein expressed
from pSH17-4 is sufficient by itself to
cause activation of the lacZ reporter
and yeast carrying the plasmid are
dark blue (blue arrow). Yeast
carrying the bait plasmid or pRFHMl
are not blue, indicating that the LexA-
SIma fusion does not autoactivate the
lacZ reporter (black arrows). B,C.
The EOY 48 strain containing the bait
plasmid was plated as serial dilutions
(only 1:1000 dilution is shown) on
media containing leucine (B) and
deficient in leucine (C). The bait
expressing strain is unable to grow on
leucine deficient media indicating that
the LexA-Slrno fusion does not
autoactivate the LEU2 reporter.
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Figure 7.4: Expression of the LexA-Slmo bait fusion in yeast. A.
Western blot using an anti-LexA antibody. The samples run on the gel are
EGY48 transformed with the reporter plasmid (pSH18-34) and either the
bait construct expressing the bait fusion (LexA-Slmo), the bait vector
expressing LexA alone (pEG202), or no additional plasmid as a negative
control (-VE). A band is detected at the expected size for a LexA-Slmo
fusion protein (approximately 50kDa). This band is not found in either of
the control lanes, indicating that the bait protein is expressed in the yeast
system at an easily detectable level. B. Coomasie stained gel run in
concert with A to show equivalence of loading.
approximately 50kDa, the size expected for a LexA-Slmo fusion protein
(LexA-20kDa, Slmo runs at -30kDa), confirming that there is a good level of
expression of bait fusion. Importantly, this band was not present in the control lanes.
7.2.4 Isolation of candidate interacting proteins
The yeast-2-hybrid screen was performed essentially as described previously
(Toby and Golemis, 2001) with LexA-Slmo as the bait. As an additional layer of
stringency for the elimination of false positives, the library "prey" clones are
expressed from the conditional yeast GALl promoter. In media containing glucose
as the carbon source (YPD(glu); see 2.8.1), the GALl promoter is repressed, no prey
fusion is produced, and the yeast cannot grow in the absence of exogenous leucine.
Transcription from the GALl promoter is dependent on galactose containing media
(YPD(gal); see 2.8.1). The interaction screen is therefore carried out using YPD(gal)
media, and many false positives can be subsequently eliminated from the screen by
their ability to grow on leucine deficient YPD(glu) media.
The yeast line containing both the bait and reporter plasmids was transformed
with 200J..Lg(2.8.3) of the RFLY3 cDNA library, plated on selective medium
(YPD(glu)-ura-his-trp) and incubated at 30°C for 4 days. Many transformants were
obtained (approximately 100,000), which were then harvested from the medium and
1ml aliquots stored as 50% glycerol stocks at -70°C (2.8.3). In order to ensure that
all the library transformants are screened, it is necessary to screen at least 7 times the
number of transform ants initially obtained (DupLEX-A user manual, OriGene
Technologies). Before screening the transformants for potential positive interactors,
it was therefore important to first titre the number of viable cells, or colony forming
units (cfu) present in each frozen aliquot of yeast transformants. A single aliquot was
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thawed and diluted 1:lOin selective (YPD(glu)-ura-his-trp) medium, and incubated
at 30°C for 4hrs. The transformants were then further diluted to 1:100, 1:1000 and
1:10,000 and all four dilutions plated on selective medium, and incubated for 3 days
at 30°C. 100111of the 1:10,000 dilution yielded approximately 2000 individual
colonies, which is equal to 2x 108cfu/ml.
To screen the library for potential interacting proteins lx lO'cfu were plated
onto selective media deficient in leucine (YPD(gal)-ura-his-trp-Ieu) and incubated at
30°C for 3 days. Many colonies were obtained of which 200 colonies were picked
and patched onto fresh selective plates. 65 of these colonies did not grow on the
selective medium a second time allowing them to be immediately eliminated as
artefacts of the screen. To eliminate false positives from the remaining 135
candidates, these were re-patched onto selective X-gal indicator plates (2.8.1) to look
for activation of the lacZ reporter. A total of97 colonies were found to produce ~-
galactosidase and were blue in colour. Examples of the selection plates employed in
the screen are shown in Figure 7.5. Colonies that activate the lacZ reporter do so to
different levels, and as a result there is marked variation in the strength of blue
colour exhibited by these yeast strains. In theory this is an indicator of the strength of
the interaction. Candidates from the screen were therefore arbitrarily classified as
weak, medium, strong or very strong activators (Figure 7.5). All candidates were
then patched onto selective glucose (YPD(glu)-ura-his-trp-Ieu) medium to eliminate
those false positives in which reporter activation is not conditional on the presence of
galactose. Of these, 43 grew on the glucose medium and were eliminated as false
positives, whilst 19 showed very weak growth and were counted as potential
positives. The remaining 35 were completely unable to grow, indicating that
activation of LexAop-LEU2 reporter is dependent on activation of the library GAL I
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Figure 7.5: Selection of candidate
Simo interactions. To screen for
potential interactions, EGY48
transformed with the bait plasmid
(LexA-Slmo), laeZ reporter plasmid
(pSHI8-34) and RFLY3 cDNA library,
was plated on galactose media deficient
in leucine (2.8.1). Colonies which grew
on this medium are potential positives
that activate the LexAop-LEU2 reporter.
A. 200 potential positive colonies were
selected and patched onto fresh selective
medium. Shown is a single
YPD(gal)ura-his-trp-leu selection plate
(2.8.1) containing 25 colonies. Of the
total 200 candidates, 65 were unable to
grow when replated (black asterisks),
indicating they were false positives. B.
The remaining 135 candidates were
plated on X-gal indicator plates (2.8.1)
to screen for activation of the laeZ
reporter. A single selection plate is
shown containing 25 colonies. A total of
97 candidate were po itive in this assay
as indicated by their blue colour.
Candidates were arbitrarily cia ified as
weak (w), medium (m), trong (s) or
very strong (vs) activators of the !aeZ
reporter.
w
promoter. The results of the yeast-2-hybrid screen are summarised in Figure 7.6 and
Table 7.1.
To initially establish the nature of these candidate Slmo interactors, Kevin
Moffat (University of Warwick) has rescued and sequenced several of these 35
primary candidates. 15 candidates were selected for further analysis (103, 109, 114,
122,125,126,134,139,140,150,153,154,155,196 and 197; see Table 7.1)
Initially, primers specific to the library vector were used to amplify the relevant
cDNA fragments by PCR. The 15 PCR products were then cut with the restriction
enzyme RsaI, a 4bp cutter that should cut often within each fragment to identify
similar restriction patterns. From the restriction pattern it was determined that all but
two (109 and 197) of the candidates were identical (K. Moffat, pers. comm.). Three
of the plasmids, 103, 125 and 197, have been rescued from the candidate yeast
strains and sequenced. Candidates 103 and 125 are both identified as cDNAs
corresponding to the same gene, designated CG40218. This gene is predicted to
encode a 241 amino acid protein of completely unknown function and has no
characterised domains. The cDNA from candidate 197 is identified as CG6259, a
gene predicted to encode a 226 amino acid protein with similarity to the yeast Snfip
protein.
7.3 Discussion
This chapter describes the application of a yeast-2-hybrid screen to search for
proteins that interact with Slmo, since their identity might impart further information
on the function of Slmo. Described here is the isolation of 35 candidate interactions
as yeast strains positive in the yeast-2-hybrid screen. Preliminary analysis of these
has identified two potential interacting partners of Slmo, encoded by the predicted
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Transformed yeast with
bait and library
1 Screen on galactose mediumlacking leucine
200 LEU2+ colonies
selected for further
analysis
1 Re-tested candidates on galactosemedium lacking leucine
135 candidates activated
LexAop-LEU2 reporter
1 Screened candidates on X-gal indicator medium
97 candidates activated
the lacZ reporter
35 candidates exhibit
galactose dependent
activation of the LexAop-
LEU2 reporter
Tested candidates on glucose
medium lacking leucine
19 candidates exhibit
weak growth on glucose
medium (potential
positives)
Figure 7.6: Flowchart to summarise the interaction trap screen
performed using LexA-Slmo as the bait.
Table 7.1: Candidates identified from the yeast-2-hybrid screen.
(et= positive, X =negative, etx =potential positive)
Colony Activate Activate laeZ Galactose
No. LEU2 None Weak Medium Strong Very Strong Dependent
1 et et X
2 et et X
3 et et X
4 et X
5 X
6 X
7 X
8 et et X
9 et et X
10 X
11 et et X
12 et et X
13 et et X
14 et X
15 et X
16 X
17 et X
18 et X
19 et X
20 et et X
21 et et X
22 et et X
23 et et X
24 et et X
25 X
26 X
27 et et X
28 et et X
29 et et X
30 et et X
31 et X
32 et et X
33 et et X
34 X
35 X
36 X
37 X
38 et X
39 et et X
40 et et X
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Table 7.1 (cont.)
Colony Activate Activate lacZ Galactose
No. LEU2 None Weak Medium Strong Very Strong Dependent
41 X
42 t/ t/ X
43 t/ v X
44 X
45 t/ v X
46 t/ t/ X
47 t/ t/ X
48 X
49 t/ X
50 t/ X
51 t/ X
52 X
53 X
54 t/ t/ X
55 X
56 t/ X
57 t/ X
58 X
59 t/ X
60 t/ t/ X
61 X
62 t/ t/ X
63 t/ v X
64 t/ t/ X
65 t/ X
66 X
67 t/ X
68 X
69 X
70 t/ X
71 X
72 X
73 t/ X
74 X
75 X
76 X
77 X
78 X
79 X
80 v t/ X
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Table 7.1 (cont.)
Colony Activate Activate laeZ Galactose
No. LEU2 None Weak Medium Strong Very Strong Dependent
81 t/ X
82 X
83 X
84 X
85 t/ t/ X
86 X
87 X
88 X
89 v X
90 v t/ X
91 t/ X
92 X
93 X
94 t/ t/ X
95 t/ X
96 t/ X
97 t/ t/ X
98 t/ v X
99 v X
100 t/ t/ X
101 t/ t/ t/X
102 X
103 t/ v t/
104 t/ t/ t/
105 t/ t/ t/
106 X
107 X
108 X
109 t/ t/ t/
110 t/ t/ t/
111 t/ t/ t/X
112 X
113 X
114 t/ t/ t/
115 X
116 X
117 t/ X
118 t/ t/ t/X
119 X
120 X
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Table 7.1 (cont.)
Colony Activate Activate laeZ Galactose
No. LEU2 None Weak Medium Strono Very Strono Dependent
121 X
122 t/ t/ t/
123 X
124 X
125 t/ t/ t/
126 v t/ t/
127 t/ t/ t/X
128 v X
129 t/ t/ t/
130 t/ t/ t/X
131 X
132 t/ t/ X
133 X
134 t/ t/ t/
135 t/ t/ t/X
136 t/ t/ t/X
137 X
138 t/ t/ t/
139 t/ t/ t/
140 t/ t/ v
141 t/ t/ t/X
142 t/ t/ t/X
143 t/ t/ v
144 t/ X
145 t/ X
146 t/ t/ X
147 v t/ t/
148 t/ v t/X
149 X
150 t/ v v
151 t/ X
152 X
153 t/ t/ t/
154 t/ t/ t/
155 t/ t/ v
156 t/ t/ t/X
157 v t/ t/X
158 X
159 v t/ X
160 X
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Table 7.1 (cont.)
Colony Activate Activate laeZ Galactose
No. LEU2 None Weak Medium Strong Very Strong Deoendent
161 t/ t/ t/X
162 v t/ t/
163 t/ t/ t/X
164 t/ t/ t/
165 X
166 t/ t/ t/X
167 t/ t/ t/
168 X
169 t/ t/ t/X
170 v t/ t/X
171 X
172 X
173 t/ t/ X
174 t/ t/ t/
175 X
176 t/ t/ t/X
177 v X
178 X
179 t/ t/ t/
180 t/ t/ X
181 t/ X
182 t/ t/ t/X
183 t/ v t/
184 t/ X
185 v X
186 t/ v v
187 X
188 t/ t/ t/
189 t/ X
190 t/ t/ t/
191 t/ X
192 v X
193 t/ X
194 t/ t/ t/
195 t/ t/ t/
196 v t/ t/
197 t/ t/ t/
198 t/ t/ t/
199 t/ t/ t/
200 t/ X
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genes CG40218 and CG6259. Importantly, neither of these proteins are known as
common artefacts of yeast-Z-hybrid screens, unlike a number of critical
mitochondrial proteins (e.g. cytochrome C, ATP-synthetase) that commonly arise as
false positives (see Golemis homepage: http://www.fccc.eduJresearchilabs/golemis).
Currently, the CG40218 and CG6259 proteins can only be regarded as candidate
Slmo interacting proteins. To confidently report a true in vivo interaction with Slmo,
it will be necessary to confirm the interaction biochemically, typically by
immunoprecipitation and ultimately demonstrate some biological relevance (e.g.
similar mutant phenotype). However, the isolation of these candidates, and others
that have yet to be identified, provides a basis for future work on the Slmo protein.
The CG40218 protein is relatively small (241 amino acids), and completely
uncharacterised with no ascribed or implied function. The PFAM database of protein
families (Bateman et al., 2000) identifies an 80 amino acid C-terminal domain of
unknown function that is present in proteins from a diverse range of species (PFAM-
B: 10149). These include mammalian proteins, BCNT, which was isolated from the
bovine brain (Takahashi et al., 1998), and CP27, which has been shown to be
expressed in various tissues including mouse brain, heart, lung, liver, salivary glands,
teeth and bones, and has been suggested to playa role in mouse embryogenesis
(Diekwisch et al., 1999). In addition, predicted proteins can be identified in C.
elegans (F39H 11.1 protein; SwissProt entry: P90867), Arabidopsis (BeNT-like
protein; SwissProt entry: Q8L8Q4) and S. cerevisiae (YB81; SwissProt entry:
P38326). The potential interaction with the CG40218 protein does not initially
appear to be informative with regards to the biochemical function of Slmo. However,
the apparent identification of this protein in 13 of the positive yeast strains, isolated
individually from the screen, make this a strong candidate for a genuine interaction.
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The CG6259 gene is also uncharacterised, but the predicted protein has
similarity to a family of small charged coiled-coil factors typified by the yeast
proteins Snf7p (sucrose non-fermenting) and Vps20p (vacuolar protein sorting)
(Kranz et al., 2001). Many members of this family (of which there are at least seven
in both Drosophila and human) remain uncharacterised, but are highly conserved
and, as with Slmo, are found in organisms as diverse as Drosophila, human, S.
cerevisiae and Arabidopsis (Stauffer et al., 2001; PFAM entry PF03357). In yeast,
Snf7p (also known as Vps32) and Vps20p are associated with the late endosomal
membrane, and operate together as part of an oligomeric complex called ESCRT-III
(endosomal sorting complex required for transport). Here they play an essential role
in protein sorting for the multivesicular body (MVB) pathway to the vacuolar lumen
(Babst et al., 2002). These proteins are therefore involved in the critical decision
between recycling and degradation of internalised plasma membrane proteins
(Lemmon and Traub, 2000). Mutation of snj7 or vps20 cause severe disruption of
endosome to vacuole trafficking, which ultimately manifests as a defect in selective
glucose metabolism, presumably due to altered turnover of a glucose sensor (Kranz
et al., 2001; Tu et al., 1993). A similar function has been demonstrated for the
mammalian Snf7p homologues CHMP4a and CHMP4b (charged multivesicular
body protein), overexpression of which alters MVB trafficking of both EGF
(epidermal growth factor) and cholesterol to the lysosome (Katoh et al., 2003; Peck
et al., 2004).
If the CG6259 protein is involved in the same physiological process as Snf7p
then it would be very unlikely to represent a true interactor of Slmo. However, given
that the Slmo yeast homologue MSFlp' has been implicated in protein sorting at the
mitochondria (Nakai et al., 1993; T. Endo, pers. comm.), a candidate interacting
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protein related to factors involved in protein sorting elsewhere in the cell is of
considerable interest. Preliminary phylogenetic analysis (PFAM entry PF03357)
suggests that CG6259 does not represent a genuine homologue of Snf7p, and there
appears to be a substantial degree of functional divergence between the various
members of this family. For example, the mammalian CHMPI is associated with the
nuclear matrix and has been shown to playa role in gene regulation by affecting
chromatin structure (Stauffer et al., 2001), whilst the closely related human gene BC-
2 has also been shown to be upregulated in the nuclear matrix of breast
adenocarcinoma (Stauffer et al., 2001). Could the CG6259 protein be involved in
protein sorting in the mitochondria? At present there is no data to support this
hypothesis. Bioinformatic programs such as PSORTII, iPSORT
(http://psort.nibb.ac.jp ) and TARGETP (Emanuelsson et al., 2000) do not predict a
mitochondrial localisation for CG6259 with any confidence, but also do not
eliminate the possibility. Clearly, it would be desirable to determine the subcellular
localisation of this protein.
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Chapter 8: General Discussion
8.1 Introduction
This thesis describes an analysis of the Drosophila gene slmo (also known as
kisir), and the related genes prel and retm. The project began with an interest in an
enhancer trap line, P(GAL4)c682, expressed specifically, but not ubiquitously,
within the CNS during embryonic development. Mutation of the corresponding gene,
slmo, results in severe larval motor defects and eventual lethality. In the course of
this thesis I have described Slmo to be a mitochondrial localised protein and a
representative of a novel family of conserved proteins, found in organisms as diverse
as flies, worms, yeast, mammals and plants. A discussion of experimental results is
provided at the end of each of each of the results chapters 3-7. This section aims to
draw together the major conclusions and address some of the under lying themes of
this research.
8.2 The role of slmo in the eNS
A functional neuronal circuit has two basic requirements. Firstly, the
component neurons must form the correct array of synaptic connections which
mediate the correct pattern of communication between neurons. This allows them to
integrate into a dynamic unit capable of generating functional output (Goodman,
1993). Secondly, the circuit must be able to modulate this functional output
according to the specific requirements of a particular behaviour (Marder and Bucher,
2001). In the case of Slmo, the protein does not appear to be required for the
establishment of neuronal connections within the CNS as all available evidence
suggests strongly that the circuitry of slmo mutants is intact (Carhan, 1999; Reeve,
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2002; see chapter 3). However, slmo is required for normal larval locomotor
behaviour in Drosophila (3.2.1). Although initially able to hatch, 1sI instars
homozygous for a slmo null allele (slmo'~69ml)are severely impaired in their ability to
generate the rhythmic peristaltic contraction waves that drive this relatively simple
stereotyped behaviour. This phenotype subsequently progresses towards total
inactivity, although the ability to move the head and mouth parts is retained. The
severely compromised locomotor activity observed in slmot.69mlmutant larvae
suggests abnormal functional output of the motor circuitry that drives this behaviour.
In addition, available data on the expression of the slmo gene suggests that this
phenotype of compromised motor output is caused by alteration of the function of a
limited subset of cells within the eNS. In the developing embryonic eNS, both the
P(GAL4)c682 enhancer trap (3.2.2.1) and in situ hybridisation to the slmo transcript
(Carhan, 1999), report expression to be exclusive to a subset of cells within the eNS.
During larval development, when the slmo mutant phenotype is first evident, the
enhancer trap reports expression only in discrete populations of neurons within the
VNe and larval brain lobes.
The precise mechanism by which Slmo might affect neuronal function is
currently unknown. Various lines of evidence suggest that the motor circuitry that
drives locomotor behaviour develops normally in the slmoA69mlmutant (chapter 3;
Carhan, 1999; Reeve, 2002; R. Baines, pers. comm.). Despite this, subtle
abnormalities in the development of the nervous system cannot be formally
eliminated. For example, defective axon pathfinding of a very small subset of
neurons would be difficult to establish. If the assembly of the nervous system is
indeed unaffected by slmo loss of function, then this presents the possibility that
Slmo is a factor important in modulating the functional activity of a specific
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subpopulations of neurons. However, it should be noted that the reported expression
ofSlmo in early CNS glia (chapter 3; Carhan, 1999) and the adult gonads (Reeve,
2002) indicate that the function of this protein is not exclusively neuronal. The
potential biochemical function of Slmo within neurons and other cell types is
therefore of considerable interest. The establishment that Slmo function is associated
with the mitochondria (chapter 4) suggests the cause of the phenotype might be
viewed as a cell biological defect with severe consequences for neuronal function.
8.3 The association of Simo with the mitochondria
Mitochondria are of course crucial in all cell types and have an integral
involvement in many cellular processes, including energy production, regulation of
intracellular calcium levels (Meldolesi, 2001; Vanden Berghe et al., 2002), and the
execution of apoptotic cell death (Claveria and Torres, 2003). The latter possibility
was addressed in chapter 3 (3.2.4), and slmo does not appear to be required for
neuronal viability. Indeed, the lack of any obvious developmental phenotype in slmo
mutants is not inconsistent with the observation that even in the total absence of
mitochondria from all neuronal projections, the synaptic terminals exhibit
surprisingly normal ultrastructure and no degeneration (Stowers et al., 2002). The
implication is that other sources of ATP, such as anaerobic respiration or diffusion
from the cell body, must compensate to some extent.
All cells depend on the mitochondria for the production of energy in the
useable form of ATP. The electrical properties of neurons have a particularly high
metabolic demand which needs to be serviced (Laughlin, 2001; Laughlin et al.,
1998). If the consequences ofloss ofSlmo function included a reduction in the
availability of ATP this could adversely affect any number of ATP dependent
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processes underlying the specialised function of neurons. These metabolic costs
include the need to package neurotransmitter into synaptic vesicles, release of the
neurotransmitter and the reuptake of neurotransmitter and metabolites (Laughlin,
2001; Laughlin et al., 1998). In particular, are the metabolic demands of regulating
the ionic contents of the cytoplasm in relation to the extracellular space. This is of
course, essential to the ability to generate electrical signals, and the ion pumps that
mediate this function are energetically expensive (Laughlin, 200 I; Laughlin et al.,
1998). It follows that the overall demand for ATP varies in proportion to the level of
neuronal activity, and it is necessary for the mitochondria to respond to the local
needs of oxidative metabolism by changes to their activity (Bindokas et al., 1998). It
is possible that Slmo is involved somehow in regulating metabolic output in specific
cells or tissues. Certainly, examples do exist of non-ubiquitous factors that affect
activity in this way, such as the mammalian mitochondrial uncoupling factor
BMCP1, which has been shown to modify mitochondrial respiratory efficiency in
particular neurons within the human brain (Kim-Han et al., 2001).
Another possibility is that loss of Slmo function in some way compromises
the regulation of intracellular Ca2+ homeostasis, perturbations of which could affect
the fitness of many cell types but would have particularly severe consequences for
neuronal signalling and excitability (Meldolesi, 200 I). Disruption of mitochondrial
function might firstly indirectly affect this process by diminishing the extrusion of
Ca2+ across the cell membrane as the Na2+ gradient diminishes due lack of ATP. In
addition, mitochondria are known to work in partnership with the endoplasmic
reticulum in buffering Ca2+ levels by rapidly and efficiently taking up Ca2+ when
concentrations are high and therefore help reduce the concentration following a Ca2+
spike (Berridge, 1998; Meldolesi, 200 I). The ER is the major organelle involved in
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regulating calcium levels but the mitochondria act to increase the speed and
efficiency of the response in localised compartments of the cell. This function is
particularly important in crucial areas such as the synaptic terminal, where the
volume of the cytoplasm is very low and regulating the intracellular ion
concentration is more challenging (Berridge, 1998). Mitochondria are therefore
closely physically associated with the ER at these locations and the relationship is to
some extent reciprocal, as the mitochondria require a supply of Ca2+ ions for the
process of oxidative metabolism. The tight regulation and buffering of calcium is
crucial for neuronal excitability, neurotransmitter release, the regulation of gene
transcription and synaptic plasticity (Berridge, 1998; Zucker, 1999). Itwould be
interesting to analyse both Ca2+ levels and metabolic activity in Slmo expressing
cells, but currently there is no data available that might suggest the precise
biochemical action of Slmo within these processes.
8.4 A role in mitochondrial protein sorting?
Mitochondria contain many proteins, only a few of which are encoded by the
mitochondrial genome. The vast majority of these factors, like Slmo, are nuclear
encoded, and manufactured in the cytosol in parallel with proteins earmarked for
other locations within the cell (Neupert and Brunner, 2002). This necessitates a
highly organised system of protein trafficking that ensures the coordinated import of
these proteins into the mitochondrion (Truscott et al., 2003). Proteins destined for the
mitochondria must be efficiently recognised and delivered to the organelle by a
system of chaperone proteins (Hoogenraad et al., 2002). In addition, imported
proteins must be accurately sorted and directed to the functionally distinctive
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subcompartments of the mitochondria, these being the outer membrane, the inner
membrane, the intermembrane space, and the matrix (Truscott et al., 2003).
The signal required for accurate targeting and sorting appears to be contained
within the protein itself. This is traditionally viewed in terms of an N-terminal
pre sequence that is ultimately removed, but in many cases, particularly proteins of
the outer and inner membranes, the targeting and sorting information is contained
within the mature protein (Truscott et al., 2003). A number of specialised translocase
complexes are responsible for the recognition of these targeting signals and
facilitating the transfer of proteins across the mitochondrial membranes. Passage
through the outer membrane is mediated by the TOM (translocase of the outer
membrane) complex, which is essentially comprised of protein import receptors and
an import channel (Truscott et al., 2003; Wiedemann et al., 2004). Proteins must
then be sorted, by a number of mechanisms, either to the outer membrane, the
intermembrane space or to the TIM (translocase of the inner membrane) complexes,
these being TIM23, which mediates translocation into the matrix, or TIM22, which
mediates insertion into the inner membrane (Truscott et al., 2003; Wiedemann et al.,
2004). In addition, these major complexes are assisted by an array of molecular
chaperones and processing enzymes. For example, a family of factors have been
identified in yeast, referred to as the "small Tims", that are involved in mediating
sorting and transport of inner membrane proteins across the intermembrane space
(Koehler, 2004). These can operate in the aqueous chamber (e.g. TimlO), or be
associated with the outer surface of the inner membrane (e.g. Tim12) (Koehler,
2004). A variety of other proteins have also been identified by Toshia Endo's lab
with potential roles in mitochondrial protein sorting (Kanamori et al., 1997).
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Toshia Endo and colleagues were responsible for the identification of the
yeast Slmo homologue, MSFlp' (Nakai et a/., 1993), a myc-tagged fusion of which
was reported to be located at the inner mitochondrial membrane. Importantly, over-
expression of the gene was reported to alter the location of a reporter directed to the
intermembrane space (T. endo, pers. comm.). This observation has been interpreted
as an indication that MSF lp' (mitochondrial sorting factor 1') is involved in the
process of intracompartmental protein sorting (Nakai et a/., 1993). Might this be the
function of the Slmo protein? Some circumstantial evidence in support of this view is
provided by the identification, from a yeast-2-hybrid screen, of a member of the
Snt7p family of charged coiled-coil proteins (Kranz et a/., 2001; Peck et al., 2004;
Stauffer et a/., 2001) as a potential interactor of the Slmo protein (see chapter 7). The
protein in question, encoded by the predicted gene CG6259 (FlyBase entry:
FBgn0036740), is itselfuncharacterised, but similar proteins in yeast and mammals
have essential roles in protein sorting systems outside the mitochondria, specifically,
for the multi vesicular body pathway between the endosome and the vacuole/
lysosome (Babst et al., 2002; Peck et al., 2004). Currently, most members of this
protein family, of which there are a least six members present in both humans and
flies, are identified from the databases only as hypothetical or predicted proteins.
However, it is likely that the various members of the Snt7p family exhibit a
significant degree of functional divergence, as indicated by the observation that two
mammalian members of the Snt7p family, CHMPI and BC-2, have functions in the
cell nucleus (Stauffer et al., 2001). Although no proteins of this type have yet been
linked to the mitochondria, the identification of a potential Slmo interacting protein
related to factors involved in protein sorting is of considerable interest and merits
further research.
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Interestingly, in humans, loss of function of the DDP 1 (deafness-dystonia
peptide 1) gene, which encodes a protein with homology to the "small Tim" family
of yeast proteins, has been identified as causing Mohr-Tranebjaer syndrome, an X-
linked degenerative disease characterised by a number of progressive neurological
symptoms including deafness, blindness, dystonia and mental retardation (Bauer and
Neupert, 2001). This severe phenotype is thought to result from defective biogenesis
of the TIM23 translocase, essential for protein import at the inner membrane,
including many components of oxidative phosphorylation system. Perhaps the
phenotypic consequences of slmo loss of function result from lowered abundance,
possibly at the inner membrane, of some mitochondrial proteins important for
neuronal function.
8.5 The function of Prel and Retm
Slmo exhibits a high degree of evolutionary conservation, and represents a
novel family of proteins present in diverse eukaryotic taxa including C. elegans, S.
cerevisiae (including MSFlp'), Arabidopsis and human (chapter 5). In animal and
yeast species, multiple Slmo related factors can be identified. For example,
Drosophila contains three such proteins, encoded by the slmo, prel and retm genes.
An interesting question is whether the Slmo/MSFlp' domain fulfils a common
biochemical role in all the proteins of the family. Although all three ofSlmo, Prel
and Retm (and related proteins in other organisms) have now been linked to the
mitochondria (6.2.1.2; Huh et al., 2003; Fox et al., 2004), the phylogenetic
relationships between these factors suggest that a degree of functional divergence is
likely (5.2.2). Even so, the SlmolMSFlp' domain may fulfil similar biochemical
roles in different cellular contexts, or take part in alternative cellular processes.
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The slmo gene appears to encode a factor with an essential role within the
mitochondria, but the requirement for this function is restricted to particular tissues at
specific developmental stages. In particular, research in both this thesis and previous
reports has focussed on the embryonic and larval eNS (chapter 3), and in the adult
germline (Carhan, 1999). In the case of the prel gene, expression appears to be
widespread, and is indeed ubiquitous during embryonic development (6.2.2). This
might suggest a general requirement for the Prel protein all tissues. Certainly, the
lethality (during larval development) exhibited by a prel mutant indicates that the
function of this gene is essential in Drosophila (6.2.3). However, the requirement for
Prel is not necessarily uniform. In the developing embryo, in situ hybridisation
suggests that transcription is upregulated specifically in the developing brain lobes
and certain regions of the midgut (6.2.2). This might suggest that the requirement for
Prel function is altered in different tissues at different developmental stages, a view
supported by the reported expression of the homologous human PRELl gene
(Guzman-Rojas et al., 2000). The PRELl transcript is expressed in a wide range of
human tissues including liver, brain, kidney, lung and spleen. In the developing
foetus, expression is specifically high in the liver, whilst mRNA levels in other
tissues are comparatively low. Conversely, at the adult stage, PRELl expression in
the liver is substantially reduced, whilst the transcript is detected at high levels in
spleen, brain, lung and kidney (Guzman-Rojas et al., 2000). However, as with Slmo,
the cellular processes affected by the Prel protein are at this stage unknown.
P-insert and deletion alleles of retm do not result in lethality (2.2.3),
indicating that the function of this gene is not essential in Drosophila. However, the
retm gene product remains interesting as a representative of a novel subclass of
proteins containing the SlmolMSFlp' domain in conjunction a functionally
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characterised motif known as the CRAL- TRIO domain (5.2.2). This conserved
domain has been shown in a number of proteins to mediate the binding and transport
of small hydrophobic ligands. In particular, the domain is defined by its homology to
the yeast phosphatidylinositol transfer protein (PITP), SECI4p. In S. cerevisiae, this
essential protein mediates the binding and transfer of phosphatidylinositol or
phosphatidylcholine, and by regulating the availability of these molecules, plays an
integral role in a variety of signal transduction and membrane transport events (Li et
al., 2000). However, not all SEC14p related proteins are PITPs, and in higher
eukaryotes, the CRAL- TRIO domain has been shown to bind alternative ligands such
as retinol, a-tocopherol and squalene (Arita et al., 1995; Crabb et al., 1998; Shibata
et al., 2001). In the case of Retm, the ligand has not yet been identified.
8.6 Implications for human disease
The importance of the mitochondria to all living cells is well established. This
view is accentuated by the more recent discovery that mitochondrial dysfunction is
involved in a variety of degenerative diseases, ageing and cancer (Schon and
Manfredi, 2003; Wallace, 1999). In many cases, the mechanisms underlying such
conditions have been attributed to disruption of nuclear encoded proteins. The
identification and characterisation of novel mitochondrial proteins is therefore
significant not only for our understanding of normal cellular function, but may also
have implications for understanding a variety of human disorders. In some cases,
relevant mutations and comparable phenotypes have been identified in model
systems such as Drosophila. For example, mutation of the technical knockout (tko)
gene, which encodes the mitochondrial ribosomal S12 protein, has been shown to
cause mechanosensory failure resulting in behavioural phenotypes such as sensitivity
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to mechanical stress and impaired response to sound stimulus (Toivonen et a/.,
2001). Such phenotypes would appear to parallel mitochondria related sensorineural
deafuess in human, itself a consequence of mechanosensory failure of the receptor
cells of the inner ear (Jacobs, 1997). The sluggish-A gene was initially identified as a
mutant causing locomotory phenotypes in adult Drosophila, and was found to
encode mitochondrial proline oxidase (Hayward et a/., 1993). Mammalian
homologues have subsequently been linked to human neurological disorders
(Campbell et a/., 1997; Gogos et a/., 1999). The scully gene encodes the Drosophila
homologue of the vertebrate type II L-3-hydroxylacyl-CoA dehydrogenase (HADH),
a mitochondrial enzyme essential for p-oxidation of fatty acids (Torroja et a/., 1998).
Mutation of scully results in abnormal photoreceptor development and sterility
phenotypes suggested to reflect human pathologies caused by p-oxidation disorders.
An excellent example is the Drosophila parkin gene, a homologue of the human
parkin gene linked to an early onset form of Parkinson's disease. In this case,
analysis of parkin loss of function has provided a valuable insight into the
mechanisms of mitochondrial dysfunction that underlie this condition (Greene et al.,
2003). The identification of a novel family of mitochondrial associated proteins may
therefore be of general relevance. Further analysis of the function of Slmo, Prel and
Retm, and the relationship to mammalian homologues is likely to prove interesting.
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Appendix I.
LOCUS
DEFINITION
ORGANISM
REFERENCE
AUTHORS
slmo
6kb BamHI genomic fragment (6176bp)
Drosophila melanogaster
Carhan (1999)
Ahmet Carhan
1 CCGGACATCG GGATAGMGA CGCTGTTCGC GATGGCAGGA GCGGGCGTGG GACGGCGCTG
61 GGCCCTTGGG CGTTCCGCTG GGGCTTCCGT TTCCGTTTGC GTCTGCMGT AGAAAGTGCC
121 TGTAGCCTGG CTTTGGGMT ATGCMCAGA TTTTGCAGAG MTGTCGCTT AGTGGCATTC
181 CGCTGACTM ATTAGATCGG CTCTGGGTM ATGGCMCGA TMGCTGGCA ATCGMGTTC
241 GGATTATACT GAGAGCACTC TGCTCTTATC TCTAGCTTCT ACTMCGGTA GACTCACATT
301 GTATTGGGAC AAACAAACAG CTGGCTTTGG GGCCGAAAAA TGCCGTATGA TTGTATTTAG
361 GCAAAGTTGT AGTTCTGCGG TTATCTATTG GCCMGTTTC CCACTTAAAA TTAGCTTTTA
421 AAACTCAAAG CCCCGMCAT GGTGATTCAT TTCGTCTTTC MTTTGGTCA CTTCCGTTCA
481 GTTMTTTTT GCATTACTAT ACCCACAGCA TTGTACATCC ATTTTMGAG TACGTGTTCA
541 TACCTTGCTT GCTCATTAGC TTCTCCTGCT GCAGGCGCGC GTTGCTCGAT CCGMGTATC
601 CGTTGATAAA TGGCAGGGGC GACATGACTA CTCCGCCCCT CAGCGMCTG TCTGGTGGAG
661 GAGGAGCGGG TCTGTTGMT GGATTTGTCC GCCTGGGCGG CGGTCTAGGC TTCGCACTCT
721 CCGATGCATT TTGTGGTCCG TCCMGGCGC TGCCGAGCAT CTCTGTAGGT TAAAGMCGC
781 AGCGGATTAG TGCACAGGGA TTGTAGGATT AGCCATTGTG CAGTCTCACT GTTTCTTGCG
841 TCCTCCATCT CTTGCMCTG GCGTTTTAGC TCGGCCAGGA TGATGCGCTT ATACTCGTAG
901 CCGGCGCATG TTAGCGCCTT CATCCACGTC TCCATGCTGT CTTGGTTTTC GGCGGCGAGG
961 ATGTAGGTGC GATTGCCGTT GMGGCGATC TCGMGCAGT AGTTGTCCAC CTCGTTAGAC
1021 AGCTCMTGG TGCAGCCCTC GACMTGATG AGGCCCMGG GCTCCTTGTC CMGCGCGAC
1081 TCGMGTAGA AGAGCAGGTT GCCTTTCAGC ACGMGTAGC GTCGCTGGM GGCCTTGTTG
1141 ACCTCGCCCC GTTTGTTGAG GMGCCTGCA AGGCGTATCG GTGTGTGATA MTGGATTAT
1201 GATTATTMT AGACGAGCGA MGGGCTCGC TTGCATACCT TCCATGTCGA AGGGCGGCGT
1261 TCTCGCGMC ACGTACAGGT TCTTCTCGTT GATCTTCATG GCTGCACTGT CTCGGGCTGC
1321 ATTCGMGCA MTATGGGTG TCCTATTTCC GCCTTTCGTC TCTTATTATT GTGATGMCA
1381 GGTAAAAAAA ATGCAAAGCG AGAAACMTT GACGCTGCGC GMCAGCTGA TGGCCAGTGC
1441 TGCCACACCT CCACCGGTTA TCGATTGCTG GGTGCGGMT TTCTAGTTTT CMTGTAGAT
1501 TGCAAACATA MCGMTTTT GMTCCTGCG AAATGTCGTA CTTACTCACG GAAATCGCGC
1561 TGGAGATGCT GGGCTACMG TTCTACGACA CCMTGGCAC ATTCCACCTG ACCAATTTTC
1621 AAAACMCTC CACGCTCAGC GAAACGCATC CCGATGAGCC CTCCCTGCAG GMTTCATTG
1681 AGTACACAAA TGAGGAGCTG AAGCMGACG CGCAACAGCA GGAGCCGCAC ACGCTGGCGG
1741 TGCAGGAGGA GTCGTACCTG GATGCCCCCA CCATACCCGA GTCACGCTAT GCGCGGCGCA
1801 CGCCGGCCAA GGCGCTGGCC AAGATAATGG ACTACGAGAG CGAGAAGATA GTCAACCAGA
1861 TCAGCACTCG TCTGGAGGGC TCGGTGTCAC GTCGGGCGGC GGCGGACAGT GACGAGCAGC
1921 TGGCCGAGAT CATCMCGAG GAGAGGAAAC TAATCGAGGC GGATGCCGAG GTAATACACA
1981 ACTTTCGGGA GCTCGTGGAG AGCCGACTAC AGCGATTGGA TAAACGGCCC TACGAGAAAT
2041 ACGTACGTAC CTTCGGGCCG CAATAGGAAG CTGCACGTGC AATGTCAAAG TGCCGCCATT
2101 ACTTTTAGM TTMTTTAGT TTATAAATTT MTAAATMG TTACCGCTAC AGGGTGCCTG
2161 CGGCACTTTC ATTTTCTCTT ACTGCGCCAG TGTGACCACC CTAGCCCATG CACTGGCCAG
2221 CGATAGCCCC ATCTATCGGA GCCACTGTCA TCTCTAGCAG CACAGCACGA GTAAAGGTCA
2281 GCTCTCGTM CTTGTCTCGG AAATATTCM TAATTCCGAG ATTGCCGTCA AAATTCGAGT
2341 CGTGTACTTC AGCTAACGCT CCCCCTGTTT AATTCCGTTC CGTCTGCCCC CGCAGGCTCA
2401 GCTCAGCCCG CATCTCGGCT GCCAATTAAG GATATAAAGC CCTCCCCGGA CGGTGACGAC
2461 MCGGCGCTT GCATMTGAA AATCTGGACA TCGGAGCACA TATTCAACCA CCCGTGGGAG
2521 ACGGTCACGC AGGCGGCGTG GCGCAAGTAC CCCAATCCGA TGACGCCCTC CATCATTGGC
2581 ACGGACGTGG TCGAGCGCCG TGTGGTGGAC GGCGTCCTGC ACACGCATCG CCTGGTGCAG
2641 TCCMGTGGT ACTTCCCCM GTGGACGCAC GCGCTGATCG GCACGGCCAA AACTTGTTTC
2701 GCCAGCGAAC GCTCCACGGT GGACCCGGAG CGCAAACAGA TGGTGCTGM GACAAACAAC
2761 CTCACCTTCT GCCGCMCAT CAGCGTGGAC GAGGTGCTCT ACTATGAGCC GCATCCGTCG
2821 GATGCCAGCA AGACGCTGCT CMGCAGGAG GCCACCGTGA CCGTCTTTGG TGTGCCGCTG
2881 TCCCACTACA TGGAGGACCT GCTCACCTCG ACCATTAGCA CAAATGCCGG CAAGGGACGC
2941 CAGGGCCTGG AGTGGGTGAT CGGGCTGATC AACACGGAGG TCAAGGGCAT CGCTCGCGGC
3001 ACCGACGMC TTCTGCACAA CACACGGCGC TCCATCGACG AGGTGACGGA GAGCGCGCGG
3061 MGAGCATGG ACGAGATCAG TGCGCAGGCC GCCMGGCGG CGMGGCGAT GCACATTACG
3121 TAGGTGTCGA CAAGGCGACA GTGCAAGGTC GCGCGGGGGC TGTTCACTAG TGMTTATTT
3181 AGATGGCGCG CGGTCGTCGT TTTAGTACAA CTMTTAATC GATGGCACGA TGGACATGGA
3241 CAGCAACATG TGGGACAGCA ACACCTTCCT CTATTCTCM GCCATTCAAT GCATATATTT
3301 TATMTTATT ACTCCCCTTC GAACGAATCG ACTGCTAATG AGTCATGTCG ATAAAGMGT
3361 GCCCCCGAAT GGCTGAACTG GAAGGAACTC GCGCTMTGC TGGCCCCCAT TCATGCAGAT
3421 CMTATATAT ATAAACCTAA AGTACATAGT CMTGTAAGC TTTGTAAGCC GCCGCAGATT
3481 TCGAAGAACG AGAGGAGCAA TTAAACGACA TATTTGCCTA CGACCAGCCA GTGTCAAGTT
3541 CAATTGTTTA ATTTTAATTC GCAGCACACT TGTACTGCGT CTTTTTTTTT TGCATTTGCA
3601 TGACGTTCGC ATGTGCAACT GCAGCAATTT TMGCATTCT GTGTATAAAT AAAACCCAAG
3661 AAAGTCGATT TGTGGGTTTT TTCTCTACAT ACATACTTGA TTAGCGATTT TTGGCGTCTG
3721 TTTTATTCGC TTATCATCAA AAGCCCACGT GCCTAGTGGC TCMCAACTG TGTACCTAGT
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3781 TAGCATCGCA GACATGGAAA CTGATATGTC CCTTATCTGG TTCAACAGTT GCGAAGAATG
3841 TGATTGAAGG GGAAAGTGGG TGCTTGGAAA CAAGTTGATG ATCAAACAGC AGGTGTTCTA
3901 GGGACAAGGT GAAATACTTT TACCTAACTT ATCAAAAGAA GTAACTTATT TATTTAGCAG
3961 TTTTCGTAAG CTTTTAATCA AAATAAACAA GTAATCCTTA CGAATTACAA TTAAACTATT
4021 TGGTTCATTG AACCCGTGTA GCATTAACCC TTGCAAGTTA CGCAATGGGT ACAATTTACG
4081 AAAGCTTTTA AAGCTCAATT CGCCTAAGGG TTAATTTGAA TTCCAGCGGC AGTCGCTGTG
4141 CAGCACTGGC CAACCGAACG CTGTGGTGGA TTGAGCCGCG AAATGAGGGG AAACCGAGCT
4201 GGAGCCTCAA AACGATCGTA ATTTGCAGCT AAGACGCACG TGTGCTCCGC TCAGTGTTAG
4261 TGTTATTGTG CTTCAATTTG GGGTATTTGG CGTTAATTAT TTACCTAAAT TCCGACCATT
4321 CAGCAACGCA GGTTTCCGTT CGTAATGGAA AATATGTTTA CGCCGGCTTA TCAGCAAACT
4381 CCCAGCCGGG GAAAAACAAA AACAAGTTGT GACGCCAGTG CAGCGATTGC TGCAGGCGAT
4441 TCCATCGATT TCGCTCGGCT GTAACCTGAT CCGCTGCTGT GGGTTGTGGG CTGTGTGGCT
4501 GTGGTATAGG TGCCGCCAGT TGATAACCCC CAGCGTGGGC ACGGACCCAC TGGTCGTCAA
4561 CCGCTTCGCA ACTCCCAAGA TCATTCTCGA TTCGACGAGC AAGGAGTGCA CACTGTCTGT
4621 ACTCAATCCG CATTTTTCGT TTCTTGCAGC CCCACGACAT GGTCATCCTT CGCTACTACG
4681 ATGTGCAGGC CCACTCCGCG GCCGAGGAGG AGAGTGTCCT GCGTCGGTTG CGCGAGGAAG
4741 ACGGCGCCGT GGTGTCCGTG CGCATGGAGC GCTGCTATCA TCTGGAGTAC AGCGCTCAGG
4801 CAGAGCACTC ACTGGCCCTG GACGAGCTGC TGGTGTGGCT GGTCAAGCAA CCGCTGAGCA
4861 AAGGCCAGAG CTTGTCCAGG CAACCTGCCC TGCAGTCAAC TGGGTCGAGT CAGTTGCTCC
4921 TGGAGATCGG GCCGCGTTTT AACTTCTCCA CGCCGTACTC CACGAACTGC GTGAACATAT
4981 TCCAGAATCT CGGGTACTCA GAGGTGCGTC GCATGGAAAC CTCCACCCGC TATCTGGTTA
5041 CTTTTGGCGA GGGATCAAAG GCGCCGGAGG CAGCCAGGTT TGTTCCTCTG CTCGGTGACC
5101 GCATGACCCA GTGCTTGTAC ACCGAGGAGA ATACCCCCAA GGCGAGCTTT GACGAGCAGC
5161 TACCTGAGCG CCAGGCCAAC TGGCATTTCG TGCCCGTTTT GGAGGAGGGT AGGGCGGCAC
5221 TGGAGCGGAT TAATCAGGAG CTGGGCTTAG CCTTCAACGA CTACGATTTG GACTACTACC
5281 ACGACTTGTT TGCCAAGGAG CTGGGCCGCA ATCCCACCAC TGTGGAGCTC TTCGATTGCG
5341 CCCAGAGCAA CAGTGAGCAC TCGCGCCACT GGTTTTTCCG CGGACGTATG GTGATCGACG
5401 GCGTGGAGCA GCCCAAGTCG CTGATTCGCA TGATCATGGA CACGCAGGCC CACACGAACC
5461 CGAACAACAC CATTAAGTTC AGCGACAACA GCAGTGCCAT GGTGGGATTC GATCACCAGA
5521 CCATAGTTCC GTCCTCCGTG GTCGCTCCCG GCGCAGTGCG TCTGCAGAGC GTGCAGTCTG
5581 ACCTGATTTT CACGGCGGAG ACCCACAACA TGCCCACTGC AGTGGCGCCT TTCAGCGGAG
5641 CCACCACCGG CACTGGCGGA CGACTGCGTG ATGTCCAGGG CGTGGGCAGA GGAGGCGTGC
5701 CGATCGCCGG CACCGCTGGC TACTGTGTTG GCGCTCTTCA CATTCCAGGT GAGCATTGCT
5761 TTTTTTTTGA GTATTTAGTT CCTATTAGTT TTTATTATAC ATCACGACTT TCTTGTCGTC
5821 GCAGGTTACA AACAGCCGTA CGAGCCTTTG GACTTTAAAT ACCCTGCGAC GTTTGCGCCC
5881 CCACTTCAGG TGCTCATTGA GGCGAGCAAT GGCGCCTCCG ACTACGGAAA TAAGTTCGGC
5941 GAGCCAGTGA TCTCTGGTTT TGCCCTCTCC TATGGACTGA ACAGTGCTGC CGATGCCAGC
6001 CAGCGGGATG AGTACGTGAA ACCGATCATG TTCAGCGGTG GCTTGGGCAC CATGCCCGCT
6061 ACCATGCGCG AGAAGCTGCC GCCGGCACGC GGTCAGTTGC TGGCCAAGAT CGGGGGCCCA
6121 GTGTACAGGA TTGGAGTGGG TGGCGGCGCC GCAAGCTCTG TGGAGATACA AGGATC
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Appendix 2: List of ESTs with similarity to slmo.
Species EST Name GenBank Accession
Ancylostoma caninum pa35e01.y1 BE352448
Anopheles gambiae 4A3B-ME-D-07 -R AJ284971
A. thaliana AV549314 AV549314
Bombyx mori AUOO0429 AUOOO429
Bos taurus 1A10C08 BG467246
Bos taurus AV616134 AV616134
C.elegans C71074 C71074
Ciona intestinalis AV672110 AV672110
Ceretopteris ricardii Cri2_8_P09_SP6 BE643491
Danio rerio fb04b02.y1 AI330985
Dictyostelium discoidum AU076350 AU076350
H.sapien 601437019F1 BE893122
H.sapien 601561340F1 BE728046
H.sapien EST390625 AW978516
Lycopersicon esculentum EST303596 AW218413
Meloidogyne incognita ra44b02.y1 AW829756
M.musculus ue18h06.y1 AI036726
M.musculus vb09b11.r1 M272853
Oryzias latipes AV668326 AV668326
Oryzias /atipes AV670130 AV670130
Oryza sativa AU057724 AU057724
Phytophthora sojae 7-11F-MY BE583294
Pinus taeda ST28D02 AW043024
Solanium tuberosum EST427241 BE923472
Strongyloides stercoralis kp55g09.y1 BE224559
Xenopus laevis db31a05.y1 BE026022
Xenopus laevis b138f03.w1
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Appendix 3. Phylogeny of the Simo family of proteins (2000).
,---- Ceratopteris ricardii
ri54.__-- Pinus taeda
,...-------1 100
,...---- T19LS_30 (A. thaliana)
.__-~185
I.____ Lycopersicon esculentum
,....--- Slmo (D. melanogaster)-----i 71
'__--FISD3.6(C. elegans)
,...----178
,...--- X laevis
f--- 70
.__-----I 97 ,....--- COI-I07 (M musculus)
'__---II 100
I.__ COI-to7 (H. sapien)
,....--- SPBC36.10 (S. pombe)
,...-------1 96 ,...---- MSFlp' (S. cerevisiaei
-61
'__--YDR18SC (s. cerevisiaey
'__---IIOO
,....--- YLR193C (S. cerevisiae)
,----1186
I._____ SPAP8A3.l0 (S. pombe)
.___~ 81
,....--- B0334.4 (c. elegans)
'--- 47 C08806 (D. melanogaster)
- 68 px19 (Gallus gallus)
'---- 57 Pre li-like (X. laevis)
'-----196
,...---- Preli (M musculus)
'-----II 100
L.____ PRELl (H. sapient
,---- T230S.2 (c. elegans)
'__--I181
I.____ C09S28 D. melanogaster
Phylogeny was generated from a ClustalX protein sequence alignment by Neighbor-joining
using the PHYLIP package (Felsenstein, 1989). Bootstrap values were calculated using 100
replicate data sets. Evolutionary distances were calculated using the DayhotTPAM matrix.
Appendix 4.
LOCUS
DEFINITION
FLYBASE ID
ORGANISM
pre] (CG8806)
pre] gene region (2041bp)
FBgn0033413
Drosophila melanogaster
1 GCACACGCAC CATCTGGCAA CTTTGCGACC AGATGTTTCC GGATGGCCTT TGAACAGGCG
61 TAAATTGTAT CCAAATTGGC AGCAAACCCT TGGAAAGCAA GCAATGAAAC CGTGTACAGA
121 CAGGAGAAGG GGGCACTGAA GGTCGAGGCA ACGCAGGAAT CGAGGGATAT CGCCAGCAAA
181 TTGCCAGAAA TTGAAGGTAA CGAACCCGAA GCACCCTGTG CCGGAGTTTG TGACGCAGTT
241 ACACAACTAA ATTCTTAGTA GGCGCCCAAA GTCGGGGCAA CAACAAGCTG CTAGCTGAAT
301 CAACGTGTGC CAGCTAATTG GTGCCAATCA CACTGCACTC TGGAGCTCTA AAACCGTAAG
361 AGACCCCCGT TCTTGGACCC CCTCGCAAAG GTACGTCCAT CGATTCGGCG ATCTATTTTT
421 AGCCGGAAAC ATGCGATTGC TATTGATGAT TATCGGTTTA TTTTTCAGAT CAGGGACACG
481 GCGGCTTTCA CTTTCGAACA CATCGGCGAG TTCATTGGTC CACCTTCAAC ATGGTCGTGG
541 CAGCATCCAC CTGCCGCACG GAGACGGTCT TCGATTACAG CTGGATGAAC GTGGTGGTCG
601 CCTACTGGAA CCGCTACCCG AATCCCTCAA GCACGCACGT CCTCACCGAG GACACTATTC
661 AGCGGGAGGT GCGCGATGGC AAGCTCTTCT CGCGCCGGCT GCTCTCCAAG ACGAATCCGG
721 TGCCGAAGTG GGGAGCTCGC TTCTACAACA ATGTGCCGGT CAAGATTGTT GAGGACTCCG
781 TGCTGGACCC GGTTAAAAAG ACATTCACCA CTTTCACCAG GAACCTGGGA ATGACCAAGA
841 TAATGGCAAG TGATCGCACA CCTACTACGA TTGCTTTAAA TAGGTCACAT ATCAATTTAA
901 AGAAATGTCT AGAAGAATTC AGCCACTAGC TGTTGGGCAT GACCGAAATA CCGGCATAAT
961 ACAAAAGCAT AAGTGTTACC TAACAGATCG ATGGTCAATG CTGTGGCATT GTTTGTTATA
1021 TTTAACCCAT GAAACGCATA CAGAACATCG GGATCCGGTT AAGATTATTG TTCGATTTAT
1081 TTTACTGCAC CCTTTTAGTG AATATGTGAA ATATGTTACT TAATCTTTTC AAGTTTAATT
1141 TAATCCTAAT TAATGATCAT TGTTTTTTCC TTTTAGAAAG TCGATGAAAT TGTCGTCTAC
1201 AGCGAGCAGA AGGATGGTAG TACTCTGGCG GTGCGAAGAG CATACATTAG TTCGCAGGTG
1261 TTCGGATTCT CGCGGGCCAT TCGCGCCTTC GGCATCGAAC GGTTTAAGGC CAATGGCAAC
1321 AAGGCCTCCA ATGGATTCAA CTACGTGCTG CGGCGCATGT TTCCGGACAG TTTGGTTGGT
1381 GGAGGACATC ACCAGCACGC GGTGACGACG ACTTCGCCAG CTGGAGAACT TCCTGCAACG
1441 ACCATCACCG TATCCACAAC AAACGGCAGT CTCAACAACC AAGGAGCTCT CAAGAGCGCC
1501 GCAAAAGTGG GCTACGAGTT CTTCAAGAGT CATGCCTCCA AGATTGCGCA ACTGTTTTCT
1561 GTCAAGAACT GAGGAACTTC TAGTCTGTAC TTTTTGGAAT AGATGTCGAA TGGGACCGAA
1621 GATTTTAATG CTTTCGGCTC CGGGAGTTAA GGAGTTTGTG GATTTGACCA GGACGGAATT
1681 AGAATGACGA GCGGAGGAGT CGTGTCGCCG GGTGTTTTTA AACATTTATT CCAAAGCAAA
1741 TCCAACTACA TACTTTGCTG CATTTCATTC CGTGTGTGCG CGAATCAAAC GGCTGATCTG
1801 AACGGAGACA CAATTTGCTG AACACATTTC CTGCATGCTA CCAAATTCTA TTATTTATCG
1861 TTACTTATTT GCACTACATT ATTATGTATC ATTCTGTTAG GTCAAGAGCA GGAAATGAAA
1921 AGCCGTGTCA AAATTGGTAT TGCTATGTAA TATGTTGTAT ATTTTTATCA AAATATAAGA
1981 AAACCAACAC TTGTAGTGGT TAAAAGTGTA GTTATTAAAA TAAACTTAGT CTGTTAGAAA
2041 T
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LOCUS
DEFINITION
FLYBASE ID
ORGANISM
retm (CG9528)
retm gene region (7134bp)
FBgn0031814
Drosophila melanogaster
1 ACACCATTGG CGTCTGTTAA TCAAACTCGG AGAAAGGCTT TCTCTGTTTT CCACGGCCAG
61 GCGGTTCTCT AGAACTCCTA CGCTAGGAGC CAACGGATAC CAGACACAAC TCAGTGAAAT
121 AAATAGCAGT GGCGTGAACT GTCACGAGCA AAAAAACAAA CCCAGCTCGG TATTCCAGTG
181 CCCAAGTTTG GTCACCTTCC CCGCCCCCGC GCGCTCATTA TACTGCAACG GAAAAGCGCA
241 GAGTGAAAAT TGATTTTTTA AACAGTGCGA ACTCCACAAT CAGTGCAACG AAAATTTGAA
301 ATAAAAAACA CGGAACGGAC GATTGAAAGG CAGCAAGATG GTGCAAAAAT TCCAGTCACC
361 CGTTCGCGTC TACAAATATC CTTTTGAGCT GGTGATGAAG GTGTGTACAT TGCATTTTCC
421 CCTCTCCATT TCGTCGTGTG GAGTGGGCGG CCTTATAGGC GTGTCCCACT GCCTGTTTAC
481 ACATACCCAT CAATTTAAGT TTAAATTGTG CATTATGCGA TGGCATAGCC ACTAATTCAC
541 TGCGACTCGC AAAGGGTCGT TGTGTATCGT TGTTTCCGCT CGGACACAGT TGCTTCATTT
601 ATTCAAATCC AAGCTGCAGA TAAATAAAAT TAACCTTGGA CAGCAATTCC TCCCCCCGCC
661 CAACATGCTC TCTCTTTCGC AGTTGCGCTC GAAGAGCGAG ATAGAGATAG ATTCTTTATC
721 CAATTGAATA ATACACACTG CATGTACGTG TGCGTGTGTG TGCGTGTGTA AATAGTTTGT
781 CGGTGGGAGG GGGCGGTTTG GTTGAAACGA CTTGTTTGTG AATTTTTCAT TTATTTTTAT
841 TAATCTACTG ATTGTTTGCG TCCAGCTTTG CGTTTTAGTC TCATTTATGC CATAGAAATT
901 TGTTCTTTTT TTAATGCTGT TAATTTACAT AATGCGCCTT TTTGAATGTA TTAACATTTA
961 TCGTAAATTA TCGAAATTGG GGTTATAAAT TTATAAGATA AAAAATGGTT GTCTTTTTTA
1021 TTGAAGCTTT TCCTCCCTCC TACCTCTGTT TCCTTTGCAA ATCATTTTAT TTTTTGCCTT
1081 TTCACTGACT GATAAGAAAA CGAACTGTTT TTTACTTCAA AAGTTTATTT AAGCAACAGA
1141 AATCACTTCA AGTGCCGTTT TTTGTACTTA AAATAACTAT ACAGTCATAT ATTAGACTAA
1201 AAGTGTAGTC CAAACACAAA TCACCTAAAA TGAAAAGCCT ATTATGGTTA TTCGATACTT
1261 TGAGTGTTTA TGTATGTTTT CCCTTGTAGA CAGAAGTAAG AAAGCGCTTT TCGTGACAGA
1321 AACTCAAAAG TCTCAAATGT CAAAGGTCAA ACATTTATTC TACGTACGTC ACCGACAGGG
1381 GTAATTTAAA TTTAAGCAAC ATTTATGAGC CGCACGATAG GACACCTGTC CACTCGCATG
1441 TCCCCAAAGA TGCAGGCAAA GTTCCAGCAT TTTAGACCAT TACCGCCCGC CAGGACAATT
1501 AAGAAAGCCT ATCTGAATAA TTAAGGACAC CAGTGCCAAC TACACAGTTT GCTAGCTGGG
1561 TCTGGGAAAA ATATGGATAT TGTAAGACAT GTCCATGTGA GGTGAGGAGT CGCCACGTGT
1621 TGGATGGCTC CCACCGCACA CTGAATTATT CAACGTGTGA ATATCCACAT GAATATCATC
1681 ATGAATATCC ACACAGCGAT TTATGACCTT TGCACTAGTA ACAAGGACTC GCAACCACTA
1741 GATAGAATTA TGATTTGGAT TGCACAATTA TCGATATGGA AAATCTATTT TTGATTTTCA
1801 TTGTTTATTG CTTGCAAACA AGGTATGGAG TTCAAACGCA ACAAGAATAA GAATAGATCT
1861 TGAGCAATAA GAACGTATTT TTCCACTGTC TTAAGAATTT TACATTTTTA AACCCAACAA
1921 TTTCATGAAA ATAGCGAAAT ATTATATGCA AAAGAACACG TTTGAGTATA TTATTTCAAT
1981 TGTATTGATT TGTTCAATCA GCAACCAATT TTTGCAGCGA TTAGGTTGTA TTCTAAATGA
2041 AAAGCTTTTC AACTGCGCAA ATTTTTGATA CAGCGATAAT TTTCTACTTT TGACCGATCA
2101 TTGATTTGGG TCCTATATAA TATAGTCGTG TTGATCAGCG GTATTTAGCA TGCATGAATG
2161 GAGCTATTCT AAGTTTTGTT TATAAGTAAA TGTAATTTTT TTTGCTAAAT ATATTTAGCA
2221 ATTTCGGAAT TTGCATTTAT TATATATGGA AGAAAACACA AGTAAACAAC ATTTTCAGGC
2281 ACTGCTCTCA CCTGCTTAAA TATTGCGCTT TTGCGTATTT ACGCCATACC CAAATAAATA
2341 ATCAAAATAA ATGTGCGTCT GCGAATTGAG TTAAAAATCC ATCACTCATA CGCGCTGTTG
2401 ACTTTAATCA AAAAGTTTTG TACTTGCAAA TATGCGATGC TTCTTTTTTG CTATTAAATA
2461 ATTATCTATT TAGTATAGAA ATATGTATAT TATAGATTTA TATAAAATAT AGGAAACAAC
2521 ATTTCGCAAC CGCCCTAATA ATTTGACCTT TTTCATCGAA AACCCAGGCA CGATTGGCCA
2581 AAAATAGACC TTCGAAATTG TTAAAGGCTT CTGAGACGTT GGCTGCAATC TGTGACGGAG
2641 GATGAGCAAA ACGGGGCGGG ATGGGGTGCA TGTACATAGA TGGCTGCAGG GCCAAGTTAT
2701 AAATTGGCCA GCGTTCAAGG TCGCTTGGCA GGGAACCGGA ATATAGAAAA TAAATACATA
2761 CACTTACCAA AACTGTTGCT AGCAATTTGA ATTCACTAAA TACTTAGCTA TCAAAGAGAG
2821 TCCTTAAATA TACATATTCA ACATACATCT AACTTATTAT CCTCGTTGCT ACTGCAGGCC
2881 TATGAGCGGC GGTTTCCCAC ATGCCCGCAG ATGCCCATCG TCCTGGACTG TGAGGTCATT
2941 AAGGACGAGT CCCTGGAGGA CGGGGCCAAG CGAAACACGA GCCGACGCTG CAAGCTGGCG
3001 GTCGACGCGC CGTACATCTT CAAAAAGCTT ATTGGCGTGG ACCATGTGTA CTTCCTGCAG
3061 CACAACTTCC TGGACCTGGC CAACCGCACG CTGAGCATCG AGGCGGTCAA CGAGAGCTTC
3121 TCGTCGCGCA TCGAAATCTT CGAGCGGTGT CGCTACTACG CCCATCCGGA CAACTCCGAA
3181 TGGACGTGCT TTGACCAGTC GGCCACGCTG GACATTAAGA ACTTCTTCGG CTTCGAGCAC
3241 TCGATGGAAA AGATGGGCAT GAAGCAGTAC ACCCAGACGA CGCTGAAGGG CAAAGAAATC
3301 ATTGAGTTCT TTATCGGGCA GCTGCGCGAG GAAGGCATCA CGCATGTGGA GCGTTGGACA
3361 TCGCCCAGTG ATGCAACCAA ATCGCCAACC CTCGATCAGG CTTCGGATCA GCAGCATAGC
3421 ATCTTGCTGG ACGGCGACTT TATCGCACGC AGCCTGGGCC AGCTGTCGCC CATGCAGGAG
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3481 TCCAAGCTGC TGGAGCTGCG AAAAATGCTG GATGGTGTCG ATGACTTGGA GCGTGTGCCC
3541 AGTTATCAGA CCATCCTGCG TTTCTTAGCA GCCAGGGACT GGCACGTTAG CCAGGCCTAC
3601 GCCATGCTCT GCGACTCGCT TCGCTGGCGT CGGGAACATC GCATCGACGC ACTGTTGGCG
3661 GAGTACTCCA AGCCAGCCGT GGTAGTGGAA CACTTTCCGG GCGGCTGGCA TCATTTGGAC
3721 AAGGACGGTC GACCCGTTTA CATTCTGCGC CTGGGACACA TGGACGTCAA GGGCCTGCTA
3781 AAGTCACTGG GAATGGATGG ACTACTGCGA TTGGTAAGCA AGCCGGCGGA GAACTTATCG
3841 CTGAGATTAC ATTTTAAACA ATATGCTGTC TGTCTATAGG CTTTGCACAT CTGCGAGGAA
3901 GGCATTCAGA AGATCAATGA ATCCGCCGAA CGCCTGGAGA AGCCAGTTCT CAACTGGTCA
3961 CTGCTTGTCG ATCTGGAGGG TCTTTCTATG CGCCACCTCT GGCGTCCCGG CATCAAAGCC
4021 CTGCTCAACA TCATCGAGAC TGTGGAGCGC AATTACCCAG AGACCATGGG CCGTGTCCTA
4081 GTGGTGCGAG CGCCCAGAGT GTTTCCCATT GCATGGACAA TCGTTAGTGC TTTTATTGGT
4141 GAGTCTGAAC AAGCCGTCAT ATGGAATTGC CTGTTAACAA CGCTTTGAAA TCCTGCAGAT
4201 GAGCACACCC GATCCAAGTT CCTGTTCTAC GGCCCCGACT GTGCGCACAT GAAGGATGGC
4261 CTGGCCCAGT ATCTCGACGA GGAGATTGTG CCTGACTTCC TGGGCGGACC GTGCAAGGTA
4321 AGCAAGCAAG GCGGCAGCCA CGACTTCCGG TAGCGCGTCT TCGGTTGGGA GCCCATTACT
4381 GCTGCATCTG TAGCAACGTA CTTACTATAT TATGTTATTA TTGTATATGT GCGTTAACTC
4441 TCTATCCCTC TGGTTTCGGC CTTGATTCCG GCTCGCTGGG GCTGCTCAGA CAGAGAACCA
4501 GCTAGTCTCG CATGTGGAGC AAGTCAGTCA GAAATACTTT AGCCATTGTT ATTTAACCAA
4561 ATGCGATTGT GTAAGCATCC TACTCTCTTG TTCTTTTGCT CCTGCTCTCG ATTTCGTTTG
4621 TCACCATCCA CAACGACAAA TTGTACTGTA CTCGTCCGCC TTTGTCTTAC TTCCTCGTTT
4681 TTGTTTCTCA CACTTTGTTC GCTGTGCGGT TCTGTTGCAA ACTGTGTCAA GCCCATGTGC
4741 GCAGCTTAGC CATGACATTC CTGCTGTAAT ATTTCCTCCA TTGTGCCCCA GCGTCCATGT
4801 CCACGTCACT TAATCTCTCT GTTCACCCGG CGGCTGTCAT ACATGTGCTC AGTCCAAGCC
4861 AACAGCCACG GAGCCTGCCC ACCAGAAACT GCTCTAACGT ATTGTCCTCT TTCCACAAAG
4921 ACCATGATTC ACGAGGGCGG ACTGGTGCCT AAGACGTTGT ACAAGATGAA TTCGCTGGAG
4981 GATCACGACG ACGAAGTGAC CGCCGAGCTG CCCACCACTG CCGCGGCACA GGCTTTGGTT
5041 CCAGGCAAGC GCCTGTCTGC CAACCAGCAA CACGATCATC GCAATCTGTA CAAGAGTGTG
5101 GATCTCAAGG CCGGATTCGC GCACGAGCTG CTCATCCGGA ACGAGGATCC CAAGAGTGTG
5161 CTCACCTGGG ACTTCGATGT GATGCGCAAC GATCTGCACT TTACGCTCTA CCGGGTCACC
5221 CAGGAGCTTC CGGAAAAGAA TGGTGAGTTA ATAATGCACT TACAAAAGGT TTTCATGTTG
5281 CTTTTTGTTT TTCTTTTGTT CTGAGAACTG GTTTTGGTTT CAAAGGTGCG AATATCACGA
5341 TGTTGTTGCC TCATTAGAAG TTGTTTTTGT TTACTTAGCA CTTTTATAAA AACACAAAGC
5401 CACGATAAAA AGCGAAAAAT GCGGAAAGTG GAAACTCTTA CACCCTTTCG AAAAGAAAAG
5461 AAAATTTGTT GTCAGGCAAC TTAAAAACAA ATTAATAACG TTTGGCTTAA ATTGAATAGT
5521 TTACTATTAC AATTAAGTAT TAAAACGTAT GTTAATTTGT GTATATATTT ATTTATATAA
5581 ATTTCCAAGG TATCTGTTGC TAGGGCTCTA TTAAATTGAT AACGCGCGCA TTTTGGTTCC
5641 GGTTTATTGA TAGGGATTGC TTTTCATATG TGTTTTGATA ATGTAGTAAA ATACGAAAAA
5701 GTTGAACCTT ATTTTATAAA GCTTTTTGTA CTTTGAACCT TTTAATTAAT TAACTTGATT
5761 AGCTTGACAG CTTACATATA ATTAAATGCC CTTCGCCCAC AGATTCCGCC GTCTCGTACT
5821 TTGATCTGCA GGACTTCGTC GAGGGCGTCA ATTATTTCCG TGAGGAGCCA ACGCTGATTT
5881 GCCGGCACAA GGAGAGCGTC CAGGGGTCGC ACGTGATGCA TCACAACGAC AGCTATCTTA
5941 TGCACTGGTT TAGTCCATCG GGTGCCCAGT TAAACGTCTT CTACGAGGTG CTCAGCTCGG
6001 CCAACTACAA GGGTTCGATG ACCAGCCTGC AGTCGGCATT CTCATCGAAC TCGTCGGCGG
6061 CCAGCTCGGT GCAGAGTCGA TGATATGAGA AAGCCGGGGA TGGCGGAACG AACGGCGCCG
6121 AATGGAGATC CCCGGCATTG GAGGAGCCCA TAGCGGCGGA CATTCTCACG GGCACCCTGA
6181 TGGAGAAGAG CCTGAATCTA TTTGAAACGC CGGACGTATT CTTTTAAGAC CGAAAGTGGT
6241 AATATCTTGT GTTTTAGTTG TCTTTAGTTG TTTAGCAGAA TGTTAGTTTG ATTTTAAATT
6301 GTATTTAGCT CAAATAGGCC ATTTATTTCC TTTTAAATTT ATTATATTCA TTCAATATAT
6361 ACAAGCATTC ATATTATTGA TAATCTTAAG AAAATTAGAA ATATCAGCGG TTTAAATGAG
6421 CAACACCAAA ATATCACGCA ACGTTTTATT TGAATCGTCA ATTTGAATTT TTCGTAAGCA
6481 GCTCTATAAA TGAAGTTTTA ATGCGTACAT ATATATGTAA AAGCGACGTA ATTTTTATAG
6541 CTTTTTCTAA TGGAACATTT TTTAGCAACA ATTAAGGAAC TTATTGCGAT TGCGCAGCCA
6601 CTGAAACGAA AATAGAAAAA ATTGAAATTG TAATCAATAA CTACGTGTTA CCTAATTAGT
6661 TTAATAAACA AATTGCCGAA ATGGCTTATT GCAAGGATTT TAGCCAGAAC TTATACAAAA
6721 GAGTGAAATG TAAGATTTGA ACTCGAAATA CACACGTAGG TTATAGCTAG ACGTCAGATT
6781 ATAATTATAA ATGTAAAATT GTATTTTAAA CATTCGAATG CAGAACGTTT TTGATTGCAC
6841 ACTAATTACC CCGTCATTTG TACGCCCTTA ATTGCTAATA TCAATCAATC TCCAAAGTGT
6901 TTTTAAAATC AAAAAAGGCA ACTTCAGTGT GTTTTTTTGG TTATTATTTA TTGTATTAAA
6961 AACGAATTAC TATGCGGATG TTTACAATTT AGTTTTATAA ATAATCTGAC GTGTATTGTA
7021 AGAATAAACT GACAAGCCAA TAACGAAGGA AAAATGAGTG CATGTTAACT AAGTGTGTAA
7081 GTTGTATTAA GAACGTAATC AAATAAATGC TATTAGATCA ATTACATGTA CATA
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Preliminary behavioural analysis of retmA69 deletion mutants. For all behavioural assays,
male and female retmM9 homozygotes were tested separately and compared to CS wild-type
controls. All assays were performed during the first four hours after subjective dawn. n=20. A.
Spontaneous locomotor activity. Flies were mouth-pipetted and placed individually in a clear
perspex IOcm x 10cm maze marked with a Iern- grid. After 5secs for acclimatisation gridl ines
crossed in the following 30secs were counted. B. Inversion assay was performed immediately
following the locomotor activity test. Singly, flies were knocked supine and the time taken to
return to an upright position measured. C. Post-shock spontaneous locomotor activity.
Immediately following the inversion assay, locomotor activity was tested again using the same
method as in A. No significant differences were observed between mutant and wild type in any
of these behaviours.
